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Abstract
In 2012, the first pharmacological HIV preventative agent, pre-exposure prophylaxis (PrEP) was
approved in the U.S. for individuals at high-risk of contracting HIV. Men who have sex with
men (MSM) are at increased HIV risk, due to their engagement in anal intercourse (AI), which is
the most common mode of HIV transmission and the riskiest type of sex. Although evidence
indicates that most PrEP paients are MSM, a paucity of evidence exists on MSM’s PrEP initation
decision-making process. The purpose of this study was to explore how HIV-negative MSM
engaging in protected or unprotected AI decide to initiate PrEP based on the evaluation and
perceptions pertaining to their: (a) PrEP knowledge and HIV risk(s)/concern(s); (b) personal and
social motivations to initiate PrEP; and (c) behavioral skills and abilities to adhere to PrEP.
Guided by the Information-Motivation Behavioral (IMB) skills model, a six-item questionnaire
was constructed and used to conduct one-on-one semi-structured interviews. Fourteen MSM
(71% African-American) living in the Southern U.S. consented to an interview between March
and August of 2018. Several themes emerged from the inductive content analysis, and these
themes were categorized into five broader concepts: (1) acknowledged HIV-risks, (2) HIV
concerns, (3) PrEP understanding, (4) PrEP accessibility, and (5) PrEP consideration. On further
analysis, the data revealed the PrEP Initiation Decision-making (PID) model, a conceptualization
of this sample’s non-linear thoughtful process of weighing and evaluating their perceptions and
attitudes surrounding these five factors in deriving at their decision to initiate PrEP. The findings
give insight into the PrEP initiation decision-making process of an HIV-vulnerable population.
Knowledge of patients’ rationale and decision-making process for initiating PrEP allows nursing
professionals to provide in-depth PrEP patient education, ensuring that patients receive accurate
and complete PrEP information including the (1) relationship between adherence and efficacy;
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(2) utilization of traditional risk-reduction behaviors in conjunction with PrEP; and (3) the
availability of financial assistance programs. This study’s evidence is foundational, establishing
a knowledge base for PrEP initiation inquiries in the MSM and other PrEP patient populations in
the U.S.
Keywords: HIV prevention, MSM, HIV pre-exposure prophylaxis, PrEP, decisionmaking
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Exploring Men who have sex with men’s HIV Pre-exposure Prophylaxis
Initiation Decision-making Processes in the Southern United States
Chapter 1: Introduction
The incidence of human immunodeficiency virus (HIV) in the United States (U.S.)
disproportionately affects men who have sex with men (MSM). MSM make up less than 3% of
the U.S. population (Ward, Dahlhamer, Galinsky, & Joestl, 2014), but represent 56% of people
living with HIV (PLWH) (Centers for Disease Control & Prevention [CDC], 2018a). Despite a
national HIV incidence decline of 19% between 2005 and 2014, MSM’s incidence rose by 6%
during that same nine-year period (CDC, 2016c). Additionally, fifty thousand new cases of HIV
are reported annually in the U.S., and MSM continually account for majority of these cases. In
2016, MSM accounted for 82% and 67% of new HIV infections among men and nationally,
respectively (CDC, 2018a). MSM’s HIV incidence rate is 44 times higher than in men engaging
in heterosexual intercourse or injection drug use (IDU) and 40 times higher than in women
(CDC, 2016d). If the incidence continues at the current rate, the CDC (2016c) estimates that 1 in
6 MSM will contract the virus in their lifetime.
HIV is the virus that causes acquired immune deficiency syndrome (AIDS), an incurable
and potentially fatal disease. AIDS' morbidity and mortality occurs when the virus proliferates
in the body, attacking CD4 cells (Fan, Conner, & Villarreal, 2014). CD4 cells are important
white blood cells that fight infections; a depleted or low CD4 count damages the body's immune
system, increasing one's risk of acquiring and dying from an AIDS induced opportunistic
infection or complication (Fan et al., 2014). Advances in HIV treatment through antiretroviral
therapy (ART) reduces HIV/AIDS related morbidity and mortality, as it works to decrease the
viral load, the amount of virus circulating in the body to a low or undetectable level (AIDS Info,
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2017b). A low or undetectable viral load is imperative for PLWH to live a long and optimal
life. ART increases life expectancy, as data show that between 2000 and 2007 the number of
years lived post-ART for PLWH increased from 36.1 to 51.4 years (Samji et al., 2013). Barring
additional co-morbidities, PLWH diagnosed and treated early and consistently with ART have a
life expectancy equivalent to those of the general population (Nakagawa, May, & Phillips, 2013;
Romley et al., 2014; Samji et al., 2013).
Unfortunately, not all PLWH achieve this optimal outcome, as in the absence of ART,
HIV progresses to AIDS. Data show that only 30% of PLWH have a low or undetectable viral
load count (Center for AIDS Information and Advocacy [CFA], 2015; CDC, 2016b, 2016f), and
this statistic contributes to the HIV/AIDS related mortality apparent in the U.S. AIDS still
claims the lives of 13,000 people each year in the U.S. (CDC, 2016c; Fan et al., 2014). Similar
to the HIV incidence, no other group is affected more by AIDS than MSM. MSM accounted for
54% of AIDS diagnoses in 2014 (CDC, 2016c), and since the start of the epidemic, MSM have
accounted for more than 360,000 (CDC, 2017b) of the 675,000 AIDS deaths (CDC, 2016f). HIV
prevention is the key to decreasing AIDS deaths, and the current and predicted HIV incidence in
the MSM population (CDC, 2016c; Fan et al., 2014).
The MSM population experiences significant HIV burden and vulnerability. MSM’s
sexual behaviors are the primary catalyst driving their HIV incidence disparity. MSM are men
who engage in anal intercourse (AI), protected or not, with other men, and most MSM report
engaging in protected and unprotected AI (UAI) (Meng et al., 2015). Although MSM are also at
HIV risk when engaging in oral sex with men and women, vaginal/AI with women, and IDU, AI
is the greatest risk factor for contracting and transmitting the disease. Overall, AI in MSM is the
most common mode of HIV transmission, as IDU accounts for the smallest percentage of new
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and existing HIV cases (CDC, 2016d). Additionally, AI is the riskiest type of sex, as HIV risk
with AI is 18 times higher than vaginal intercourse (CFA, 2014; Pebody, 2010). HIV risk is
significantly higher because rectal tissue is fragile and thin that easily tears during AI, which
allows viral transmission through rectal tissue and penile openings, scratches, or sores (CDC,
2016a). Although both partners are at high HIV risk, the receptive partner has an HIV risk 6.2
times higher than the insertive partner (Meng et al., 2015). Therefore, accurate and consistent
condom use is the best defense to prevent new HIV infections (CDC, 2015c, 2016c). During AI,
male condom use significantly decreases HIV risk by 63% for the insertive partner, and 72% for
the receptive partner (CDC, 2015c). Unfortunately, MSM's condom use adherence is an ongoing
challenge; a secondary analysis utilizing data from two previously conducted prospective studies
sampling HIV-negative MSM concluded that only 16% of MSM report consistent condom use
with each sexual encounter (Smith, Herbst, Zhang, & Rose, 2015).
MSM HIV prevention efforts have focused on interventions promoting individual
behavioral changes in both HIV positive and negative persons (CDC, 2015a). Using peers or
health professionals in virtual or in-person settings, individual interventions provide counseling
and information about utilization of HIV risk-reduction behaviors through problem solving and
skill building (CDC, 2015a, 2017a). In addition to consistent condom-use, other risk-reduction
behaviors include decreasing sexual partners, serosorting (having unprotected sex only with
persons with the same HIV status), avoiding sex cognitively impaired, substance abuse
treatment, and abstinence (Caceres et al., 2015; CFA, 2014; CDC, 2016c). For the purposes of
this paper, the investigator will refer to the aforementioned behaviors collectively as traditional
HIV prevention behaviors. A combination of traditional behaviors is recommended for optimal
HIV protection (Caceres et al., 2015; CFA, 2014; CDC, 2016c). Interventions targeting
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individual behavior changes are best practices to increasing MSM’s and other individuals’ riskreduction behaviors (CDC, 2014a). Despite these best practices, the MSM HIV incidence rate
and epidemic are a public health concern. As a result, HIV scientists and researchers developed
a new preventative modality (CDC, 2014b).
HIV Pre-exposure Prophylaxis (PrEP)
In July 2012, the U.S. Food and Drug Administration (FDA) approved the first
pharmacological HIV preventative regimen. Pre-exposure prophylaxis (PrEP) is the fixed daily
dose of Truvada (emtricitabine and tenofovir disoproxil fumarate) in HIV-negative persons 18
years of age and older (CDC, 2014b), and in May 2018, the FDA approved PrEP for adolescents
and persons under 18 years of age weighing at least 35kg or 77lbs (CDC, 2018b). Truvada is a
nucleoside reverse transcriptase inhibitor (NRTI), initially approved in 2004 for HIV ART;
however, Truvada as PrEP is used for HIV prevention to reduce transmission risk (CDC, 2014b).
Clinical trial data showed that in the event of an exposure, PrEP is efficacious, reducing the risk
of HIV seroconversion by as much as 92% (CDC, 2014b), but it has limitations. Adherence to
the daily regimen is necessary to achieve optimal efficacy (CDC, 2014b; Koenig, Lyles, &
Smith, 2013). Additionally, Truvada does not provide invincibility to HIV transmission;
therefore, PrEP is a complementary regimen, recommended to be used in conjunction with other
traditional HIV risk-reduction behaviors, especially consistent condom use (CDC, 2014b).
PrEP is clinically indicated for HIV-negative persons with reported and documented high
HIV-acquisition risks (CDC, 2014b). Due to MSM’s HIV incidence and vulnerabilities, MSM is
a population with PrEP clinical indications. Specifically, PrEP is appropriate for MSM when
their sexual history confirms: (a) one or more bacterial sexually-transmitted infections (STIs) in
the past six months, (b) multiple sex partners, (c) inconsistent or no condom use with vaginal or
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anal sex, (d) work as a commercial sex worker, (e) involved in a serodiscordant relationship, or
(f) frequent non-occupational post-exposure prophylaxis (nPEP) treatment (receiving ART after
a suspected or known sexually related exposure to HIV) (CDC, 2014b).
PrEP initiation has remained slow nationally (Mayer et al., 2015; Siemieniuk et al.,
2015). Utilizing a representative U.S. sample, the CDC (2015d) determined that 25% of MSM
have PrEP indications. Gilead®, the pharmaceutical maker of PrEP, surveyed U.S. retail
pharmacies about the number of patients that filled a PrEP prescription for the first time during
2012 to 2015 and found that most patients initiating PrEP to be male (76%) and White (74%)
(National AIDS Manual [NAM], 2018). Additional data indicate that most current and former
PrEP patients are MSM (Krakower et al., 2015; Rooney, 2013; Tellalian, Maznavi, Bredeek, &
Hardy, 2013), but that only accounts for a small percentage of this HIV-vulnerable population.
Data show that approximately 3% of the MSM population are, or have initiated PrEP (Krakower
et al., 2015; Krakower & Mayer, 2015; Tellalian et al., 2013). These descriptive statistics
regarding PrEP patients confirm that despite PrEP’s indications and efficaciousness, initiating
the complementary regimen is an individual choice and decision.
Problem and Purpose Statement
PrEP initiation decision-making processes are unknown in MSM or any population.
Decision-making details what and how individuals consider and evaluate the different factors
surrounding a choice or option (Poortaghi et al., 2015; Popejoy, 2005). The purpose of the study
is to apply qualitative methods to explore PrEP initiation decision-making processes of HIVnegative MSM engaging in protected or unprotected AI. Qualitative research is necessary when
the study’s purpose is to understand the meaning of a human experience in the terms and
perspectives from the people experiencing the phenomenon (Creswell, 2013; Lo-Biondo &
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Haber, 2014). Congruent with qualitative research, this study explores the factors and process
that influence this population’s decision to initiate PrEP based on what they know and perceive
about PrEP and their HIV risk(s)/concern(s).
Background
Despite FDA approval of Truvada as PrEP in 2012, a paucity of literature exists about
MSM's PrEP initiation decision-making process. Most research on MSM and PrEP pertain to
gauging their interest in initiating this complementary regimen. The literature documents
MSM’s interest in initiating PrEP to arise for different reasons. MSM perceive PrEP to be a
form of proactive prevention (Oldenburg et al., 2016), which is more effective than reactive
prevention (i.e., nPEP treatment) (CDC, 2014b; Siemieniuk et al., 2015). Research show that
MSM believe PrEP is empowering, as it provides added HIV protection (Brooks et al., 2012;
Collins McMahan, & Stekler, 2016; Taylor et al., 2014). Pertaining to MSM's PrEP initiation
decision-making, limited data exist. Inquiries about MSM’s PrEP initiation either are few in
numbers or conducted in the hypothetical context of PrEP (Hoff et al., 2015; Koblin et al., 2011).
Currently in the literature, two publications explore some aspect of MSM's PrEP initiation from
actual patients; however, these studies only confirm that MSM initiate PrEP to prevent
contracting HIV (Garcia & Harris, 2017; Parker et al., 2015), as the processes determining how
MSM came to the decision is not known. Given MSM’s HIV prevention challenges and PrEP's
efficacy, knowledge of MSM's PrEP initiation decision-making processes is necessary to
understand this population’s most important and valued factors motivating and determining their
initiation of this new and effective HIV preventative regimen.
Decision-making to initiate other HIV preventative regimens have been studied in the
MSM population, especially condom use. Consistent condom-use is the best defense to HIV
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prevention regarding AI (CDC, 2015c, 2016c), and MSM’s decision-making processes to utilize
condoms has been extensively researched and discovered to be a complex entity. HIV concern,
psychosocial issues, and relationship dynamics all are factors in their decisional process to use or
not use condoms (Balan et al., 2013; Bauermeister, Carballo-Dieguez, Ventuneac, & Dolezal,
2009; Calabrese, Reisen, Zea, Poppen, & Bianchi, 2012; Campbell et al., 2014; Eaton,
Kalichman, O’Connell, & Karchner, 2009; Goldenberg, Finneran, Andes, & Stephenson, 2015;
Greene, Andrews, Kuper, & Mustanski, 2014; Herrmann, Johnson, & Johnson, 2015; Neville &
Adams, 2009; Neville, Adams, Moorley, & Jackson, 2016). Like condom use, PrEP initiation is
a preventative behavior, but findings regarding MSM's condom-use decision-making cannot be
automatically generalized to PrEP initiation decision-making.
PrEP shares similarities with condom use. Both PrEP and condom-use significantly
reduce HIV risk, up to 92% and 72%, respectively, and are personal choices. Additionally, for
optimal risk-reduction, both are recommended to be used together and in combination with other
traditional HIV prevention practices (Caceres et al., 2015; CFA, 2014; CDC, 2016c, 2014b).
Despite these similarities, several variances exist, as accessibility, pharmacotherapeutic risks,
drug-resistance, and clinical indications make PrEP significantly different from condom use.
PrEP is not readily accessible in comparison to condoms. Truvada’s monthly cost ranges
from $1300 to $1425 U.S. dollars (USDs), with an estimated annual cost of at least $10,000 to
$17,000 USDs (Hellinger, 2013; Horberg & Raymond, 2013; Krakower & Mayer, 2015;
McMahon et al., 2014; Petroll, Staden, & Westergaard, 2016). Given FDA approval, most third
party payers should cover PrEP, and many state Medicaid formularies declare that it will be
covered (Krakower & Mayer, 2015). Data also show that private insurances are covering some
portion of the cost, but actual insurance coverage percentages and out-of-pocket patient expenses
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are presently unknown (McMahon et al., 2014; Rooney, 2013). Due to PrEP’s exorbitant cost,
patients may receive assistance from Gilead®. Gilead® provides a medication assistance
program for qualifying persons with a low socioeconomic status (SES) and inadequate insurance
coverage (Horberg & Raymond, 2013; McMahon et al., 2014; Rooney, 2013). Condoms,
however, are cheap (Terris-Prestholt & Windmeijer, 2016), costing $6 to $12 USDs for a box of
three to twelve condoms, respectively (Planned Parenthood, 2017). Due to low cost, condom
distribution programs (CDPs) in the U.S. are able to provide condoms free of charge to the
public (CDC, 2015b), which is not an option for PrEP.
Compounding PrEP access is the fact that the approved drug, Truvada, is a prescription
medication. Consequently, initiating PrEP requires one to access a prescribing provider and to
submit to follow-up care at least quarterly (CDC, 2014b); however, there are a limited number of
PrEP providers. Studies report that less than 20% of sampled providers in the U.S. have ever
prescribed PrEP (Krakower et al., 2015; Tellalian et al., 2013), and 30% of providers who have
never prescribed PrEP believe they are unlikely do so in the future (Krakower et al., 2015).
Access to a prescribing provider is not apparent with condoms, as they are conveniently
available in stores throughout the U.S., detached from any required follow-up care.
Like many medications, Truvada poses pharmacotherapeutic risks. Although typically
resolved within the first two weeks of initiation, nausea, headache, and abdominal pain are
common side effects of Truvada (CDC, 2014b); however, long-term risks are associated with
PrEP. Over a period of taking Truvada, patients can develop nephrotoxicity and bone mineral
density loss (CDC, 2014b). These pharmacotherapeutic risks have been reported as reasons that
providers are resistant to prescribing PrEP (Blackstock et al., 2016; Hakre et al., 2014; Krakower
et al., 2015; Krakower, Ware, Mitty, Maloney, & Mayer, 2014; Tellalian et al., 2013).
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Additionally, there is a chance Truvada can cause other unknown side effects, adverse effects, or
decrease in efficacy. Another pharmacological aspect to Truvada is the onset of effectiveness.
For optimal efficacy, Truvada must be taken daily, but its effectiveness is not immediate (CDC,
2014b). At present, no data exists regarding when HIV protection is achieved in penile tissues,
but evidence shows Truvada reaches an optimal HIV prevention level in blood and rectal tissue
approximately after seven days of consistent use (CDC, 2014b). Adherence remains the caveat,
as continued adherence to the daily regimen is necessary to maintain effectiveness (CDC,
2014b). Condoms do not present patients with pharmacotherapeutic risks, and with proper use,
condoms are instantly effective, and only need to be used during sexual encounters.
For PrEP patients who seroconvert, development of Truvada-associated drug resistance is
also a possibility (CDC, 2014b; Grant & Liegler, 2015; McCormack et al., 2016). Truvadaassociated drug resistance develops because an individual continues to use the drug after
becoming infected (acquired drug resistance, ADR) (Dimitrov et al., 2016). Although Truvada is
approved for treating HIV, Truvada, an NRTI alone is not an appropriate HIV treatment regimen
(AIDS Info, 2017b). Generally, treatment naive PLWH’s first regimen includes two NRTIs in
conjunction with an integrase strand transfer inhibitor (INSTI), an non-nucleoside reverse
transcriptase inhibitor (NNRTI), or a protease inhibitor (PI) with Tybost or Norvir to increase the
PI's effectiveness (AIDS Info, 2017b). After contracting HIV, the virus replicates rapidly; viral
replications that develop while taking an inadequate HIV regimen cause the virus to mutate into
a resistant strain resulting in therapy ineffectiveness and treatment failure (AIDS Info, 2017a).
Although PrEP clinical trial data show the development of overall ADR to be low (37 out of 117
seroconverters in the investigational groups developed resistance in six different clinical trials)
(CDC, 2014c; Gupta et al., 2013), more research is necessary to assess the relationship between
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PrEP seroconversion and ADR (Dimitrov et al., 2016; Grant & Liegler, 2015; Gupta et al.,
2013). The implications of PrEP-ADR is another barrier and reason preventing providers from
implementing and offering PrEP in their practices (Blackstock et al., 2016; Hakre et al., 2014;
Krakower et al., 2015; Krakower et al., 2014; Tellalian et al., 2013), and condoms do not present
ADR concerns or threats.
Lastly, depending on one’s HIV risk factors, PrEP may not always be clinically indicated.
PrEP is recommended for those at increased risk for contracting HIV (CDC, 2014b). An
individual’s personal behaviors and circumstances can change, making PrEP not always
necessary, whereas, condoms and other traditional behaviors are always appropriate for reducing
HIV transmissions. Given the differences between PrEP and condom use, an inquiry regarding
MSM’s decision-making to initiate this new and unique HIV preventative regimen is appropriate
and necessary.
Research Question
Based on the knowledge gap and study purpose, the investigator proposes the following
research question: How do HIV-negative MSM, engaging in protected or unprotected AI, decide
to initiate PrEP? The study objective is to explore how HIV-negative MSM decide to initiate
PrEP based on the evaluation and perceptions pertaining to their: (a) PrEP knowledge and HIV
risk(s)/concern(s); (b) personal and social motivations to initiate PrEP; and (c) behavioral skills
and abilities to adhere to PrEP.
Theoretical Framework
A theory is a set of empirically defined assumptions, concepts, perceptions, and
predictions that explain phenomena logically in a particular context or setting (McEwen, 2014).
This study explores the PrEP initiation decision-making processes in HIV-negative MSM, and an
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appropriate theoretical framework captures decision-making’s dynamic process in the context of
HIV prevention.
The investigator reviewed HIV/AIDS prevention behavioral literature, and found the
Health Belief Model (HBM) and Theory of Planned Behavior (TPB) to be commonly used.
These theories have historically guided inquiries including partner condom-use discussions, HIV
testing, pregnancy prevention (Li, Lei, Weng, He, & Williams, 2016; Montanaro & Byran, 2014;
Schnall, Rojas, & Travers, 2015); PLWH’s medication adherence (Jones, Smith, & Llewellyn,
2014); STI testing and treatment adherence; receipt of HIV results; and condom and drug use
(Gredig, Nideroest, & Parpan-Blaser, 2006; Mausbach, Semple, Strathdee, & Patterson, 2009;
Montanaro & Byran, 2014; Prabawanti, Dijkstra, Riono, & Hartana, 2015; Prati, Mazzoni, &
Zani, 2014; Thomas, Shiels, & Gabbay, 2014; Thompson-Leduc, Clayman, Turcotte, & Legare,
2014; Tyson, Covey, & Rosenthal, 2014).
The HBM and TPB both explain and represent some aspect regarding health behavioral
decision-making; however, these models do not fit this inquiry’s clinical context. Developed in
the 1950s and 1960s by social psychologists Hochbaum, Rosenstock, and Kegels, the HBM is a
cognitive model to explain and predict the likelihood or intention of performing health behaviors
(Jones et al., 2014; Li et al., 2016; Montanaro & Byran, 2014; Schnall et al., 2015). In this study,
intention to initiate PrEP is not the investigated phenomenon, as participants have already
initiated PrEP, therefore, deeming the HBM’s to be inappropriate to guide this study. The TPB
originated from the psychology discipline by Ajzen to predict heath behaviors based upon one’s
personal perceptions (Ajzen, 2002, 2011; Madden, Ellen, & Ajzen, 1992). The TPB is not a
befitting theory for this investigation, because it conceptualizes decision-making to be based on
the personal perceptions about the behavior alone, but this inquiry’s context includes PrEP
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initiation based upon multiple factors: (a) PrEP knowledge and HIV concern(s)/risk(s); (b)
personal and social motivations to initiate PrEP; and (c) behavioral skills and abilities to adhere
to PrEP. Since neither model represents the clinical context of the proposed study, the
investigator chose a different framework that better attests to this study’s context.
The Information-Motivation-Behavioral (IMB) skills model is the theoretical framework
guiding this exploration into MSM’s PrEP initiation decision-making processes. The IMB skills
model is rooted in and specific to AIDS preventative and treatment behaviors (Aliabadi et al.,
2015; Chang, Choi, Kim, & Song, 2014; Fisher & Fisher 1992; L. Smith, Fisher, Cunningham, &
Amico, 2012). Originating from the psychology discipline, Fisher and Fisher (1992) conducted a
comprehensive review of AIDS-related risk-reduction literature. From their empirical synthesis
and analysis, they constructed the IMB skills model (see Figure 1) to explain one’s process for
initiating AIDS risk-reduction behaviors (Aliabadi et al., 2015; Chang et al., 2014; Fisher &
Fisher 1992; L. Smith et al., 2012; Traube, Holloway, & Smith, 2011). For clarity, the
investigator refers to the model’s purpose to explain the phenomenon of an individual initiating
HIV risk-reduction behaviors, as HIV is the virus that causes AIDS, and HIV prevention is
necessary to reduce HIV/AIDS incidence (CDC, 2016c; Fan et al., 2014).
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The IMB skills model conceptualizes the decision to initiate HIV risk-reduction
behaviors as involving one’s information, motivation, and skills (Aliabadi et al., 2015; Amico,
Toro-Alfonso, & Fisher, 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992;
Macapagal, Greene, Andrews, & Mustanski, 2016; L. Smith et al., 2012). Information is the
initial prerequisite to health behavior, as it is the knowledge, myths, and means known to reduce
the risk of contracting HIV (Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang
et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016). Motivation encompasses two types,
personal and social. Personal motivations are one’s attitudes, beliefs, and perceptions regarding
the outcomes from performing or not performing HIV prevention behaviors (Aliabadi et al.,
2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992;
Macapagal et al., 2016). Social motivations are the perceived social support and acceptance
from peers and significant others in performing the specific behavior (Aliabadi et al., 2015;
Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et
al., 2016). Behavioral skills are the abilities needed to perform that behavior, and are a reflection
of one’s knowledge and motivation (Chang et al., 2014; Traube et al., 2011). Engagement in a
behavior requires one to possess and utilize certain skills to achieve and perform the behavior
(Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher &
Fisher, 1992; Macapagal et al., 2016). In regards to MSM HIV prevention, those skills include
having condoms readily available and accessible, using condoms accurately and consistently,
reducing sexual partners, and avoiding sex while cognitively impaired (Herbst et al., 2007;
Motley, Hammond, & Mustanski, 2017; Sullivan et al., 2012). While the model’s three concepts
individually influence HIV prevention behaviors, the combination of all three concepts shows
the decision-making process for initiating HIV preventative behaviors (Aliabadi et al., 2015; L.
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Smith et al., 2012). The information and motivation one has regarding HIV risk-reduction
behaviors directly influence their skills and abilities to perform and adhere to the behavior
(Fisher & Fisher, 1992). In this model, however, information and motivation are unique
constructs, meaning that these concepts do not directly influence the other (Chang et al., 2014;
Fisher & Fisher, 1992). A highly motivated person can lack adequate knowledge, while a wellinformed person can have little to no motivation (Traube et al., 2011).
As a whole, the three concepts influence initiation of HIV prevention behaviors, but the
concepts are context and value-dependent (Aliabadi et al., 2015; Chang et al., 2014; Fisher &
Fisher, 1992; L. Smith et al., 2012). Under this framework, an individual’s culture, values and
beliefs, social standing, SES, environment, and life circumstances determines their
understanding, motivation, and abilities regarding their decision-making to utilize HIV
preventative behaviors (Aliabadi et al., 2015; L. Smith et al., 2012; Traube et al., 2011).
Therefore, Fisher and Fisher (1992) recommend conducting HIV prevention research among a
subsample of a population in order to prevent making overzealous generalizations (Aliabadi et
al., 2015). Additionally, Aliabadi et al. (2015) stated that a qualitative approach is appropriate
with the IMB skills model so information can be elicited using dialogue and open-ended
questions.
Although not as commonly used in HIV research as the HBM and TPB, investigators
have applied the IMB skills model to investigate different behaviors related to HIV prevention.
These investigated HIV behaviors include risky sexual behaviors in HIV positive and negative
persons (Chang et al., 2014; Macapagal et al., 2016), PLWH medication adherence (Aliabadi et
al., 2015; Chang et al., 2014; Horvath, Smolenski, & Amico, 2014; Rongkavilit et al., 2010), and
intervention development and testing (Chang et al., 2014). The IMB skills model has also been
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applied in exploring health-related behavioral initiation in other diseases and diagnoses:
coronary artery disease (Zarnai, Besharat, Sarami, & Sadeghian, 2012), Type 2 diabetes mellitus
(Gavgani, Poursharifi, & Aliasgarzadeh, 2010; Meunier et al., 2016; Osborn et al. 2010), and
cervical or endometrial cancers (Jefferies, Robinson, Craighead, & Keats, 2006). As the newest
and first pharmacological HIV prevention intervention, PrEP, inquiries into initiating this
regimen can be conducted utilizing this framework.
The proposed study explores MSM's decision-making processes to initiate PrEP based on
their (a) PrEP knowledge and HIV concern(s)/risk(s); (b) personal and social motivations to
initiate PrEP; and (c) behavioral skills and abilities to PrEP adherence. This investigator
believes the IMB skills model provides the most congruent context given the complexity
surrounding HIV behavioral prevention initiation. Figure 2 displays the theoretical construct
specific to this study.

Assumptions
Assumptions for this inquiry are based on the presumption that individuals institute
prevention behaviors due to a health concern or scare (Poortaghi et al., 2015), and that qualitative
research seeks to understand human experiences from participants’ personal experiences
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(Creswell, 2013; Lo-Biondo & Haber, 2014). Therefore, specific to this inquiry, the investigator
assumes MSM PrEP patients: (a) acknowledge they are at risk for HIV; (b) are concerned about
contracting HIV; (c) do not want to contract HIV; (d) believe PrEP initiation decreases their HIV
risk(s); (e) are the experts of this phenomenon; and (f) tell the truth as they see it. The
investigator also assumes health decision-making to be a personal and individualistic process of
considering, weighing, and rationalizing the benefits and consequences perceived by initiating or
not initiating health related behavior(s).
Definition of Terms
Defining key terms is imperative to provide phenomenal clarity throughout the
investigation.
Health professionals are licensed nurses, physicians, and mid-level practitioners providing
medical services and care to patients.
HIV is the virus that causes AIDS, which is transmitted through blood, breast milk, semen, and
vaginal fluids.
MSM are men who engage in sex with other men.
PrEP or Truvada as PrEP is the fixed daily oral-dose of Truvada in HIV-negative persons.
PrEP initiation is the act of a person beginning to take PrEP.
Decision-making process is the individual process of weighing different factors, as understood
by the individual, surrounding that behavior or choice’s requirements, benefits, and outcomes,
prior to one taking action or inaction regarding that particular behavior or choice (Poortaghi et
al., 2015; Popejoy, 2005).
Limitations
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Limitations are weaknesses in a study, restricting the application and relevance of its
findings in clinical practice (Colorafi & Evans, 2016; LoBiondo-Wood, 2014b; Neergaard,
Olsesen, Andersen, & Sondergaard, 2009). In this study, limitations relate to the proposed
study’s research question, methodology, and implications.
Inquiring about MSM's PrEP initiation decision-making process makes this investigation
privy to respondent bias. Respondent bias occurs when participants are less than honest,
answering research questions according to social norms and acceptance; relevant research data
depend on participants’ responses being authentic and truthful (Friis & Sellers, 2013). Although
PrEP is initiated in HIV-negative persons, HIV and PrEP are sensitive topics, as fears and
concerns of stigmatization remain among patients seeking HIV care and prevention services
(CDC, 2016b). Given that PrEP is clinically indicated for those at high HIV risk, PrEP users
have been labeled “Truvada whores”, and the negative stigma prevents patients from seeking and
initiating PrEP (Auerbach, Kinsky, Brown, & Charles, 2015; Calabrese & Underhill, 2015;
Collins et al., 2016; Dolezal et al., 2015; Haire, 2015). Likewise, the negative stigma might
deter participants from being honest about their PrEP initiation decision-making process.
Patients are shown to have reservations when discussing sexual health matters with health
professionals. Suspicions and experiences of medical judgment and mistrust prevent patients
from discussing their sexual behaviors (Auerbach et al., 2015; Collins et al., 2016; Eaton et al.,
2014; Garcia & Harris, 2017; Perez-Figueroa, Kapadia, Barton, Eddy, & Halkitis, 2015; Taylor
et al., 2014). These reservations can extend into this study, as participants may not be as open
and honest with discussing their HIV risks and concerns, or motivations for initiating PrEP.
Gender differences can also influence respondent bias, as participants may not be as forthcoming
and honest in their responses with a female interviewer.
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Utilizing a qualitative methodology causes this study to be limited by interviewer bias
(Sullivan-Bolyai & Bova, 2014). Interviewer bias, implicit or explicit, occurs when the
interviewer leads the participant to answer in a certain manner (Sullivan-Bolyai & Bova, 2014),
distorting the emic view. The emic view is the actual view and perspective of the person
experiencing the phenomenon (Streubert, 2014). The researcher’s professional experience with
HIV and PrEP patients can cause the investigator, intentionally or not, to lead participants’
responses during interviews. While the investigator is experienced in clinical research, she is a
novice investigator, inexperience in conducting and analyzing qualitative research. During data
collection and analysis, inexperience and interviewer bias makes this process at risk to
misinterpretations, threatening the authenticity of study findings.
Study implications are also limited in this study, as these findings are not transferable to
the larger MSM PrEP population. Usually, a rigorous study is transferable to the larger
population of the study sample (Colorafi & Evans, 2016; Creswell, 2013; LoBiondo-Wood,
2014b; Neergaard et al., 2009); however, those studies are generally replications of previous or
similar studies (Houghton, Casey, Shaw, & Murphy, 2013). Prior to this investigation, there are
no publications exploring MSM’s PrEP initiation decision-making processes. Given the lack of
knowledge on MSM’s PrEP initiation decision-making processes, it is premature to assert that
these initial findings are applicable to other MSM PrEP patients. Additionally, qualitative
research is based on a philosophical foundation that “reality is socially constructed and context
dependent” (Toles & Barroso, 2014b, p. 96). Therefore, these findings are transferable to this
sample, and possibly to MSM of similar social demographics who are accessing PrEP. Future
replicated studies are needed before making generalizations regarding MSM’s PrEP initiation
decision-making in the U.S.
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Significance to Healthcare & Nursing
Health behavior decision-making has been studied in numerous specialties and areas:
exercise (Lee, Chiang, Hwang, Chi, & Lin, 2016), hormone replacement therapy (Carpenter,
Studts, & Bryne, 2011), medication adherence (McGrady, Brown, & Pai, 2016), healthy eating
(Haws, Reczek, & Sample, 2017), smoking cessation (Hoie, Moan, Rise, & Larsen, 2012), selfcare (Karimi & Clark, 2016), and sexual behaviors (Scott-Sheldon et al., 2016). The consensus
is that decision-making is an individualistic process where the decision-maker weighs different
factors, as they understand them, surrounding that choice’s requirements, benefits, and outcomes
(Poortaghi et al., 2015; Popejoy, 2005). Exploring MSM's PrEP initiation decision-making
processes informs health professionals of MSM’s (a) knowledge and values about PrEP, (b) HIV
risks and concerns; and (c) perceptions and abilities surrounding PrEP initiation and adherence.
Knowledge from this study has cost saving implications for the U.S. health-care system.
HIV care and treatment costs the health-care system an estimated $12.3 billion annually (CDC,
2015a). Each prevented HIV infection saves an estimated $355,000 in lifetime HIV treatment
costs (CDC, 2015a). Experts estimate that PrEP initiation in at-risk groups can reduce HIV
incidence by 70%, preventing 185,000 U.S. infections by 2020 (CDC, 2016e), but the capacity to
achieve the projected decline depends on PrEP indicated persons deciding to initiate the
complementary regimen. Although this study will not lead to an increase in PrEP initiation, the
findings are informative, providing context and information surrounding MSM's PrEP initiation
in the U.S. MSM is the population most affected and vulnerable to HIV, and given the poor
PrEP initiation in this population (Krakower et al., 2015; Krakower & Mayer, 2015; Tellalian et
al., 2013), knowledge of HIV-negative MSM’s PrEP initiation decision-making processes is a
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step to gauge if the complementary regimen can have the estimated impact to change the
narrative surrounding the current U.S. HIV epidemic and MSM disparity.
Knowledge of MSM’s PrEP initiation decision-making processes implicates the nursing
profession. Nurses advocate, support, and educate patients on health-promoting options to help
patients achieve the best outcomes they perceive for themselves (Kemppainen, Tossavainen, &
Turunen, 2012; Kim, 2015). The findings inform nurses of how MSM process and rationalize
these factors when deciding to initiate PrEP. With greater understanding of the knowledge and
factors influencing and determining PrEP initiation decision-making, nurses are able to identify
opportunities to assist patients in resolving occurrences of internal and external conflict,
misunderstanding, or other concerns regarding HIV and PrEP.
Empirical evidence of MSM’s PrEP decision-making processes informs nurses of
possible content to include when providing PrEP patient education to MSM. This study’s
findings educate nurses on ways to counsel and support MSM considering PrEP. A greater
feeling of support and advocacy increases health behavioral adherence (Popejoy, 2005; Thom et
al., 2016), and optimal and accurate PrEP initiation among willing and HIV at-risk persons is the
most effective way for PrEP initiation to have the projected impact on the HIV epidemic (CDC,
2016e).
Findings from this study are foundational, extending the current knowledge base
encompassing MSM's PrEP initiation decision-making. Additionally, findings from this study
build on previous evidence pertaining to health behavioral decision-making, HIV prevention, and
PrEP and MSM decision-making. PrEP initiation is a new phenomenon, and this study’s
findings establish a knowledge base for conducting future inquiries into PrEP initiation.
Qualitative explorations such as this inquiry are indicated and useful in contributing to the
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development of evidenced-based instruments and tools (Toles & Barroso, 2014b). Evidencedbased practice is applying and instituting clinical standards and interventions based on empirical
evidence (Lo-Biondo & Haber, 2014). Specific to MSM's PrEP initiation decision-making,
decision aids and decisional coaching are possible interventions, which can be developed from
inquiries such as this. Decision aids assist nurses to counsel and coach patients when debating
between different options (Stacey et al., 2008), as it is a complementary, pamphlet, form, web
page, or video “that helps patients make decisions by (a) providing information about the
available options and outcomes and (b) clarifying their personal values” (Eggertson, 2010, p.
39). Decision coaching is another avenue in which nurses educate and support patients in
choosing the best health-care plan and intervention (Stacey et al., 2008; Thom et al., 2016). For
accuracy and relevancy, best practices recommend the targeted population to be involved in the
development of population-specific interventions (Dugas et al., 2017). Therefore, this study
contributes to future development and testing of MSM PrEP initiation decision tools and
interventions, which can lead to devising and implementing evidenced based resources and
strategies for achieving PrEP initiation success.
Summary
The MSM HIV epidemic continues to thrive in the U.S., as MSM account for majority of
current and past HIV/AIDS diagnoses. MSM’s HIV incidence rate is 44 times higher than in
other men and 40 times higher than in women (CDC, 2016d). At this rate, the CDC (2016c)
estimates that 1 in 6 MSM will contract the virus in their lifetime. AI is MSM’s greatest risk
factor for contracting and transmitting HIV, as it is the overall most common mode of HIV
transmission (CDC, 2016d), and the riskiest type of sex (CFA, 2014; Pebody, 2010). HIV
prevention is the key to decreasing MSM’s current and predicted HIV incidence in the U.S.
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(CDC, 2016c; Fan et al., 2014). Although HIV prevention behavioral interventions provide best
practices to increasing MSM’s implementation of HIV risk-reduction behaviors (CDC, 2015a,
2017a), the HIV incidence shows that prevention challenges persist. Therefore, a new HIV
prevention modality, PrEP, was introduced as the first pharmacological agent.
PrEP is the fixed daily dose of Truvada in HIV-negative persons with reported and
documented high HIV-acquisition risk (CDC, 2014b). Clinical trial data showed that in the
event of an exposure, PrEP reduces HIV seroconversion by as much as 92%; however, adherence
to the daily regimen is necessary to achieve optimal efficacy (CDC, 2014b; Koenig et al., 2013).
Although efficacious, PrEP does not provide 100% HIV protection and is complementary,
recommended to be used in conjunction with other traditional HIV risk-reduction behaviors,
especially consistent condom usage (CDC, 2014b). Despite PrEP’s indications and
efficaciousness, initiating PrEP is an individual choice and decision. Most current and former
PrEP patients are MSM (Krakower et al., 2015; Krakower & Mayer, 2015; Tellalian et al.,
2013), but currently there is no research exploring PrEP initiation decision-making processes in
MSM or any population.
This study's purpose is to explore PrEP initiation decision-making processes of HIVnegative MSM engaging in protected or unprotected AI. Decision-making details what and how
individuals consider and evaluate the different factors surrounding a choice or option (Poortaghi
et al., 2015; Popejoy, 2005). The study objective is to explore how HIV-negative MSM decide
to initiate PrEP based on the evaluation and perceptions pertaining to their: (a) PrEP knowledge
and HIV concern(s)/risk(s); (b) personal and social motivations to initiate PrEP; and (c)
behavioral skills and abilities to adhere to PrEP. The IMB skills model guides this inquiry, as it
is consistent with this study’s objective and the conceptualization of health-behavioral and HIV

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

35

decision-making. Under this framework, the decision to initiate HIV risk-reduction behaviors
includes one’s knowledge, motivation, and skills regarding the preventative behavior (Aliabadi
et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992;
Macapagal et al., 2016; L. Smith et al., 2012).
Knowledge from this study implicates the health-care system and nursing profession.
Although this study will not lead to increasing PrEP initiation in the U.S., the findings are
informative. Experts estimate that PrEP initiation in at-risk groups can reduce HIV incidence by
70%, and prevent 185,000 U.S. infections by 2020 (CDC, 2016e). Each prevented HIV infection
saves an estimated $355,000 in lifetime HIV treatment (CDC, 2015a). Knowledge from this
study is a step to gauge if this complementary regimen can have the estimated impact on the HIV
epidemic, and change the current MSM HIV disparity. MSM's PrEP initiation decision-making
process informs nursing practice of factors that influence PrEP decision-making and how MSM
rationalize initiating PrEP based on their HIV and PrEP perceptions and understanding. With
this knowledge, nurses are able to identify opportunities to assist patients during the decisionmaking process, clarifying HIV and PrEP misunderstandings and misconceptions. Therefore,
this study’s findings educate nurses on ways to counsel and support MSM considering PrEP.
Additionally, this study contributes to the future development and testing of MSM PrEP
initiation decision tools and interventions, which can lead to devising and implementing
evidenced based strategies for achieving PrEP initiation success.
Despite the study’s implications, this study is still privy to limitations. Inquiring about
MSM's PrEP initiation decision-making process requires the investigator to ask about behaviors
and perceptions related to HIV, sex, and PrEP. PrEP users are negatively stigmatized as
“Truvada whores” (Calabrese & Underhill, 2015; Haire, 2015), and some patients fear discussing
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their sexual behaviors with health professionals (Auerbach et al., 2015; Collins et al., 2016;
Eaton et al., 2014; Garcia & Harris, 2017; Perez-Figueroa et al., 2015; Taylor et al., 2014).
These fears and concerns make this study at risk for respondent bias, as participants may be less
than truthful with their responses (Friis & Sellers, 2013). A qualitative methodology and the
investigator’s professional background also make this study limited by interviewer bias, which
can distort the emic view due to data collection errors or misinterpretation. Lastly, as the first
known investigation into MSM’s PrEP initiation decision-making processes, transferability is
limited. Rigorous studies are usually transferable to the study sample’s larger population
(Colorafi & Evans, 2016; Creswell, 2013; LoBiondo-Wood, 2014b; Neergaard et al., 2009);
however, these findings are only transferable to this sample, and possibly to MSM of similar
social demographics and accessibility means to PrEP.
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Chapter 2: Literature Review
In July 2012, pre-exposure prophylaxis (PrEP) was introduced as HIV prevention’s
inaugural pharmacological agent for individuals at increased HIV risk. As PrEP, HIV-negative
patients take Truvada, an antiretroviral therapy (ART) drug, once a day to decrease HIV risk by
as much as 92% (CDC, 2014b). PrEP is complementary, as it is to be used in conjunction with
other traditional HIV risk-reduction behaviors, and strict adherence is required to achieve
optimal efficacy (CDC, 2014b). Despite these limitations, the introduction of Truvada as PrEP
has the potential to end the HIV epidemic in the U.S., as PrEP initiation in HIV at-risk
populations is predicted to result in a 70% reduction in HIV incidence in the U.S. by 2020 (CDC,
2016e). Although HIV risk is significant in other populations, men who have sex with men
(MSM) are most vulnerable, experiencing the highest HIV incidence and prevalence annually
and historically. MSM represent 56% of people living with HIV (PLWH), and account for more
than half of the new cases each year in the U.S. (CDC, 2018a). The MSM HIV epidemic is so
alarming that CDC (2016c) estimates that 1 in 6 MSM will contract the virus in their lifetime if
this rate continues, making PrEP initiation HIV-negative MSM significant to the U.S. MSM HIV
epidemic.
Research shows that MSM are interested in initiating PrEP (Brooks et al., 2012; Collins
et al., 2016; Taylor et al., 2014), because they perceive it to be an empowering form of HIV
proactive prevention (Oldenburg et al., 2016). Although most current and former PrEP patients
identify as MSM (Krakower et al., 2015; Rooney, 2013; Tellalian et al., 2013), approximately
3% of the MSM population have ever initiated the complementary regimen (Krakower et al.,
2015; Krakower & Mayer, 2015; Tellalian et al., 2013). At present, the literature lacks evidence
of PrEP initiation decision-making processes in any population and this study attempts to address
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this knowledge gap by exploring PrEP initiation decision-making processes in the most HIVvulnerable population, HIV-negative MSM.
In order to understand this study’s implications, a literature review was conducted to
establish the foundation for the proposed study. A literature review functions as the knowledge
base on a phenomenon by gathering and appraising current and relevant evidence (Fulton &
Krainovich-Miller, 2014). PrEP is an HIV preventative regimen, and this chapter provides the
literary foundation for an inquiry into this exploration into MSM’s decision-making to initiate
this regimen. First, the investigator discusses recommendations and best practices for MSM
behavioral HIV prevention. Second, the significance health-behavioral decision-making
research has in clinical practice are revealed. Thirdly, the synthesis details the factors and
processes involved in HIV-negative MSM’s condom-use decision-making. Finally, the results of
this literature review determines the current knowledge base on MSM and PrEP. The chapter
concludes with a summary validating the need for the proposed study based on the literature's
current knowledge gap.
HIV Prevention
Since the beginning of the epidemic, HIV incidence shows that “HIV prevention is
neither simple nor simplistic” (Coates, Richter, & Caceres, 2008, p. 669). In the initial onset,
HIV prevention was a challenge due to the lack of knowledge and understanding about HIV’s
etiology and disease progression. Over the past three decades, HIV science and research have
discovered the virus’ transmission modes, therefore, allowing successful development of best
practice prevention strategies. Although the national HIV incidence has declined by 19%
between 2005 and 2014, prevention challenges remain, as approximately fifty thousand new HIV
cases are reported annually in the U.S. (CDC, 2016c). Due to these continued challenges, HIV
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prevention has expanded into a three-tiered approach: behavioral interventions, routine testing,
and treatment as prevention (TasP) (CDC, 2015a; Yagoda & Moore, 2016).
Undiagnosed infections fuel the HIV epidemic, as these cases allow the virus to spread
unknowingly (CDC, 2016b). To eliminate missed opportunities for early diagnosis, the CDC
(2006, 2012) currently recommends routine testing, which advises health professionals to
conduct HIV testing on all patients 13-65 years of age during all health care encounters
regardless of clinical indications or reported risks. Patients meeting the age criteria with an HIVnegative or unknown status should be offered an HIV test each and every time they present for
any medical services, but patients maintain the right to decline, or “opt-out” of the service (CDC,
2006, 2012). Routine testing’s goal is to identify new and unknown cases sooner and more
frequently by making it an aspect of routine care (CDC, 2012). Once diagnosed, treatment naïve
PLWH can be connected to care to begin ART.
Connection to care or, TasP, involves PLWH receiving consistent and adequate ART.
ART decreases the viral load in the body to a low or undetectable level, which decreases HIV
transmission risk by at least 90% (CDC, 2016f; CFA, 2015; O’Byrne & MacPherson, 2016;
Young & McDaid, 2014). PLWH not on ART strains prevention, as the virus remains unstable
in their body and readily transmissible. Both routine testing and TasP play a significant role in
HIV prevention; however, this study pertains to PrEP initiation, which is the newest option in
HIV prevention behavioral interventions.
MSM’s HIV Prevention Behavioral Best Practices
Behavioral interventions encourage individuals to utilize risk-reduction behaviors by
“ensuring people have the information, motivation, and skills necessary to reduce their risk”
(CDC, 2015a, p. 1). Although behavioral interventions are specifically devised for several at-
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risk populations, only those interventions targeting HIV-negative MSM are relevant to this
literature review. Anal intercourse (AI) is the most common mode of HIV transmission (CDC,
2016d), the riskiest type of sex (CFA, 2014; Pebody, 2010), and the most common sexual
behavior practiced by MSM (Meng et al., 2015). Therefore, most MSM HIV prevention
behavioral interventions target reducing HIV risk during AI. Specific to AI for MSM, traditional
risk-reduction behavioral interventions include abstaining, using condoms consistently,
decreasing sexual partners, serosorting, avoiding sex cognitively impaired, and submitting to
substance abuse treatment (CDC, 2017a). A combination of these traditional behaviors is
recommended for optimal HIV protection (Caceres et al., 2015; CFA, 2014), but the CDC
(2016a) affirms that correct and consistent condom use is the best defense to prevent the spread
of HIV during sexual encounters. Protected AI reduces HIV risk by 63% for the insertive
partner and 72% for the receptive partner (CDC, 2015c), and serosorting provides an estimated
54% in risk reduction (CDC, 2015c). Although no statistics are available, the logic behind
decreasing sexual partners is that this action lessens one’s exposure to an individual with a
known or unknown HIV positive status (CDC, 2017d). Additionally, engaging in sexual acts
while under the influence of drugs or alcohol decreases one’s inhibitions and cognitive ability to
avoid risky sexual encounters and behaviors (CDC, 2017d). Therefore, avoidance of sex while
cognitively impaired and substance abuse treatment reduces opportunities for HIV risky
encounters (CDC, 2017d). Behavioral interventions’ provide HIV prevention education and
support at individual, group, and community levels with the shared goal of increasing at-risk
individual’s utilization of HIV preventative behaviors (CDC, 2014a, 2017a, 2017c); however,
each level's intervention is distinct and implemented differently.
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Specific to HIV prevention, individual interventions are strategies provided in an intimate
setting on a one-on-one basis (CDC, 2014a, 2017a, 2017c), while group interventions are
rendered amongst a group of homogenous persons (Herbst et al., 2007). Both individual and
group interventions' effectiveness are determined by individual participants’ responses to
treatment (CDC, 2014a, 2017a, 2017c). Although either of these intervention types can be
provided in health care facilities/specialties or other group organizations, they are often
conducted and administered at an HIV clinic or health care entity/institution (CDC, 2014a,
2017a, 2017c).
Unlike HIV prevention’s individual and group interventions, community interventions
bring the intervention directly to the population (CDC, 2014a, 2017a, 2017c). In this type of
research, community is defined as a group of individuals sharing common traits and
characteristics in a relative close geographic region prior to initiating the intervention (CDC,
2017c). MSM community interventions take place in settings frequented by MSM: gay bars,
community based organizations (CBOs), and other social and public areas (i.e., outpatient or
community clinics, community colleges, and gay pride events) (CDC, 2017a). The effectiveness
of community interventions is measured according to the response from the entire studied
community, and not on an individual basis (CDC, 2014a, 2017a, 2017c).
To identify HIV prevention behavioral interventional best practices, the investigator
reviewed the CDC’s HIV Evidenced Based Interventions (EBIs). Determining evidenced-based
interventions is a systematic process of analyzing and evaluating relevant and related research
based on data and outcomes (Lo-Biondo & Haber, 2014). The result of the literature analysis
and synthesis assists in defining best practice recommendations, protocols, or standards based on
objective and sound evidence (Lo-Biondo & Haber, 2014). The CDC’s EBIs is a compendium
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from their analysis of published HIV behavioral interventional evidence shown to increase
initiation of HIV traditional risk-reduction behaviors at the individual, group, and community
levels (CDC, 2014a, 2017c). For MSM, the following were considered traditional prevention
behaviors: abstinence, decreasing the number of sexual partners, and decreasing the occurrence
of unprotected sex (CDC, 2014a, 2017c). Appendix A provides a list of the eleven identified
EBIs for MSM at the individual, group, and community levels.
Evidenced Based Interventions (EBIs)
Relative to individual and group interventions, counseling strategies utilizing technology,
peers, and health professionals are shown to be most effective (CDC, 2017a). Although these
approaches are facilitated differently, the commonalities remain the same and are imperative to
their successes. Regardless of whether information is delivered by a video or virtual component,
an MSM peer, or a health professional, information is culturally adapted to provide behavioral
risk-reduction education, recommendations, and support specific to MSM of different races and
ethnicities (CDC, 2017a). After receiving HIV counseling, participants engage in discussions
within their group or individual sessions to clarify and expound upon the presented information
(CDC, 2017a). Counseling strategies utilizing MSM peer counselors provide opportunities to
discuss social barriers, hardships, decision-making, and problem solving (CDC, 2017a).
Trained counselors and health professionals are not MSM’s peers, but they are equipped and
capable to have candid conversations in a safe, non-judgmental environment, as they support and
assist clients to devise risk-reduction goals and strategies (CDC, 2017a).
Although not considered best practices, community interventions are shown to be
effective and good strategies in improving MSM’s HIV risk-reduction behaviors. Community
interventions utilize peers and community leaders respected and trusted by MSM to render risk-
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reduction counseling (CDC, 2017a). Similar to individual interventions, community
interventions empower MSM to develop risk-reduction goals, plans, and skills (CDC, 2017a).
At the community level, HIV prevention is an ongoing collaborative effort, as these interventions
are provided within the community as an attempt to provide preventative services to those who
may not be able to access individual and group level interventions due to personal and
disadvantaged circumstances: limited finances, unreliable transportation, and/or inadequate
health care access, to name a few.
The CDC conducted a comprehensive and exhaustive review of several literature
databases to identify and evaluate applicable studies meeting defined research criteria (CDC,
2014a, 2017c). Although complete details of this evaluation process were not available, the
CDC (2014a, 2017c) analyzed each study rigorously according to specific criteria to determine
which interventions demonstrated optimal evidence to increase the studied sample’s HIV riskreduction behaviors (CDC, 2017c). Reviewed interventional studies had to meet and
demonstrate certain risk-reduction efficacy standards set by the CDC’s Prevention Research
Synthesis (PRS) Project (CDC, 2017c). The pre-defined evaluation criterion for reviewing the
interventional studies strengthens the EBIs’ evidence, as setting the required criteria first
standardizes and reduces bias in the evaluation process (LoBiondo-Wood, 2014a).
The criteria measuring the interventions' efficacy was determined by evaluating a
combination of the intervention’s study design and reported outcomes (CDC, 2017c). PRS
Project’s standards placed more value on a study being a randomized clinical trial (RCT), having
a large sample size, maintaining a high retention rate, and utilizing multiple comparison groups
(CDC, 2017c). Additionally, included studies reported a statistically significant (p< .05) increase
in one or more of the HIV traditional prevention behaviors in comparison to the control group
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(CDC, 2017c). These characteristics are indicators of a robust study, increasing the findings'
reliability and trustworthiness (LoBiondo-Wood, 2014a). From the analysis, the interventions
were classified as either best or good practice (CDC, 2014a, 2017c).
The distinction between good and best practice was based upon the overall quality of the
study's design and methodology (CDC, 2017c). Individual and group interventions were
evaluated utilizing the same criteria (CDC, 2017c); this investigator assumes that was done
because both interventions evaluate behavioral change in the individual. For individual and
group level interventions, best practices were derived from RCTs utilizing a sample greater than
50 participants per study arm, with a 70% retention rate, and a follow-up period of at least three
months post intervention completion (CDC, 2017c). On the other hand, good evidence for
individual and group interventional studies utilized random assignment of 40 participants per
study arm, with a 60% retention rate, and a follow-up period of at least thirty days post
intervention completion (CDC, 2017c). A similar pattern was apparent in the distinction
between best and good practices for community interventional research. Best practice
community interventional studies utilized four or more communities per study arm, maintained a
70% retention rate, and had a follow-up period of at least three months post intervention
completion (CDC, 2017c). Good practice community interventional studies had at least one or
more communities per arm, a 60% retention rate, and a follow-up period of thirty days post
intervention completion (CDC, 2017c).
Although not an aspect of the PRS Project’s evaluation criteria, each reviewed study
utilized a theoretical framework to guide the investigation. Appendix B provides a list of the
applied theories. Applied theory strengthens the EBIs' conclusions, as developing effective and
efficient knowledge for clinical practice depends “on marshaling the most appropriate theory to
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guide inquiries that contextually represent the investigated phenomenon” (Glanz et al., 2008b, p.
35). Systematic reviews show interventions constructed from a theoretical framework are more
effective compared to interventions not founded on theory (Glanz, Rimer, & Viswanath, 2008a).
One benefit of theory application in research is that it allows researchers and health professionals
to understand the context and practice settings in which the study findings are most applicable
(McEwen, 2014). All interventions are not universally feasible, and should be selected
strategically and systematically based upon characteristics and resources of the population and
community being served (Collins & Sapiano, 2016). Therefore, theory allows health
professionals to better identify the best strategies to implement given their clinical practice
settings and populations.
Evidenced Based Interventions (EBIs) Synthesis
Synthesis of the CDC’s compendium implicates the proposed study’s significance to the
nursing profession. The applied theoretical frameworks assume that health behavior
interventions at different levels are necessary to support individuals and populations being able
to initiate and sustain effective behavioral change (Glanz et al., 2008a). Therefore, the
compendium demonstrates that health professionals are integral to increasing MSM’s use of riskreduction behaviors, as MSM need support and guidance from a professional, trusted resource, or
program knowledgeable in HIV prevention in order to increase utilization of HIV risk-reduction
behaviors (CDC, 2017a, 2017c). Additionally, this evidence shows that MSM are receptive to
counseling and education from health professionals in an environment and manner that
acknowledges their specific needs and perspectives respectfully and without judgment.
Therefore, findings from an exploration of MSM's PrEP initiation decision-making processes
inform and educate nurses on the ways and content necessary to counsel and support this

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

46

population during this decision-making process. This study is foundational to devising best
practices for MSM’s PrEP initiation successes, and contributes to the development of future
evidenced-based PrEP initiation interventions.
The EBIs' evidence is still privy to weaknesses. Most of the synthesized studies utilized
participant self-reporting (i.e., condom use percentage and number of sex partners) to measure
effectiveness. The effect of social desirability may have caused research participants to answer
questions according to socially expected or accepted norms (Friis & Sellers, 2013), making
participant bias a limitation of the evidence. Although nearly impossible to gather, more
objective data would have strengthened this evidence, but there was no way to know the true
extent of participants' behaviors before study enrollment, and if a participant actually increased
their risk-reduction behaviors. Therefore, the evaluation of the treatment's effectiveness may not
have been indicative of reality. Additionally, the follow-up period to evaluate the interventions’
effectiveness ranged from three to twenty-four months, a period that this investigator believes to
be rather short. While the EBIs offer sufficient evidence on the strategies that improve MSM's
usage of HIV preventative and risk-reduction behaviors, this evidence does not attest to these
interventions’ long-term effect. Additionally, none of the referenced studies investigated
decision-making, therefore weakening this evidence, as it does not explain MSM's decisionmaking to implement those behaviors. HIV prevention is an on-going and long-term endeavor of
deciding to perform behaviors that reduce one’s HIV risks (Caceres et al., 2015; CFA, 2014).
Decision-making is the process of weighing different factors surrounding a behavior or choice
determining if one will implement the respective behavior (Poortaghi et al., 2015; Popejoy,
2005). The effectiveness of the referenced EBIs’ strategies to influence long-term and
permanent behavior change is unknown.
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Health Behavior
Health behavior is the action patients take to attain information and tools regarding health
promotion, risks, and illness (Poortaghi et al., 2015). These actions are ongoing, and may occur
purposefully or inadvertently, as individuals perform health behaviors with or without potential
or actual health concerns (Poortaghi et al., 2015). A preponderance of evidence exist regarding
health behavioral decision-making and is relevant to this study and clinical practice.
Health-behavioral Decision-making Research
Investigators have inquired about health-behavioral decision-making regarding
engagement in primary, secondary, and tertiary care. Specifically, studies have been conducted
to explore and understand individuals’ choices and decisions to initiate or not initiate behaviors
related to health promotion (Brown-Kramer & Kiviniemi, 2015; Rao, Lozano, & Taani, 2014;
Thom et al., 2016; Wang, Clymer, Davis-Hayes, & Buttenheim, 2015), immunizations (Allan &
Harden, 2014; Perez et al., 2015; Wang et al., 2015; Wheldon et al., 2016), screenings and
treatment (Bayliss, Duff, Stricker, & Walker, 2017; Brown-Kramer & Kiviniemi, 2015; Mac
Bride et al., 2013; Schmidt, Damm, Prenzler, Golpon, & Welte, 2016; Tranberg et al., 2016;
Wheldon et al., 2016), and diet and exercise regimens (Bui, Droms, & Craciun, 2014; Kaur,
Scarborough, & Rayner, 2017; Kosma, Buchanan, & Hondzinski, 2017), to name a few. There
was some variance seen in how investigators conducted decision-making research. The literature
showed decision-making research to use sample sizes ranging from five (Schmidt et al., 2016) to
87 (Allan & Harden, 2014). While some studies utilized quantitative methods (Schmidt et al.,
2016), most research designs implemented a qualitative methodology, interviewing participants
using focus groups or semi-structured interviews (Allan & Harden, 2014; Hussain, Flemming,
Murtagh, & Johnson, 2015; Rose, Rosewilliam, & Soundy, 2017).
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Decision-making research has been conducted within a variety of contexts. The process
of making health choices has been studied from the experiences and perspectives of the patient/
patient's legal authority (Allan & Harden, 2014; Coombs, Parker, & de Vries, 2016; Grant,
Rodger, & Hoffmann, 2015; Hamilton, Soinks, White, Kavanagh, & Walsh, 2016; Ling, Payne,
Connaire, & McCarron, 2015; Lucas, Cabral, Hay, & Horwood, 2015; Perez et al., 2015), the
family (Allan & Harden, 2014; Coombs et al., 2016; Grant et al., 2015; Hamilton et al., 2016;
Ling et al., 2015; Newson, Povey, Casson, & Grogan, 2013; Nichol, Thompson, & Shaw, 2011;
Perez et al., 2015; Siouta et al., 2015), and health professionals (Chong, Aslani, Chen, 2013;
Coombs et al., 2016; Rose et al., 2017; Siouta et al., 2015; Thom et al., 2016). Explorations of
decision-making did not necessarily compare one group to another; however, the investigators
narrowed their inquiry to a specific population. Decision-making has been investigated among
different social statuses: low socioeconomic status (SES) (Vesely, 2013), racial/ethnic
minorities (Carvajal, Gioia, Mudafort, Brown, & Barnet, 2017; Kosma et al., 2017; Lu, 2017;
Mead et al., 2013; Tung, Cook, & Lu, 2012; Vesely, 2013), indigenous persons (Dugas et al.,
2017; Gainer et al., 2017; Mitchell, 2011; Tranberg et al., 2016), sexual minorities (i.e., lesbian,
gay, bisexual, and transgender persons) (Wheldon et al., 2016), men and women (Kosma et al.,
2017; Mead et al., 2013; Tranberg et al., 2016; Wheldon et al., 2016), different age groups
(Kosma et al., 2017; Mitchell, 2011; Rao et al., 2014; Wheldon et al., 2016), and specific
diagnoses and conditions (Coombs et al., 2016; Gainer et al., 2017; Ling et al., 2015; Mitchell,
2011; Rose et al., 2017; Siouta et al., 2015). Geographically, these studies have been conducted
throughout the U.S. (Bui et al., 2014; Thom et al., 2016; Wheldon et al., 2016) and abroad (Grant
et al., 2015; Mitchell, 2011; Perez et al., 2015; Siouta et al., 2015). The numerous inquiries in
combination with the various contexts health behavioral decision-making research has occurred
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provides this investigation the necessary foundation to understand this phenomenon, and reveals
the importance and impact health behavioral decision-making research evidence has on clinical
practice.
Even in the different contexts that health behavioral decision-making research has
occurred, systematic reviews and meta-analyses consistently reveal that decision-making is an
individualistic process of weighing and considering various factors (Allan & Harden, 2014;
Poortaghi et al., 2015; Schmidt et al., 2016; Tranberg et al., 2016). Factors most commonly
involved in health-related decision-making include one’s personal and social circumstances like
SES and employment, gender, race/ethnicity, culture, religion/spirituality, neighborhood and
environment, relationship status, and previous experiences (Poortaghi et al., 2015; Popejoy,
2005). Additionally, knowledge and perspectives (i.e., attitudes, beliefs, myths, and motives)
about health, the health behavior, and the disease or condition itself are also weighed in this
process (Bui et al., 2014; Clifford, Ryan, Walsh, & McCurtin, 2017; Dugas et al., 2017;
Hamilton et al., 2016; Keatley, Clarke, & Hagger, 2013; Newson et al., 2013; Nichol et al.,
2011). Replicated studies reporting the same factors in this phenomenon strengthens this
evidence’s reliability to generalize what is typically involved in health behavioral decisionmaking.
Although the literature shows the factors of knowledge, personal and social
circumstances, and perceptions about health, the health behavior, and the health condition to be
involved in health-related decision-making, it is still difficult to generalize and ascertain how
each individual values, weighs, views, and processes those factors. The literature inquiries about
decision-making occur in homogenous populations, as commonly those with similar
backgrounds are more likely to experience and perceive phenomenon in the same way (Popejoy,
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2005); however, researchers are cautioned against generalizing. Decision-making is
individualistic and value dependent, determined by one’s previous and current personal
experiences and circumstances (Allan & Harden, 2014; Bui et al., 2014; Clifford et al., 2017;
Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al.,
2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016). Even within narrowed and
uniquely defined samples, each person is an outlier, as no one’s existence is exactly like another.
Therefore, disseminating and applying study implications to the sample’s larger population is
challenging and limited (Allan & Harden, 2014; Bui et al., 2014; Clifford et al., 2017; Dugas et
al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al., 2011;
Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016). Despite these limitations, decisionmaking research provides health professionals with knowledge that allows them to assist patients
deciphering between health options (Chong et al., 2013; Coombs et al., 2016; Popejoy, 2005;
Rose et al., 2017; Siouta et al., 2015; Thom et al., 2016).
Health Professionals’ Roles
Health professionals play an important role in patients’ health-related decision-making
processes (Chong et al., 2013; Coombs et al., 2016; Popejoy, 2005; Rose et al., 2017; Siouta et
al., 2015; Thom et al., 2016), and knowledge gained from health-behavioral decision-making
research is used to educate and prepare health professionals to function in that role. Healthrelated decision-making evidence informs health professionals about what patients know,
understand, and perceive about the health behavior and condition (Clifford et al., 2017; Thom et
al., 2016). With this knowledge, health professionals are able to clarify patients’
misunderstandings, uncertainties, and concerns regarding the particular health option and
condition. For example, health professionals can offer coaching and support, assisting patients in
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identifying their self-defined goals, applicable choices, and avenues for implementing change
(Popejoy, 2005; Thom et al., 2016). Decisional coaching “provide[s] support to patients to
achieve quality decisions by . . . assessing patient’s level of decisional conflict, knowledge
deficits, [and] their values and [needed] support” (Stacey et al., 2008, p. 25). Similar to the
investigator’s conclusion from the EBIs’ evidence, when engaged and engrossed in health related
decision-making, patients value open communication and the transparent, non-judgmental
exchange of information (Carvajal et al., 2017; Chong et al., 2013; Siouta et al., 2015; Thom et
al., 2016). An increased sense of support and advocacy increases behavioral adherence, which
improves patient outcomes and successes with health choices (Popejoy, 2005; Thom et al.,
2016).
Decision-making research has led to the development and testing of interventions and
tools devised to render support and assistance to patients deciding between available health
options and treatment (Clifford et al., 2017; Dugas et al., 2017; Llic et al., 2015; Mead et al.,
2013). For example, decision aids are complementary tools used to explain and help patients
make decisions by providing information about the available options and possible outcomes
(Clifford et al., 2017; Dugas et al., 2017; Eggertson, 2010; Stacey et al., 2008). A systematic
review of decision aids literature reveals that these tools are treatment-specific and targeted to a
specific population affected by a particular disease (Clifford et al., 2017).
Health-behavioral Decision-making Literature Synthesis
Regardless of the context or situation, synthesis of health-related decision-making
research defines health decision-making as an individual process of weighing different factors
surrounding that behavior or choice that determine one’s implementation or not of that particular
behavior or choice (Poortaghi et al., 2015; Popejoy, 2005). The literature shows the common
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factors involved in this process to include an individual’s social and personal factors, as well as
knowledge and perspectives about health, the health behavior, and the disease (Allan & Harden,
2014; Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et
al., 2013; Newson et al., 2013; Nichol et al., 2011; Schmidt et al., 2016; Tranberg et al., 2016).
These repetitive factors to be a part of health-related decision-making process demonstrate
consistency, strengthening this evidence. Additionally, this evidence is congruent with this
study’s context, as this study explores how HIV-negative MSM make the decision to initiate
PrEP based on their PrEP and HIV knowledge/concerns, social and personal motivations to
initiate PrEP, and abilities to adhere to PrEP. Additionally, these concepts are consistent with
the conceptualization of decision-making in the Information-Motivation-Behavioral (IMB) skills
model. The IMB skills model conceptualizes one’s decision to initiate HIV prevention behaviors
to be based on their knowledge, motivation, and skills surrounding HIV and HIV risk-reduction
behavior (Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher
& Fisher, 1992; Macapagal et al., 2016; L. Smith et al., 2012). From this synthesis, it was
discovered that the proposed study’s conceptualization of decision-making is consistent with the
literature, demonstrating the significance and contribution this study’s findings have on
extending the existing decision-making knowledge base.
Decision-making being individualistic and value dependent (Allan & Harden, 2014; Bui
et al., 2014; Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013;
Newson et al., 2013; Nichol et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al.,
2016), determines this study’s methodology and implications. This review found that most
decision-making research is conducted using qualitative methods (Allan & Harden, 2014;
Hussain et al., 2015; Rose et al., 2017), and this investigator believes this approach is used to
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account for the variances and differences among individuals’ experiences and circumstances
influencing their decisions. This investigator agrees that factors involved in decision-making are
unique and are constructed based on the person’s reality and experiences, justifying this
qualitative exploration into HIV-negative MSM’s PrEP initiation decision-making processes.
The uniqueness and individualism of decision-making restricts generalizability, as findings from
this inquiry into MSM’s PrEP initiation decision-making are reflective of the sampled
participants and possibly MSM with similar experiences and circumstances. Therefore, the
initial implications this study has in the MSM population and PrEP initiation will not be
immediate.
Synthesis of health-related decision-making research implicates the proposed study’s
impact on clinical practice. As seen with the EBIs, health professionals have a pivotal role in
patients’ health-behavioral decision-making processes. The literature demonstrates that
decision-making research allows health professionals to clarify patients’ knowledge and
understanding, and can lead to the development and testing of decision tools and interventions
(Clifford et al., 2017; Dugas et al., 2017; Llic et al., 2015; Mead et al., 2013). Despite the
limitations in transferability, this study’s findings educate nurses on ways and topics for
counseling and supporting MSM considering PrEP, which can increase HIV prevention through
PrEP initiation success. Optimal and accurate PrEP initiation among willing and HIV at-risk
persons is the most effective way for PrEP to have the projected impact on the HIV epidemic
(CDC, 2016e). This study contributes to establishing a foundation regarding MSM’s PrEP
initiation decision-making that can be integral in developing more evidence on this phenomenon
and evidenced-based and best practice interventions for this population.
HIV-negative MSM’s Condom-use Decision-making
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As the first pharmacological HIV preventative regimen, PrEP, finding evidence
comparable to PrEP initiation decision-making in the context of MSM HIV prevention is
difficult. PrEP is indicated in HIV-negative MSM practicing other at-risk behaviors (i.e.,
intravenous drug use (IDU), unprotected anal/vaginal sex with women, serodiscordant
relationship, etc.), but this study investigates PrEP initiation decision-making among MSM who
engage in AI with other men. AI is the primary catalyst driving the HIV incidence disparity in
MSM, as most MSM report engaging in AI (Meng et al., 2015). Additionally, AI is the riskiest
type of sex (CFA, 2014; Pebody, 2010), and the overall most common mode of HIV
transmission (CDC, 2016d). While there are other recommendations in reducing MSM’s HIV
risk during AI, accurate and consistent condom use is the best defense to prevent new HIV
infections (CDC, 2015c, 2016c). Not only is condom-use the best behavior to reduce HIV risk,
but condom use decision-making is frequently investigated in this population regarding HIV
prevention. Therefore, reviewing the literature specific to HIV-negative MSM’s condom-use
decision-making provides a foundation into MSM's HIV-prevention decision-making processes.
Researchers report that MSM understand that condom use is necessary for HIV
prevention (Neville & Adams, 2009; Neville et al., 2016), but MSM recognize that their
community’s commitment to condom-use consistency is an ongoing challenge. A secondary
analysis utilizing data from two previously conducted prospective studies sampling HIVnegative MSM revealed that 84% of MSM do not use condoms consistently (Smith et al., 2015).
This outcome demonstrates that MSM’s decision-making to use condoms is not due to a
knowledge deficit, but to other factors. There is also a consensus that certain situations increase
the chances of engaging in unprotected AI (UAI): internet-hook-ups, dating internet sites and
applications, and substance abuse (Neville & Adams, 2009; Neville et al., 2016). Researchers
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agree that pleasure is another factor in condom-use decision-making, as data showed MSM to
deliberately serosort to avoid condoms, as condoms diminish sexual sensations and penile
erections (Calabrese et al., 2012; Eaton et al., 2009; Neville & Adams, 2009; Neville et al.,
2016). This review was not merely identifying factors influencing MSM’s condom-use decision
making, but understanding how those factors are processed and rationalized in their decisionmaking. Therefore, this section of the literature review is organized thematically according to
the common concepts apparent in HIV-negative MSM’s condom-use decision-making process:
HIV concern, psychosocial issues, and relationship dynamics.
HIV Concern
Researchers found that HIV-negative MSM are concerned about contracting HIV (Balan
et al., 2013; Neville & Adams, 2009; Neville et al., 2016); however, there is no consensus
showing HIV concern to result consistently in MSM deciding to use condoms. Evidence
demonstrates that HIV concern is rationalized in the process, but MSM are shown to decrease
and increase condom use despite or because of the concern, and various phenomenon: ART
success, delayed discounting, barebacking, sexual positions, and “bug-chasers” address the
conflicting findings.
Like many Americans, MSM no longer view HIV as a serious problem or public health
issue (CDC, 2016b). Data analysis from qualitative studies of 960 participants, mixed-methods
studies of 89 participants, and literature reviews of 250 articles have documented the advances in
HIV care have diminished HIV concern (Balan et al., 2013; Neville et al., 2016; Neville &
Adams, 2009). ART has changed HIV from being a fatal disease, to a chronic disease, which
rationalizes some MSM to have UAI, as becoming infected is no longer feared (Balan et al.,
2013; Neville& Adams, 2009; Neville et al., 2016).
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One example showing a decreased fear and concern in contracting HIV, which influences
condom-use decisions, is the concept of delay discounting. As defined by Herrmann et al.
(2015), "delay discounting is how sometimes individuals choose less valuable, immediate
rewards (e.g., UAI with a risky partner) over more valuable, delayed options (e.g., greater odds
of a remaining HIV negative)" (p. 1656). Questionnaires from Herrmann et al.'s (2015) study of
108 MSM practicing UAI revealed that delay discounting is an important factor in condom-use
decision-making, as that sample of MSM discounted the value of protected AI, more so than
increased HIV protection and concern (Herrmann et al., 2015). In most instances, delayed
discounting occurred in the context when a condom was not readily accessible, and immediate
gratification had more value than waiting to use a condom (Herrmann et al., 2015). Results
showed delay discounting to occur most often in MSM who are younger in age, of a lower SES,
abuse substances, routinely engage in sex cognitively impaired, or suffer psychological issues
such as depression; however, the investigators reiterated that delayed discounting to be
individualistic and value-dependent (Herrmann et al., 2015), which is consistent with decisionmaking. Delayed discounting is a relatively new concept in the realm of MSM HIV prevention
and condom use decision-making, making future research necessary for phenomenal
understanding before any conclusions can be determined (Herrmann et al., 2015); however, this
evidence indicates that MSM’s apparent HIV concern does not always result in consistent
condom use.
Barebacking, or the intentional act of engaging in UAI, demonstrates HIV concern exists.
Evidence shows that barebacking has been explored as a factor surrounding HIV concern and
engaging in unprotected sex (Balan et al., 2013; Bauermeister et al., 2009). Balan et al.’s (2013)
investigation of 89 barebacking MSM showed this sample to have HIV concern, however,
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instead of using condoms, the concern led to the substitution of condoms with other prevention
behaviors: serosorting, occasional condom-use, reducing sexual partners, proof of partner’s HIV
and STI status, avoiding persons with STIs, touching and masturbation, and cleansing rituals
(i.e., washing, enemas, gargling, and urination). Upon reviewing the literature, there is not
sufficient evidence to explain the rationale and process behind MSM’s decisions to substitute
these behaviors for consistent condom use. This lack of knowledge makes it difficult to
understand MSM’s thought processes, but confirms MSM’s concerns for contracting HIV cause
them to implement other preventative measures, in addition to occasional condom use.
HIV concern in relation to sexual positioning is also a factor influencing MSM’s condom
use decision-making. Receptive partners have a significantly higher HIV risk than insertive
partners (CDC, 2015c, 2016c; Meng et al., 2015). Neville et al.’s (2016) findings demonstrated
that HIV concern associated with sexual positioning is a part of the condom use decision-making
process. Concern due to positioning determines a need to use condoms, as explained by one
MSM study participant: “we are unwilling to [be on the] bottom without a condom, but we are
willing to [be on] top without using one ourselves” (Neville et al., 2016, p. 3594).
Although not as commonly documented, researchers have reported that some MSM have
a desire to become infected with HIV (Neville & Adams, 2009). “Bug chasers” is the term for
individuals who purposefully engage in UAI with the goal of contracting HIV (Neville &
Adams, 2009, p. 133). Due to the higher risk of HIV transmission as the bottom partner, “bug
chasers” are primarily the receptive partner and refuse to use condoms (Neville & Adams, 2009).
“Bug chasers” are not devoid of HIV concern, as they seek to seroconvert; however, evidence of
their rationale for desiring to become positive is unknown. More data are necessary to
understand this thought process (Neville & Adams, 2009).
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Psychosocial Issues
Social and personal motivations like, psychosocial issues are also involved in MSM’s
condom use decision-making process. Neville and Adams (2009) identified AIDS fatigue or
burnout as a reason justifying UAI. AIDS burnout is “a direct consequence of constant exposure
to prevention messages” (Neville & Adams, 2009, p. 133). HIV is a significant national public
health issue, as HIV prevention campaigns and messages are scattered abound. Qualitative
interviews revealed MSM’s decision to engage in UAI is a form of social resistance to public
standards (Neville & Adams, 2009; Neville et al., 2016). Ironically, decisions to have UAI are
supported with the common notion and cliché that it is a man’s nature to take risks (Neville et al.,
2016). AIDS burnout and social resistance are not common factors a part of decision-making
(Neville & Adams, 2009). At present, further research is needed to understand the impact AIDS
burnout and social resistance have on MSM’s condom use decision-making. Researchers have
more commonly reported intrapersonal influences upon condom use decision-making
(Bauermeister et al., 2009; Neville & Adams, 2009). Depression, low self-esteem, loneliness,
homophobia, and sexual identity conflict are issues and reasons deterring condom use
(Bauermeister et al., 2009; Neville & Adams, 2009). This evidence demonstrates that condomless or UAI is an avenue and mechanism to escape these personal hardships (Neville & Adams,
2009), but it is difficult to understand whether MSM with significant intrapersonal prioritize
escaping personal-psychosocial hardships over a concern of contracting HIV, which warrants the
need for more additional research.
Relationship Dynamics
Relationship dynamics are a factor in HIV-negative MSM’s condom use decision-making
process (Campbell et al. 2014; Neville & Adams, 2009; Neville et al., 2016). MSM’s habit to
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use, or not use, condoms depending on the relationship status being open or closed is well
documented (Neville & Adams, 2009; Neville et al., 2016). MSM routinely report having
protected sex with a casual partner, and having unprotected sex with their main or monogamous
partner (Neville et al., 2016). This literature search, however, sought to understand the influence
relationship dynamics have on condom use decision-making. Partner conversations and
emotions are relationship aspects that MSM commonly state decide condom use.
Partner conversations are a decision-making process of its own, as they involve
discussing each persons’ sexual risks, preferences, and concerns (Campbell et al., 2014).
Campbell et al. (2014) conducted 48 interviews of MSM couples regarding their practice and
outcomes from implicit and explicit sexual decision-making discussions. The findings confirm
stark differences in the rationales and results from each type of discussion. Explicit discussions
among HIV concordant couples involve discussing each partners’ HIV and condom-use
“concern, boundaries, and level of comfort” (Campbell et al., 2014, p. 704). The discussions
allow an open dialogue to express each person’s perspective regarding the risks and benefits of
UAI given their relationship status (Campbell et al., 2014). Campbell et al. (2014) found that a
similar process occurs between HIV discordant couples, but the discussions pertain to each
partner’s comfort level with the HIV risk for the uninfected partner given the positive person’s
HIV treatment, viral load, and CD4 count. With viral suppression, TasP rationalize their
decision to have UAI, as HIV transmission risk is significantly decreased (Campbell et al.,
2014). On the other hand, implicit conversations do not allow partners to acknowledge each
other’s risks and concerns (Campbell et al., 2014). The decision to not use condoms is “just
understood”, as the absence of the “full picture of their partner’s testing and sexual history”
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rationalizes UAI (Campbell et al., 2014, p. 704). Despite MSM’s knowledge of AI being an HIV
risk factor, without a definitive cause of concern, condom-less sex is acceptable.
Other researchers have investigated and found that emotions to rationalize decisions
about condom use (Bauermeister et al., 2009; Goldenberg et al., 2015; Green et al., 2014).
Studies by Goldenberg et al. (2015) and Greene et al. (2014) found that love, intimacy, and trust
between partners decrease condom use. Green et al. (2014) had 23 MSM couples complete
questionnaires and interviews while Goldenberg et al. (2015) conducted interviews and analyzed
diary entries from 25 MSM about the influences of relationship characteristics on condom use
decision making. The presence of love, intimacy, and trust lower the perception of their
partner’s HIV risk and concern, justifying UAI (Bauermeister et al., 2009; Goldenberg et al.,
2015; Green et al., 2014). Lust is another emotion integral to condom use decision-making.
Although lust does not alter risk perception (Goldenberg et al., 2015), lust rationalizes UAI, as
the desire and immediate gratification from UAI is worth the risk (Herrmann et al., 2015).
HIV-negative MSM’s Condom-use Decision-making Literature Synthesis
Synthesis of this literature is consistent with previous explorations of health-related
decision-making research. From this evaluation of MSM's condom-use decision-making
research, health-related decision-making is revealed to be a process of evaluating and assessing
the different personal, social, and knowledge factors surrounding that choice (Poortaghi et al.,
2015; Popejoy, 2005). This evidence confirms that even in a homogenous group, decisionmaking is unique, individualistic, and value dependent (Allan & Harden, 2014; Bui et al., 2014;
Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et
al., 2013; Nichol et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016). This
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conclusion provides further validation of this study’s conceptualization of decision-making, but
also has significant implications for the proposed study’s findings.
Research showed MSM know that condom use is necessary for HIV prevention (Neville
& Adams, 2009; Neville et al., 2016), but MSM still have inaccuracies and misconceptions about
HIV prevention strategies. Balan et al. (2013) reported MSM still believe cleansing rituals like
washing, enemas, gargling, and urination are appropriate substitutes to condom use. Cleansing
rituals have never been an approved HIV prevention behavior since the first HIV incidence in the
1980s. In addition, MSM still errantly rely on perceptions and emotions to determine a current
or potential partner’s HIV risk/status and their decision to use condoms (Bauermeister et al.,
2009; Campbell et al., 2014; Goldenberg et al., 2015; Green et al., 2014). Therefore, this
evidence indicates to the investigator that misconceptions and elements of trust are aspects of
MSM's condom-use decision-making process, warranting the need for decision-making research,
especially with PrEP, a new and unique prevention modality.
As the newest and first pharmacological HIV preventative agent, this investigator
concludes that there may be some possible inaccurate information regarding HIV prevention
through PrEP initiation. Exploring HIV-negative MSM’s decision-making processes to initiate
PrEP may uncover such misconceptions regarding HIV or PrEP. Due to PrEP’s distinct
differences from condoms (i.e., ADR, nephrotoxicity, bone density loss, and unknown adverse
events) (CDC, 2014b), knowledge of the decision-making process is imperative to ensure MSM
accurately understand PrEP’s clinical indications, instructions, and consequences. From these
findings, nurses can devise education and counseling tools that target HIV and PrEP knowledge
inaccuracies and deficits.

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

62

Health behaviors can occur with or without an actual concern (Poortaghi et al., 2015);
however, this literature evidence on HIV-negative MSM’s condom-use decision-making
consistently documented HIV concern as a factor in this process. Despite MSM having any HIV
concern, there is no consensus on how that concern determines MSM’s decision to use or not use
condoms. Despite the lack of consensus regarding how HIV concern influences condom use, the
consistency of HIV concern to appear in condom-use HIV prevention decision-making is the
strength of this evidence, and leads to the conclusion that HIV prevention decision-making is
best understood in the context of HIV concern. For that reason, exploring MSM’s PrEP
initiation decision-making based on HIV concern is a part of this study’s objective. However,
this concept is inconsistently defined, as none of the articles explicitly defined concern.
Participants, investigators, and readers can have their own conceptualization of concern. In
Neville and Adams’ (2009) and Neville’s et al. (2016) studies, concern is assumed to pertain to
susceptibility to contracting the virus. While Balan et al.’s (2013) qualitative analysis perceive
concern to be the difficulties and challenges associated with being HIV positive. The
investigator believes that having both definitions represented in the literature to have equal merit
and relevance to condom-use decision-making, therefore, both types of concern are incorporated
into the proposed study’s investigation into MSM’s PrEP initiation decision-making processes.
The ambiguity associated with how each study defines concern is related to the inconsistency of
researchers to identify or utilize theoretical frameworks that define the conceptualization of HIV
concern. Therefore, another significant finding from this review is the importance of applying an
appropriate theoretical framework.
IMB Skills Model in MSM's HIV Prevention Research
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The IMB skills model guides this study, as it conceptualizes the decision to initiate HIV
risk-reduction behaviors as involving one’s information, motivation, and skills (Aliabadi et al.,
2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992;
Macapagal et al., 2016; L. Smith et al., 2012). Fisher and Fisher (1992) developed this
conceptualization of HIV-related behavior change by conducting an extensive review of AIDS
risk-reduction literature. Information is the knowledge, myths, and means known to reduce HIV
risk; motivation is the attitudes, beliefs, and perceived social support regarding the preventative
behavior; and behavioral skills are the abilities to perform that behavior (Aliabadi et al., 2015;
Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et
al., 2016). This model assumes an individual’s culture, values and beliefs, social standing, SES,
environment, and life circumstances determines their understanding, motivation, and abilities
regarding their decision-making to utilize HIV preventative behaviors (Aliabadi et al., 2015; L.
Smith et al., 2012; Traube et al., 2011), but those factors are not represented in the model. The
absence of these personal demographic characteristics in the model is a limitation, as it does not
provide the complete process involved in initiation of HIV prevention decision-making (Traube
et al., 2011). Despite this limitation, the IMB skills model represents factors shown to influence
initiation of HIV risk reduction behaviors, and is consistent with health-related and HIV-negative
MSM’s condom-use decision-making processes.
The literature shows investigators to use this model to study condom usage in HIVnegative MSM (Macapagal et al., 2016), PLWH medication adherence and retention in care
(Amico et al., 2005; Amico et al., 2009; Horvath et al., 2014; Rongkavilit et al., 2010; L. Smith
et al., 2012), and to develop and test interventions (Aliabadi et al., 2015; Chang et al., 2014). To
account for variances in HIV prevention behavioral decision-making, Aliabadi et al. (2015)
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states that using a qualitative approach is appropriate with the IMB skills model so information
can be elicited using dialogue and open-ended questions. Adherence to this recommendation is
apparent, as the IMB skills model is commonly applied in large qualitative studies using semistructured interviews and focus groups (Chang et al., 2014; Horvath et al., 2014; Macapagal et
al., 2016; Rongkavilit et al., 2010) with samples utilizing 96 (Macapagal et al., 2016) to 312
participants (Horvath et al., 2014). Therefore, the evidence validates the investigator’s chosen
methodology for conducting this exploration into HIV-negative MSM’S PrEP initiation decisionmaking processes.
MSM and PrEP
Despite FDA approval in 2012, there is a paucity of literature on PrEP initiation decisionmaking in any population. Most of the available literature pertains to PrEP’s pre-approval
clinical trials, effectiveness and efficacy, health professionals’ perspectives, and clinic start-ups.
Therefore, this literature review establishes the knowledge base for the proposed study by
synthesizing the available evidence of MSM’s PrEP interest, initiation, and decision-making.
Interest
Although only 25% of MSM in America report being knowledgeable of PrEP (AlTayyib, Thrun, Haukoos, &Walls, 2014; Raifman, Flynn, & German, 2017), PrEP interest is
high in the MSM community. Studies show MSM’s PrEP interest arises from a desire to
promote health and enhance sexual pleasure (Brooks et al., 2012; Collins et al., 2016; Gamarel &
Golub, 2015;Garcia & Harris, 2017; Golub, Gamarel, Rendina, Surace, & Lelutiu-Weinberger,
2013; Mimiaga, Closson, Kothary, & Mitty, 2014; Oldenburg et al., 2016; Taylor et al., 2014).
These studies sampled anywhere from 19 to 699 MSM in serodiscordant relationships through
semi-structured interviews, focus groups, and online and paper questionnaires in Boston, MA;
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Pittsburg, PA; San Juan, Puerto Rico; and Atlanta, GA. PrEP is believed to empower MSM to
practice proactive HIV prevention as opposed to post-exposure reactivity (Oldenburg et al.,
2016). During PrEP clinical trials, MSM study participants were motivated to participate to
“protect themselves” and to assist in preventing future infections (Taylor et al., 2014, p. 875).
Due to condom failures and inconsistent use, MSM found comfort in PrEP’s added protection
(Collins et al., 2016). The added protection reduces anxiety and shame associated with risky
sexual behaviors, as well as reduces fears of contracting the virus when MSM have AI with a
person with a positive or unknown HIV status (Brooks et al., 2012; Collins et al., 2016; Mimiaga
et al., 2014; Oldenburg et al., 2016; Taylor et al., 2014).
Researchers found that MSM believe an increase in UAI will be a motivating factor
leading to their peers’ decision to initiate PrEP (Brooks et al., 2012; Collins et al., 2016; Garcia
& Harris, 2017; Golub et al., 2013; Oldenburg et al., 2016; Perez-Figuerora et al., 2015; D.
Smith, Toledo, Smith, Adams, & Rothenberg, 2012; Taylor et al., 2014). Risk compensation is
the purposeful increase in HIV risky behaviors while taking PrEP (Blackstock et al., 2016;
Calabrese et al., 2014; Calabrese & Underhill, 2015; Karris et al., 2014; Yagoda & Moore,
2016). Findings from PrEP clinical trials did not show any evidence of risk compensation to
occur (CDC, 2014b; Marcus et al., 2013; McCormack et al., 2016; Mugwanya et al., 2013), but it
is speculated that PrEP may lead to intentional UAI for increased intimacy and pleasure (Collins
et al., 2016; Gamarel & Golub, 2015), which is lost when using condoms (Calabrese et al., 2012;
Calabrese & Underhill, 2015; Higgins & Wang, 2015). These perspectives, however, are only
assumptions, as the problem is that MSM’s PrEP initiation decision-making processes are
unknown.
Initiation
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Gilead® surveyed U.S. retail pharmacies about the occurrence of patients filling a PrEP
prescription for the first time during 2012 and 2015 (NAM, 2018). During the three year period,
49,158 patients were dispensed their initial PrEP prescription from a reporting pharmacy (NAM,
2018). Most patients initiating PrEP are White (74%) followed by Hispanics (12%), AfricanAmericans (10%), and Asians (4%) (NAM, 2018). This data also show males (79%) to initiate
PrEP more commonly than women (NAM, 2018). Lastly, the data indicates that PrEP patients
are older in age, as 8% of patients are younger than 25 years of age (NAM, 2018). This recent
data from Gilead® is similar to initial statistics about PrEP patients, as Rooney (2013) reported
the average PrEP patient is 37 years of age and male. Furthermore, researchers consistently
report most current and former PrEP patients are MSM (Krakower et al., 2015; Rooney, 2013;
Tellalian et al., 2013). Despite MSM being the most common PrEP consumers, approximately
3% of the MSM population are or have ever initiated PrEP (Krakower & Mayer, 2015). The
literature offers speculated reasons as to why PrEP initiation is low, not only in MSM, but
nationally as well.
Poor PrEP initiation is speculated to be the result of structural barriers (Auerbach et al.,
2015; Flash et al., 2014; Oldenburg et al., 2016; Perez-Figueroa et al., 2015; Rolle et al., 2017;
Taylor et al., 2014; Underhill et al., 2014; D. Smith et al., 2012). Stigma is a barrier to PrEP
initiation from survey (Dolezal et al., 2015; Eaton et al., 2014; Oldenburg et al., 2016), focus
group (D. Smith, et al., 2012; Taylor et al., 2014), and semi-structured interview studies (Collins
et al., 2016; Golub et al., 2013; Perez-Figuerora et al., 2015). These studies have occurred
throughout the U.S., but primarily in areas with high HIV rates and MSM populations: Atlanta,
GA; Baltimore, MD; Boston, MA; New York, NY; Pittsburg, PA; San Juan, Puerto Rico, and
Seattle, WA utilizing samples of 14 to 699 MSM. PrEP patients are stigmatized as “Truvada
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whores”, undermining HIV prevention and PrEP initiation (Calabrese & Underhill, 2015; Haire,
2015). Perceived negative stigma and judgmental reactions from peers and health professionals
are believed to deter MSM from seeking and initiating PrEP (Auerbach et al., 2015; Collins et
al., 2016; Dolezal et al., 2015; D. Smith, et al., 2012); however, this is only a presumption.
Another barrier to PrEP initiation is inaccessibility due to high cost and lack of insurance
coverage (Oldenburg et al., 2016; Perez-Figueroa et al., 2015; Rolle et al., 2017; D. Smith et al.,
2012; Taylor et al., 2014). Patients are more willing to use PrEP if it is conveniently available at
minimal or no cost (Golub et al., 2013; D. Smith et al., 2012). Insurance coverage and cost does
not only implicate the ability to purchase the drug, but returning for required routine follow-up
care at least quarterly (Oldenburg et al., 2016; Perez-Figueroa et al., 2015; Rolle et al., 2017; D.
Smith et al., 2012; Taylor et al., 2014). Rolle et al. (2017) conducted a study among 184 PrEP
eligible young Black MSM to understand PrEP initiation in this population in the absence of
accessibility and cost barriers. In this MSM sample, 63% (n=116) expressed PrEP interest and
were notified that participation provided them with access to the medication and required followup care at no cost (Rolle et al., 2017). Despite these favorable conditions, only 34% (n=63)
actually initiated PrEP (Rolle et al., 2017); however, the study provides no evidence explaining
how participants made their decision. Even in the absence of structural barriers, initiation was
less than optimal, therefore, leading this investigator to presume that the decision to initiate PrEP
to encompass more than overcoming structural barriers, and reiterates the need for the proposed
study’s inquiry into MSM’s PrEP initiation decision-making processes.
Decision-making
This literature review contained two publications regarding PrEP decision-making in
MSM. Garcia and Harris (2017) analyzed survey results from their study of 159 Latino MSM
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currently taking PrEP in San Antonio, TX. Garcia and Harris (2017) found that the main reason
for initiating PrEP was that the participants had multiple sex partners (34.7%) and did not want
to become HIV infected (40%). Only 1.6% of the sample evaluated engagement in condom-less
sex as a reason to initiate PrEP (Garcia & Harris, 2017). One other article explored MSM PrEP
patients’ experiences taking PrEP in a real-world context. Parker et al. (2015) conducted
qualitative interviews of 24 MSM PrEP patients in Providence, RI. Most participants engaged in
inconsistent or condom-less sex and did not use any other HIV preventative behaviors (Parker et
al., 2015). The participants were currently on PrEP and had been on the regimen for at least
three months prior to study participation. Patient interviews surrounding PrEP experiences
included a variety of topics: cost and insurance issues, risk compensation, interest, and which
medical specialties were providing PrEP. Parker et al. implied that MSM’s decisions to initiate
PrEP were made in order to reduce their risk or concern of contracting HIV. Additionally,
participants reported that despite being on PrEP, choosing to use condoms is still a complex
process; however, the participants did not show evidence of risk compensation, as there was not
a reported increase in HIV risky encounters and behaviors (Parker et al., 2015).
Other available evidence on PrEP initiation decision-making is speculative. From this
review, two articles provided knowledge of MSM’s condom-use decision-making in the
hypothetical context of PrEP. Koblin et al. (2011) inquired about the efficacy of PrEP’s
influence on condom use decision-making among a sample of 630 MSM who engaged in both
UAI and in AI while under the influence of alcohol or non-injection drugs. At the time the study
was conducted, PrEP’s efficacy was definitively unknown; therefore, Koblin et al. (2011)
utilized PrEP’s efficacy uncertainty as a variable to gauge condom-use decision-making. Most
of Koblin and colleagues’ high-risk sample reported that they would eliminate condom-use only
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if PrEP has a moderate to maximal efficacy, as it reduces the level of HIV concern for
contracting the virus (Koblin et al., 2011). Although this evidence reiterates the importance HIV
concern plays in HIV-prevention decision-making, this evidence would have more significance if
conducted in a sample with less HIV risk factors. This HIV high-risk sample already engaged in
UAI in the absence of PrEP, and this investigator believes the research purpose would have had
more meaning in a sample of MSM reporting consistent condom use. Therefore, these results
only validate the need for PrEP availability.
On the other hand, Hoff et al. (2015) qualitatively explored anticipated condom use
among 48 MSM in HIV-negative concordant (n=26) and discordant couples (n=22) (Hoff et al.,
2015). Findings were not conclusive, as results equally reported participants to continue and
discontinue condoms in conjunction with PrEP (Hoff et al., 2015). Additionally, most
participants viewed the decision to initiate PrEP to be made after engaging in an explicit
conversation with their partner (Hoff et al., 2015). Although seemingly favorable, these results
do not provide any significance, as the investigators did not collect couples’ current condom-use
habits. Therefore, the effect PrEP would have on condom-use in this sample cannot be
determined. In regards to decision-making, this evidence does not provide any data on MSM’s
PrEP initiation decision-making processes, as the study’s occurred in the hypothetical context of
PrEP.
MSM and PrEP Literature Synthesis
This evidence concluded that MSM’s PrEP initiation decision-making process is
currently insufficient for understanding this phenomenon. Demographic and statistical data on
PrEP initiation demonstrates that the most HIV-vulnerable population, MSM, is initiating PrEP.
Although that data is optimal, these survey findings cannot determine these patients HIV risks
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and PrEP clinical indications, or their decision-making processes to initiate PrEP. Evidence
from Hoff et al. (2015) and Koblin et al. (2011) is speculative, and Garcia and Harris’s (2017)
research findings only reveal that MSM initiate PrEP out of the behaviors and factors they
perceive to increase their HIV risk and concern. While this is a part of decision-making, this
evidence does not provide the depth necessary to contribute to decision-making literature, as the
factors and processes involved in how MSM derive to their decision is absent.
Knowledge Gap
Research into MSM's PrEP initiation decision-making is imperative. The literary
findings cause one to presume that MSM to currently have HIV prevention misconceptions and
may have misconceptions about PrEP. PrEP is a complementary regimen, and is to be used in
combination with other HIV prevention behaviors, especially consistent condom use (CDC,
2014b). This review’s synthesis of the few studies specific to MSM and PrEP showed MSM
have a misconception about this requirement, and demonstrates that MSM will require support,
education, and behavioral counseling when considering PrEP initiation. Due to the implications
of decision-making evidence, research into PrEP decision-making from actual patients is
necessary (Hoff et al., 2015; Koblin et al., 2011) to understand what MSM patients know and
understand about PrEP.
The proposed study is foundational evidence to fill this knowledge gap. Decisionmaking details what and how individuals consider and evaluate the different factors surrounding
a choice or option (Poortaghi et al., 2015; Popejoy, 2005). The study’s objective is to explore
how HIV-negative MSM decide to initiate PrEP based on their: (a) PrEP knowledge and HIV
concern(s)/risk(s); (b) personal and social motivations to initiate PrEP; and (c) behavioral skills
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and abilities to adhere to PrEP. Knowledge from this study details the factors and aspects that
are considered and weighed during the PrEP initiation decision-making process.
Summary
In summary, the personal endeavor of decision-making makes a qualitative approach
appropriate, as this methodology gives voice to the emic view and participants’ realities and
perspectives (Streubert, 2014; Toles & Barroso, 2014b). Health professionals, however, should
be cautious in determining study implications, as even in the presence of consistent and
replicated evidence, personal and social perspectives and circumstances make generalizing study
findings difficult (Bauermeister et al., 2009; Campbell et al. 2014; Goldenberg et al., 2015;
Greene et al., 2014; Herrmann et al., 2015; Neville & Adam, 2009). Despite the transferability
limitations, decision-making research is still valuable, as decision-making research allows health
professionals to clarify patients’ knowledge and understanding (Clifford et al., 2017; Dugas et
al., 2017; Llic et al., 2015; Mead et al., 2013). Information gleaned from the proposed study
educates nurses about the topics and techniques needed to support and coach patients during this
process. This study lays the foundation for nursing research, as future studies are replicated to
develop and refine these findings. Additionally, this foundational study can contribute to the
development and testing of decision tools and interventions, which can be used to assist and
educate patients during PrEP initiation decision-making process. That evidence can determine
the best strategies for achieving MSM HIV PrEP prevention success.
The literature shows health-related decision-making to be an individual process of
weighing different personal, social, and knowledge factors surrounding that behavior or choice
(Poortaghi et al., 2015; Popejoy, 2005). While the literature exhibits a consensus that these are
the primary factors involved in health-related decision-making, there is no consensus on how
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each individual evaluates and views these factors. These factors are value dependent, influenced
by previous and current circumstances (Allan & Harden, 2014; Bui et al., 2014; Clifford et al.,
2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol
et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016). Research also
demonstrates individuals perform health behaviors consciously or subconsciously aware of
health concerns (Poortaghi et al., 2015), but MSM’s condom-use decision-making found HIV
concern to be consistently a part of the process (Balan et al., 2013; Bauermeister et al., 2009;
Campbell et al. 2014; Neville et al., 2016; Neville & Adams, 2009). This investigator concludes
concern to be an influential factor into HIV prevention behavior decision-making, which now
extends to PrEP initiation. PrEP initiation is deliberate, as it is initiated purposefully and
intentionally out of a personal HIV concern. Two types of concern are apparent in the literature
(i.e., HIV concern regarding susceptibility and concern about living with the virus), and both
concern types have merit in deciding HIV preventative behaviors and this exploration.
The CDC’s compendium demonstrates that knowledgeable health professionals are
integral to increasing MSM’s use of risk-reduction behaviors, as MSM need support and
guidance from a professional, trusted resource, or program knowledgeable in HIV prevention in
order to increase utilization of HIV risk reduction behaviors (CDC, 2017a, 2017c). Additionally,
the compendium revealed that MSM are receptive to the counseling and support rendered by
health professionals with a respectful and non-judgmental rapport. Health professionals’ abilities
to intervene during the decision-making process are imperative for MSM, as this review shows
misconceptions regarding HIV prevention behaviors still exist. PrEP initiation presents potential
risks unlike any other HIV preventative intervention (i.e., acquired drug resistance (ADR),
nephrotoxicity, bone density loss, and unknown adverse events) (CDC, 2014b), making

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

73

knowledge of the understandings, motives, and abilities MSM patients have determining their
decisions to initiate PrEP imperative to their overall health.
While studies by Garcia and Harris (2017) and Parker et al. (2017) offer some evidence
into this population’s decision-making, these investigations’ research designs and questions only
validate and confirm MSM initiate PrEP to prevent HIV, which is a known and appropriate
clinical indication. Structural barriers are believed to be factors in MSM’s decision-making
process, but this belief has not been evaluated. Research in PrEP decision-making from actual
patients is necessary to understand the phenomenon of PrEP initiation (Hoff et al., 2015; Koblin
et al., 2011). The proposed investigation contributes to filling this knowledge gap, as the
purpose is to explore MSM’s decision to initiate PrEP based upon their evaluation and
perceptions pertaining: (a) PrEP knowledge and HIV concern(s)/risk(s); (b) personal and social
motivations to initiate PrEP; and (c) behavioral skills and abilities to PrEP adherence.
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Chapter 3: Methodology
The methodology for this study was Sandelowski’s qualitative description. Qualitative
description is rooted in naturalistic research and constructivism, used to gather, understand, and
describe individuals’ authentic experiences (Colorafi & Evans, 2016; Neergaard et al., 2009;
Polit & Beck, 2012; Sandelowski, 2000, 2010; Willis, Sullivan-Bolyai, Knafl, & Cohen, 2016).
Naturalistic research is best when studying a new phenomenon, so that participants can speak
their truth, uninfluenced by outsiders’ expectations, as each individual’s personal, social, and
environmental factors shape human experiences, and this methodology focuses on understanding
the contextual, cultural, personal, and social aspects of a phenomenon (Creswell, 2013; Frey et
al., 1999; Polit & Beck, 2012; Willis et al., 2016).
Health-behavioral decision-making is the process of weighing different factors
surrounding a behavior or choice, which determines if one will implement or not implement the
respective behavior or choice (Poortaghi et al., 2015; Popejoy, 2005). Decision-making is
individualistic and value dependent, determined by one’s previous and current experiences and
circumstances (Allan & Harden, 2014; Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017;
Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al., 2011; Poortaghi et
al., 2015; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016). Other factors commonly
involved in health-behavioral decision-making include one’s knowledge and perspectives about
health, the behavior, and the disease (Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017;
Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al., 2011). The
personal nature of decision-making is congruent with qualitative description’s philosophical
view to understand and describe authentic experiences (Colorafi & Evans, 2016; Neergaard et
al., 2009; Sandelowski, 2000, 2010; Willis et al., 2016).
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The Information-Motivation-Behavioral (IMB) skills model guided this inquiry, as it
conceptualizes HIV risk-reduction decision-making to include an individual's knowledge,
motivation, and skills regarding the HIV prevention behavior (Aliabadi et al., 2015; Amico et al.,
2005; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016; L. Smith et al., 2012).
In this framework, knowledge includes all the information, both accurate and mythical, about the
preventative behavior; motivation encompasses social and personal support and perspectives
regarding the behavior; and behavioral skills are the necessary abilities to perform the behavior
(Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher &
Fisher, 1992; Macapagal et al., 2016); however, MSM’s HIV prevention literature showed that
HIV concern is also a factor in their decision-making. Therefore, consistent with the model’s
concepts and the literature, this study explored HIV-negative MSM’s PrEP initiation decisionmaking based on their (a) PrEP knowledge and HIV risk(s)/concern(s); (b) personal and social
motivations to initiate PrEP; and (c) behavioral skills and abilities to PrEP adherence. Similar to
decision-making literature, a qualitative approach is best when using this model, as the use of
dialogue and open-ended questions will allow the phenomenon to be explored in-depth (Aliabadi
et al., 2015).
Conducting one-on-one semi-structured interviews was the method for collecting data, as
it offered several benefits to the study’s findings and participants. One-on-one interviews
provided each participant increased anonymity given the stigma surrounding their sexual identity
and PrEP (Calabrese & Underhill, 2015; Haire, 2015). This method allowes an exploration into
participants' PrEP initiation decision-making processes authentically and uninfluenced by others,
giving a voice to the emic view (Hutchinson, Wilson, & Wilson, 1994; Streubert, 2014). Lastly,
this qualitative research may have provided a therapeutic benefit to participants, as expressing
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their feelings and perspectives in an open conversation could have fostered an internal feeling
and sense of acknowledgement, catharsis, purpose, and empowerment (Hutchinson et al., 1994).
Conducting this study with a qualitative description design implicates clinical practice
and future studies. Qualitative description is appropriate when there is a need to answer
questions influencing clinical practice (Sandelowski, 2000). Additionally, qualitative studies are
also indicated and useful in research instrument development (i.e., decision aids and coaching
strategies) (Toles, & Barroso, 2014b). Health professionals are advocates in patients’ decisionmaking processes, rendering support and education to patients when choosing the treatment
course and option best suited and congruent with patients' self-identified health goals (Carvajal et
al., 2017; Chong et al., 2013; Mead et al., 2013; Popejoy, 2005; Rose et al., 2017; Stacey et al.,
2008; Tariman & Szubski, 2015; Thom et al., 2016). This study’s findings of MSM’s
knowledge, motivations, and skills to initiate PrEP revealed this sample’s PrEP knowledge, and
their perceptions regarding their HIV risk(s)/concern(s) also revealed their understanding about
HIV. With this data, health professionals are able to identify opportunities to assist patients in
resolving occurrences of internal and external conflict, PrEP and HIV etiology
misunderstandings, or other concerns when deciding to initiate PrEP. Findings from this study
help identify factors influencing MSM’s PrEP initiation decision-making process and may
provide content for health professionals to educate, support, and coach patients during this
process. The proposed study is foundational, extending the knowledge base of health-behavioral
decision-making, HIV prevention, and MSM and PrEP initiation, contributing to future
development of evidenced-based strategies and tools best for counseling and supporting MSM
during this process leading to HIV prevention success through PrEP initiation. This chapter
details the study procedures the investigator followed to conduct this study.
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Study Procedures
Study procedures explicitly describe the process for recruiting and collecting data from
participants. For a qualitative investigation to be trustworthy, the study procedures must match
and align with the research objective, literature findings, theoretical framework, and
methodology (Colorafi & Evans, 2016; Neergaard et al., 2009). Although the timeframe for
performing and conducting a study from start to completion cannot be predetermined, the
investigator anticipated this study to be conducted over a twelve-month period. Appendix C
displays the timeline of study milestones from study approval to study closure.
Human Subjects’ Protection
Protecting the safety and confidentiality of research participants included receiving the
appropriate approvals and securing participant data. The investigator received approval from
Kennesaw State University’s (KSU) Institutional Review Board (IRB) in March 2018, and
adhered to their research and ethical principles. Additionally, the investigator sought and
received approvals from identified and consenting PrEP practices’ administrations and research
departments between March and August of 2018. Interested patients meeting the inclusion
criteria underwent informed consent, and after giving written informed consent, the participant
was enrolled into the study, assigned a participant identification (PID) number, and provided a
pseudonym. When disseminating this study's findings in publications or conference
presentations, the investigator will refer to the participants using their pseudonym or PID
number.
Upon the completion of the written consent and enrollment forms, the documents were
scanned and saved onto a password protected and encrypted thumb drive. All hardcopy forms
were locked and maintained in the investigator’s office. Each participants’ audio recordings,
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transcripts, data analyses, and field notes were identified according to the participant’s PID
number and scanned and saved on the thumb drive. Study related materials (i.e., thumb drive,
audio recordings, transcripts, etc.) were kept in a locked cabinet in the investigator’s office. This
information will be stored in the investigator’s locked office three years post-study closure or
according to KSU’s IRB’s guidelines. Once the span of time has expired, all study related
materials will be shredded and discarded according to KSU's guidelines.
Setting
The setting is the place where participant recruitment will occur. Participants were
recruited from identified clinics with from providers offering PrEP and PrEP services; however,
interviews occurred at the recruitment clinic, public library, office, conference room or location
providing participants with comfort, privacy, and anonymity.
Identify PrEP clinics. Recruitment for qualitative studies typically occur in an area
commonly affiliated with, or frequented by the study population of interest (Toles & Barroso,
2014a). The proposed study sought to identify HIV-negative MSM's PrEP initiation decisionmaking process; therefore, participant recruitment targeted MSM PrEP patients. Since PrEP is a
preventative regimen, there is no funding source for these clinics, as federal and state programs
like the AIDS Drug Assistance Program (ADAP), and Ryan White Care Act Part B only fund
HIV/AIDS’ treatment efforts, not prevention efforts (Horberg & Raymond, 2013; McMahon et
al., 2014). As a preventative regimen, any clinician with prescribing authorities or capabilities
can prescribe PrEP, but from this investigator’s own experience, most PrEP clinics are started as
another service or discipline within an HIV clinic. Additionally, patients are referred by word of
mouth from peers or from accessing a service in a facility that provides PrEP.

Therefore, the

investigator identified clinics with health professionals known and documented to offer PrEP
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services in the states of Alabama and Georgia. The investigator searched the Greater Than AIDS
website, https://greaterthan.org/get-prep/PrEP, a site used to provide HIV/AIDS information
including clinics and providers known to offer PrEP. The investigator also identified PrEP
clinics and providers by gathering information from Alabama’s and Georgia’s state health
departments' HIV/AIDS division, and Appendices D and E provide a list of those identified
clinics and providers. Due to slow recruitment, the investigator identified other PrEP clinics and
providers in other parts of the Southern U.S. using the Greater Than AIDS website and
respective state health departments' HIV/AIDS divisions. Specifically, the investigator contacted
clinics in Florida, Mississippi, and Louisiana to gauge their interest in participating.
Access PrEP clinics. Once identified, the investigator contacted the PrEP clinics for
permission to recruit study participants. Each contacted practice received a recruitment
invitation letter and study synopsis (see Appendices F and G, respectively). The investigator
requested a face-to-face meeting with the necessary administration and staff to further describe
the study and to answer any questions; however, most correspondences occurred through
electronic mail (email) and phone conversations. Once granted permission to recruit, the
investigator provided recruitment handouts and posters (see Appendix H and I, respectively) to
those consenting facilities. Clinic staff disseminated or made the recruitment materials available
and visible to patients in waiting areas and examination rooms. By this recruitment strategy,
patients made the choice to participate in the study, which was thought to make providers feel
more comfortable with supporting the study, as the investigator did not have access to patient
records. The handout had a brief study synopsis and the investigator’s contact information.
With the permission of the facility, the investigator was willing to be on-site during clinic hours

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

80

at least once a week to recruit and answer questions from staff and patients. Given the fact that
these clinics provided services and care to PLWH, such permissions were not granted.
Sample
Although qualitative descriptive researchers commonly use purposeful sampling, as it
gives researchers immediate access to the population specifically experiencing the investigated
phenomenon (Colorafi & Evans, 2016; Neergaard et al., 2009; Sandelowski, 2000), but the
investigator used convenience and snowball sampling. Convenience sampling is “the use of the
most readily accessible persons” as research participants (Haber, 2014, p. 236), as participant
recruitment occurred at PrEP clinics that were not specific to serving MSM alone. As the
investigator identified study participants, snowball sampling occurred as she asked participants
to refer the study to other potential study participants (Polite & Beck, 2012).
In qualitative studies, an exact sample size is difficult to predict, as data saturation
determines the sample size. Although an exact number of participants can be difficult to
estimate, researchers have given guidance on potential sample size for qualitative research
studies. Recommendations for understanding the essence of experiences tend to have a sample
of six (Sandelowski, 1995). Mason (2010) stated that the average sample size used in doctoral
qualitative research studies was 31. For a fairly homogenous group, data saturation could occur
with a sample size of 12 (Boddy, 2016). Similarly, Toles and Barroso (2014a) concluded that a
sample size of less than 30 participants is best given the significant amount of text to be
analyzed. A systematic review reported qualitative descriptive sample sizes to use between 11
and 20 participants (Kim, Sefcik, & Bradway, 2017). Lastly, Parker et al.'s (2015) qualitative
inquiry of MSM PrEP patient experiences used 24 participants. Therefore, given the variances in
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qualitative studies’ sample size, the investigator anticipated a sample size of 10 to 30 participants
in order to achieve data saturation.
Inclusion criteria. To be eligible for this study, participants had to meet all of the
following inclusion criteria at the time of consent: (a) assigned a sex of male at birth; (b) 18
years of age or older; (c) verbally confirm engagement in anal intercourse (AI) with men; (d)
currently taking PrEP; (e) began taking PrEP in the past six months; (f) verbally confirm being
HIV-negative; (g) read, speak, understand, and write English; and (h) provide written informed
consent.
Participant recruitment. Participant recruitment began when a patient voluntary
contacted or approached the investigator by phone or on-site for study information. The
investigator provided an overview of the study, and asked three questions:
1. Did you start taking PrEP in the last six months?
2. Do you have sex with men?
3. Are you at least 18 years of age?
If the participant answered “no” to any of the questions then they did not meet the study’s
criteria. If the participant answered “yes” to all questions, the investigator made an appointment
with the patient. The participant was instructed that during this appointment the informed
consent and study requirements will be reviewed. Additionally, the participant was told to bring
their PrEP prescription bottle to validate they were taking PrEP. Participants were encouraged to
ask any questions pertaining to the study. The investigator told the participant to allot for two
hours, as after the consenting process concluded, the interview began. Although this did not
occur in this study, participants had the option to separate the consenting and interview
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processes. In that event, the initial appointment was anticipated to last up to an hour to conduct
the informed consent process only.
The investigator and participant discussed potential dates, times, and locations for this
meeting. The investigator was aware that depending on space and availability, utilizing the
clinic to meet with participants was not be feasible or guaranteed. Therefore, the investigator
proposed a secondary interview location, offering participant anonymity and confidentiality. A
public library, office, or conference room with a closed door offered the necessary privacy and
anonymity for participants. Due to safety concerns, if a mutual location and time could not be
agreed upon, the investigator declined pursuing any further research activities with the
participant.
During the initial appointment, the investigator determined the patient’s eligibility. First,
the participants confirmed they (a) were assigned a sex of male at birth; (b) were 18 years of age
or older; (c) engaged in AI with men; (d) were currently taking PrEP; (e) began taking PrEP in
the past six months; (f) were HIV-negative; and (g) could read, speak, understand, and write
English. To verify the participant’s PrEP status, the investigator looked at the prescription bottle
verifying that Truvada was dispensed to the consenting participant within the past month.
Second, the investigator detailed the study requirements: (a) informed consent, (b) one 60-minute
audio recorded interview, and (c) completion of a demographic form. Participants were
informed that after completing the interview and demographic form they would be compensated
with a $30 Visa® credit gift card for their time. The investigator detailed the steps taken to
protect their confidentiality, and clarified any study related questions. Lastly, the investigator
reiterated that participation was voluntary, as consent could be withdrawn at any time without
penalty, and had no impact on care or services receiving at the current or any PrEP location. If
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the participant agreed to the research procedural terms, the participant underwent the informed
consent process.
Informed Consent
Each eligible and willing participant underwent informed consent. The participant was
given the most currently approved consent form (see Appendix J), which detailed the study
purpose and procedures, and the investigator read and reviewed the form with the participant.
All study questions were answered at that time and at any point during study enrollment. For
participants unwilling to provide consent, the investigator discontinued all study procedures with
the participant. In the future, if the participant wished to be a part of the study, they would have
to contact the investigator. Consenting participants provided their legal signature in the indicated
areas on two copies of the most current and approved consent form. The investigator likewise
signed in the appropriate places on both copies. The investigator and participant each kept one
of the signed consent forms to keep for their records. The research participant had the right to
withdraw their consent verbally at any time during study enrollment.
Researcher-participant Relationship
Trust, respect, and empathy are actions believed to establish rapport with the participant,
so that the participant can be authentic during the interviews (Dang, Westbrook, Njue, &
Giordano, 2017). A neutral relationship and rapport tactics allow participants to not feel judged
by their answers, or respond in a manner perceived to be pleasing to the investigator (Dang et al.,
2017); therefore, the investigator maintained a neutral and impartial stance and relationship with
participants. Additionally, the investigator built rapport by completing agreed upon tasks (i.e.,
return phone calls, timeliness of appointments and meetings), being open and honest in
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answering participants’ questions, and respecting participants’ choices (i.e., study participation,
sexual behaviors, PrEP initiation, and information uncovered during interviews).
Study Enrollment
Once written consent was attained, the participant was enrolled in the study. The
investigator completed the Study Enrollment Form (see Appendix K), which documented the
participant’s eligibility. The participant was assigned a PID number, beginning with PID-001,
and was provided or assigned a pseudonym.
Research Instruments
In qualitative research, the primary research tool is the interviewer (Creswell, 2013), but
participants dominated the discussion, with the investigator guiding the interview. The
investigator followed the six-item interview guide (see Appendix L), asking probing questions to
gather more information or gain more clarity regarding the responses. The demographic form
(see Appendix M) was completed by the participant at the end of the interview which collected
the participants’ age, race, ethnicity, annual income, PrEP start date, AI behaviors, number of
sexual partners in the previous 3 months, and condom-use percentage. The interview guide and
demographic form were specifically developed for this study. Although this weakens the
validity and reliability of the tool, the theoretical framework was used to construct the guide.
Immediately after completing the interview, the investigator took field notes, documenting
participants’ nonverbal and/or emotional behaviors.
Conducting Interviews
Participant interviews occurred after written consent was obtained. Although this did not
occur during this investigation, the investigator devised a contingency plan for patients wishing
to separate the consenting and interviewing processes. In those circumstances, the investigator
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would have scheduled the interview immediately after the patient provided written informed
consent. When scheduling the interviews, the investigator would have utilized the same
procedures identified in the initial appointment procedure. Conducting participant interviews in
the same location as the initial appointment would have been encouraged, but not guaranteed.
Pre-interview procedures. Prior to each interview, the investigator self-identified all
assumptions and biases related to MSM and PrEP. These self-identified assumptions were
written down and bracketed. Bracketing is the process of the investigator acknowledging
personal biases regarding the phenomenon and clarifying how those biases can influence and
misconstrue the interpretation of the participants' interviews (Toles & Barroso, 2014b). For this
study, the investigator identified and reported personal feelings, beliefs, and experiences
pertaining to PrEP and MSM. Twenty-four to 48 hours before meeting with a participant, the
interviewer confirmed the interview location, date, and time with the participant. The
investigator documented the confirmation or any changes to the agreed upon plans on the study
participant's enrollment form. This allowed time to prepare for the interview, and ensured the
setting still met the anonymity and confidentiality requirements.
Interview procedures. During the interview, the investigator followed the six-item
interview guide. The interviewer had bottled water and tissues on site for participants' use.
Additionally, the interviewer utilized two audio recording devices during the interviews.
Post-interview procedures. Post-interview, there were requirements for both participants
and the investigator. Participants completed the demographic form, and the investigator gave the
participant a $30 Visa® credit gift card. Each participant acknowledged receiving compensation
at that time by completing the indicated area on the demographic form. Once completed, the
participant was un-enrolled from the study. The investigator took field notes, to capture
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participants’ nonverbal and/or emotional behaviors they exhibited during the interview. Postinterview, journaling is encouraged as it allows the investigator to bracket biases before
conducting additional interviews (Toles & Barroso, 2014b). Therefore, the investigator also set
aside time for reflective journaling to identify personal biases about participants’ responses.
Data Analysis
Descriptive statistics. Descriptive statistics only described the sample’s demographics, as
no inferences were based on this information. Specifically, means were used to describe the
sample’s age, number of sex partners, and condom-use rate, while percentages described
ethnicity, race, annual income, and sexual behaviors.
Transcribing interviews. In qualitative studies, data analysis entails the process of
transcribing the interview raw data, which determines the study's findings and results (Toles &
Barroso, 2014a, 2014b). The investigator used the paid transcription services of Rev.com,
https://www.rev.com/, to have the audio recordings from the interviews transcribed verbatim.
The interviews were submitted for transcription within 24 hours of completing the interview.
After receiving the transcript, the investigator performed a transcript audit while listening to the
interview within 48 hours of receiving the transcribed interview to verify the transcript’s
accuracy.
Inductive content analysis. After verifying the transcript’s accuracy, the data was
analyzed using a content analysis approach. Content analysis is used commonly in qualitative
description studies (Neergaard et al., 2009; Sandelowski, 2000; Vaismoradi, Turunen, & Bondas,
2013). The purpose of content analysis is to analyze text to describe its characteristics “by
examining who says what, to whom, and with what effect” (Vaismoradi et al., 2013, p. 400).
The findings of the content analysis reveal “a true insider perspective”, that adds to the study’s
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credibility (Neergaard et al., 2009, p. 4). An inductive approach was warranted due to the
absence of previous research pertaining to the phenomenon (Elo & Kyngas, 2008).
This investigator followed the inductive content analysis process of Elo and Kyngas
(2008) (see Appendix N), which encompasses three phases: preparation, organizing, and
reporting. In the preparation stage, the interviewer thoroughly and carefully read the transcribed
interviews and acquired an understanding of the main ideas. From the main ideas, the
investigator selected themes that emerged regarding this sample’s PrEP initiation decisionmaking process. The investigator then asked who, what, when, where, and why regarding the
content. The investigator organized the themes through open coding, as she wrote notes and
headings that described the content, and this process was repeated multiple times. The headings
were transferred to coding sheets that were grouped into broader abstract categories.
The investigator used peer checking to verify the accuracy of the analysis. Peer checking
involves the use of an external colleague or committee to validate the investigator’s findings and
conclusions (Colorafi & Evans, 2016; Houghton et al., 2013; Neergaard et al., 2009). The
investigator had an assembled four-member research oversight committee, but peer checking
occurred with the committee chairperson. The investigator submitted the content analysis results
electronically (i.e., email) of the first two interviews to the chairperson within 24 hours of
completing the analysis of the second interview. The chairperson provided feedback within five
to seven business days. Once the chairperson believed the investigator was analyzing the data
competently, or to their standards, the analysis results were then submitted to the committee
chairperson after analysis completion of every fourth interview. This collaboration ensured that
the investigator’s analyses were evaluated and confirmed by an experienced qualitative
researcher. As more interviews were collected that allowed more understanding, the investigator
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had to revert to the preparation and organizing phases. Lastly, in reporting and disseminating the
study findings, the investigator detailed the content analysis process, explained the connection
between the data and concluded results, and used actual participant phrases and statements to
demonstrate authenticity.
Interviews were ongoing until data saturation of the themes representing MSM’s PrEP
decision-making process was reached. Data saturation is “the point in the data collection process
when no new concept-relevant information is being elicited” (Kerr, Nixon, & Wild, 2010, p.
271). After data analysis reflected that data saturation had been reached, the investigator
conducted two more interviews to ensure no new concepts were missed. At this point, the study
closed to recruitment. The investigator informed the participating PrEP clinics of the study’s
closure to participant accrual, and requested that they discard any remaining recruitment
materials.
Trustworthiness
Trustworthiness is the reliability of study findings based upon the consistency and
appropriateness of research procedures (Colorafi & Evans, 2016; Toles & Barroso, 2014b).
Criticality improves rigor and trustworthiness, as it is the thought process leading to research
decisions and procedures (Neergaard et al., 2009), and the investigator was critical in conducting
research procedures. Trustworthiness occurred on a continuum, requiring the investigator to
remain objective, neutral, and consistent in performing research procedures throughout the
investigation (Colorafi & Evans, 2016; Neergaard et al., 2009).
The most appropriate methodology was selected given the study’s question, purpose,
literature review findings, and theoretical framework, which increased the trustworthiness of the
study's results (Fulton & Krainovich, 2014). Currently the literature lacks evidence of MSM’s
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PrEP initiation decision-making, and qualitative description was the best method, as the study
objectives were to gather and identify aspects of the phenomenon. Qualitative description is a
naturalistic research approach, which allows investigators to gather information based on the
sampled populations' human experiences, which are shaped by each individual’s personal, social,
and environmental factors (Creswell, 2013; Frey et al., 1999; Willis et al., 2016). In developing
the interview guide, the investigator used the definitions and concepts of the study's theoretical
framework, the IMB skills model. Utilizing the study's theory to design study instruments
increased rigor and study trustworthiness, as it demonstrated the research to be theory driven
(Stewart & Klein, 2016).
All study procedures were consistent and clearly identified prior to study conduction,
which contributed to this study’s trustworthiness. The identified recruitment and consenting
procedures were followed for each participant. Trustworthiness was established by asking openended questions that allowed participants to speak freely telling their story unimpeded (Colorafi
& Evans, 2016). During interviews, the interviewer did not interject thoughts, or finish
participants' sentences or thoughts. These procedures ensured that the data collected was
context-rich with the truth as seen and perceived by the participant (Colorafi & Evans, 2016;
Neergaard et al., 2009).
Trust in the data analysis process required the methods used in evaluating the data to
follow a consistent and logical pattern and approach (Colorafi & Evans, 2016; Toles & Barroso,
2014b). Following the pre-identified inductive content analysis process, which explains the
coding process also increased credibility of the findings (Colorafi & Evans, 2016). Additionally,
the investigator instituted journaling and bracketing to maintain the investigation’s objectivity
and transparency. Journaling and bracketing allowed the investigator to recognize and
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acknowledge biases, increasing trustworthiness, as the interviewer did not distort the emic view
(Toles & Barroso, 2014b).
Another method to maintain trustworthiness was confirmability, which is the process for
evaluating and verifying the results from the study's data analysis (Neergaard et al., 2009). The
investigator utilized peer checking to accomplish confirmability, verifying the accuracy and
credibility of the transcribed interviews and content analysis results, respectfully (Colorafi &
Evans, 2016; Houghton et al., 2013; Neergaard et al., 2009). Adhering to these qualitative
traditions, data analysis and collection occurred simultaneously (Colorafi & Evans, 2016).
Additionally, the investigator reported findings using actual participants’ phrases and statements
to link data to the results (Elo & Kygnas, 2008). This upholds authenticity and credibility, as
participants’ voices were heard (Neergaard et al., 2009). The investigator was the only
researcher conducting this process, which built trustworthiness and the credibility of the findings
as there was no variance in how the interviews were conducted, reviewed, and interpreted
(Colorafi & Evans, 2016; Toles & Barroso, 2014b).
The investigator was well equipped and knowledgeable to function as the principal
investigator for this study. She had previous experience as a research coordinator in several
medical and health-care specialties including HIV/AIDS. Due to her clinical research
experience, she was knowledgeable and familiar in research regulations and principles. She
shadowed in different PrEP clinics to further understand the population served and the clinic
flow and process. Additionally, her passion and commitment to advancing the knowledge
regarding HIV prevention reaffirmed that she had the capacity to conduct this study with the
appropriate research integrity.
Summary
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This study was conducted following Sandelowski’s qualitative descriptive research
approach. The absence of evidence regarding MSM’s PrEP initiation decision-making and the
individualistic phenomenon of decision-making made a qualitative descriptive approach
befitting. Qualitative description is appropriate when investigations are conducted to explore
individual’s authentic experiences, as a way to seek to gather, understand, human experiences
from the perspectives of the actual source (Colorafi & Evans, 2016; Neergaard et al., 2009; Polit
& Beck, 2012; Sandelowski, 2000, 2010; Willis et al., 2016). The study’s implications are
consistent with this naturalistic research methodology, as qualitative studies are indicated for
developing tools and interventions for clinical practice (Toles & Barroso, 2014b). From this
study, health professionals will know what this sample of MSM understood about HIV and PrEP,
which can be used to identify opportunities to assist current and future patients in resolving
occurrences of uncertainties and misconceptions about PrEP and HIV.
The investigator identified PrEP providing clinics in the states of Alabama and Georgia
first and later expanded to other clinics in the Southern U.S. Practices agreeing to support the
investigator’s study were sent IRB approved recruitment handouts and posters to make available
to their patients. Interested participants had to voluntarily contact the investigator to express
interest in study participation. For those patients, the investigator reviewed the study criteria and
requirements in depth, and if the patient had no uncertainties or objections, they were provided
informed consent. Audio-recorded one-on-one interviews was the method for collecting data,
and the investigator used the study specific and theory-derived six-item interview guide. The
investigator utilized a paid transcription service to have interviews transcribed verbatim, and
interviews were on-going until data saturation was achieved. At that point, the investigator
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conducted two more interviews to ensure no emerging themes were missed. The investigator
projected the sample size to be 10-30 participants.
To ensure the study findings were deemed rigorous, the investigator instituted certain
procedures and parameters to ensure trustworthiness. The investigator was critical in making
research decisions, and remained objective throughout the investigation. Given the study’s
question, purpose, literature review findings, and theoretical framework, the most appropriate
methodology, qualitative description, was selected for conducting this study. The investigator
followed all study procedures consistently according to the predefined procedures. The
interview guide was developed using the definitions and concepts of the study's theoretical
framework, and contained open-ended questions that allow participants to speak freely
unimpeded. During data analysis, the investigator compiled appropriate descriptive statistics to
summarize the sample, and followed the three-phase inductive content analysis process of Elo
and Kyngas (2008) to analyze and identify the common themes describing the phenomenon. The
investigator performed reflective journaling and bracketing to identify biases and assumptions
regarding PrEP and MSM. In disseminating study findings, the investigator used actual
participants’ phrases and statements to ensure participants’ voices were heard (Neergaard et al.,
2009). Lastly, the investigator reported that these findings cannot be transferred to the larger
MSM population, and are relative to this sample and possibly of MSM PrEP patients with similar
demographics and circumstances.
During this study, the identities of study participants was protected and remained
confidential. The researcher adhered to KSU’s IRB and participating PrEP clinics' guidelines.
Data collection occurred after participants gave voluntary written informed consent, at which
point the participant were assigned a PID and pseudonym. Upon the completion of study related
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documents, the investigator scanned and saved them onto a password protected and encrypted
thumb drive. The hardcopy forms were kept locked and maintained in the investigator’s office.
This information will remain secured in the investigator’s locked office three years post-study
closure or according to KSU’s IRB’s guidelines. Once the span of time has expired, all study
related materials will be discarded according to KSU's guidelines.
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Chapter 4: Findings
HIV pre-exposure prophylaxis (PrEP) initiation decision-making process is relatively
unknown. The purpose of this study was to explore this phenomenon in HIV-negative men who
have sex with men (MSM) engaging in protected or unprotected anal intercourse (AI).
Therefore, the following research question was proposed: How do HIV-negative MSM,
engaging in protected or unprotected AI, decide to initiate PrEP? Study objective was to explore
how this population decided to initiate PrEP based on the evaluation and perceptions pertaining
to their: (a) PrEP knowledge and HIV risk(s)/concern(s); (b) personal and social motivations to
initiate PrEP; and (c) behavioral skills and abilities to adhere to PrEP.
This chapter details the findings from this study’s data analysis. The investigator used
descriptive statistics to summarize the sample’s demographics, and described the themes that
emerged from participants’ semi-structured interviews. Referring to participants by their
pseudonyms, the investigator quoted phrases and statements to link and define relationships
between these themes. Through open coding, the themes were organized into five broader
categories: HIV-risk acknowledgement, HIV concern, PrEP understanding, PrEP accessibility,
and PrEP consideration, and the investigator detailed these categories to be the major concepts in
a conceptual model detailing this sample’s PrEP initiation decision-making process.
Participant recruitment occurred between March and August of 2018. Although the
investigator contacted 16 known PrEP clinics in Alabama, Georgia, Louisiana, Florida, and
Mississippi, eight responded in agreeing to receive and post IRB approved study recruitment
materials in their clinics. Appendix O provides a list of those participating PrEP clinics.
Fourteen participants consented, enrolled, and completed the study requirements. This
predominantly African American sample (10/14, 71%) ranged in age from 20-59 years, with a
mean age of 34 years. Fifty-seven percent (8/14) of the sample completed some form of post-
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secondary education, and most participants had an annual income of either less than $20,000
(6/14, 43%) or between $20,001 and $40,000 (5/14, 36%). Table 1 provides the demographic
information for each participant.
Table 1
Participant Demographic Data
PID*

Age

Ethnicity

Race

Education**

Annual Income

001

28

Non-Hispanic

African-American

High school

<$20,000

002

33

Non-Hispanic

White

College

$40,001- $60,000

003

21

Non-Hispanic

African-American

College

$20,001- $40,000

004

49

Non-Hispanic

White

Graduate school

>$80,000

005

31

Non-Hispanic

White

College

$20,001- $40,000

006

33

Non-Hispanic

African-American

High school

<$20,000

007

27

Non-Hispanic

African-American

High school

<$20,000

008

49

Non-Hispanic

African-American

High school

<$20,000

009

30

Non-Hispanic

African-American

High school

<$20,000

010

51

Non-Hispanic

African-American

College

$20,001- $40,000

011

48

Non-Hispanic

African-American

College

$20,001- $40,000

012

33

Non-Hispanic

African-American

College

$40,001- $60,000

013

20

Non-Hispanic

Other

College

$20,001- $40,000

014

24

Non-Hispanic

African-American

High school

<$20,000

* Participant Identification Number
** Highest level of education completed

Emerging Themes
Application of Elo and Kyngas’ (2008) three phase inductive content analysis (see
Appendix N) revealed several themes to emerge regarding this sample’s PrEP initiation decisionmaking process. The interviewer thoroughly, carefully, and repeatedly read the transcribed
interviews and acquired an understanding of the main ideas. The investigator selected a theme,
being either a word or a phrase that best described the main ideas. Themes regarding PrEP
knowledge were revealed to be perceptions and understanding of PrEP’s indications, benefits,
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risks, and consequences. HIV risks and concern themes included susceptibility from risky
behaviors and factors, deception/lack of disclosure, and HIV/sexually transmitted
infection/disease (STI/STD) exposure scares. Additionally, this sample’s HIV concern
encompassed both physiological fears and social implications from contracting the virus.
Although social motivations were not apparent in this data, personal motivations were revealed
to be added protection and peace-of-mind that initiating PrEP provided. Cost and availability of
services were the themes associated with the sample’s behavioral skills and abilities to adhere to
PrEP. The data demonstrated these themes were weighed and evaluated, leading to their
decision to initiate PrEP. The investigator analyzed the transcribed interviews to assess and
understand how the identified themes were rationalized as factors a part of this sample’s PrEP
initiation decision-making processes. From that analysis, five broader and more abstract
categories: HIV-risk acknowledgement, HIV concern, PrEP understanding, PrEP accessibility,
and PrEP consideration were revealed to detail this sample’s PrEP initiation decision-making
process. The investigator’s process for discovering these five categories are discussed below.
HIV-risk Acknowledgment
Participants were asked about their perceived HIV risks, and each openly admitted to
knowing the behaviors and factors placing them at HIV risk. Table 2 lists the overall HIV-risk
behaviors and factors reported by the sample, and Table 3 summarizes the sample’s reported
sexual and AI activities in the previous three months.
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Table 2
Participants’ Overall Reported HIV-risk Behaviors & Factors
# Participants Reporting
14
10
10
6
5
4
2
2
3
3
2
2
1

Behaviors & Factors
HIV status deception/ lack of disclosure
Multiple sex partners
Inconsistent/no condom use
Open/casual/impulsive sex
HIV MSM disparity
Sex with partner with an unknown HIV status
Sex with partner with HIV
Sex with partner with an STI
Engaging in sex
Condom failures (breaks)
Having sex cognitively impaired
HIV prevalence (geographic region)
Threat of physical violence or sexual assault

Table 3
Participants’ Reported AI & Sexual Behaviors*
PID

# of Sexual
Partners

001
002
003
004
005
006
007
008
009
010
011
012
013
014

Condom-use

Anal sex

Anal sex

Oral sex (give)

Oral sex

Percentage

(insertive)

(receptive)

Yes = Y No = N

(receptive)

Yes = Y No = N

Yes = Y No = N

Yes = Y No = N

30

75

Y

N

N

N

8

20

Y

Y

Y

Y

10

0

Y

N

Y

Y

5

0

Y

Y

Y

Y

4

0

Y

Y

Y

Y

1

50

Y

N

N

Y

0

--

--

--

--

--

2

100

Y

N

N

N

4

100

N

Y

Y

Y

0

--

--

--

--

--

3

90

N

Y

N

N

3

100

Y

N

Y

N

3

25

Y

Y

Y

Y

N

Y

Y

8
80
Y
*Refers to behaviors that occurred in the previous 3 months
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As Tables 2 and 3 indicate, this sample admitted to engaging in several sexual behaviors
placing them at risk for HIV. The most commonly reported HIV-risk behaviors were having
multiple sex partners, using condoms inconsistently or not at all, and engaging in
open/casual/impulsive sex. The responses indicated that these behaviors were the norm for this
sample prior to initiating PrEP; however, the study did have an outlier. One participant reported
that due to the availability of PrEP, he deliberately changed his sexual behaviors, increasing his
HIV risks for the purpose of initiating PrEP. Dan, age 49 described,
I had one long-term relationship from the age of 18 to 25 in college. [So for] seven years,
[I was with] one person. Uh, 25 to 47 [I had] one relationship, monogamous, [and] I've
only recently branched out, because I honestly feel like I missed out on a lot of sexual
exploration in my youth that I wish to make up lost time, and PrEP seemed like the only
logical way to do that.
Without PrEP, Dan said, “I would not be putting myself out there with multiple people. No, I
would not.” Acknowledging the risks accompanied by this new behavior, prompted Dan’s
initiation of PrEP.
Although sexual behaviors were significant HIV risk factors, as Table 2 indicates, HIV
deception was the most commonly non-behavioral perceived HIV risk factor. HIV deception
was discovered to be the deliberate act of a person with a known HIV-positive status lying about
or withholding their positive status from their partner prior to a sexual encounter. Ace
commented, “I’ve learned a lot of people don't disclose themselves,” and Beyonce echoed this
sentiment stating,
No one will tell the truth when you ask. I mean you be sitting there having a general
conversation with someone, and y'all are discussing sex things. Okay, well if it's
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comfortable enough for us to discuss sex, we should be comfortable enough to discuss
our status. And, for some odd reason, a lot of them don't like to discuss their status.
Participants conveyed and shared their personal experiences regarding peers being
actually deceived by an HIV-positive partner. Participants did not have to experience or be
personally involved in HIV deception in order to perceive it as a risk factor, as participants
repeatedly voiced HIV deception as an HIV risk from listening and hearing stories from peers.
Bruce reiterated, “Yeah, they're gonna lie, and I find that too often. And I know people be
deceptive and try to get what they want.” Participants believed that deception is done
maliciously as Steve said he has heard “horror stories of men purposely infecting others.” Dre
further explained his experience, “I've encountered people who just don't give a fuck, and they're
just like, ‘Well I've got it, and nobody told me that they had it. So I'm just gonna give it [to]
somebody else.’” Beyonce shared his story of learning about his best friend contracting HIV due
to deception, and that experience was key to his decision to initiate PrEP as he stated, “When I
found out my best friend was HIV positive, I knew right then I needed to do something. Because
if you can be with a man that says he loves you, and yet, he basically took your life from you,
then, I mean, what makes me different from [him]?” Today, HIV deception is perceived to be
easier, due to the advances in HIV care and treatment, as PLWH look no different from those
who are HIV-negative. Percy confirmed this perception from his experience with a former
partner who was positive, “He looks very nice, like you wouldn’t even [have thought he was
positive]. HIV doesn't have a face or anything.”
The impact on acknowledging HIV deception and the lack of disclosure was seen by this
sample to significantly increase HIV risk and was a factor in their decision to initiate PrEP. Ace
declared, “On a scale of 1 to 10, I would say 10, [with] 10 being the greatest,” and Alex admitted
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that concerns about HIV deception “was like one of the major factors [be]cause you can trust
somebody but you're never 100% sure.” The ease and frequency in which this sample perceived
HIV deception to occur created a sense of distrust in potential or current sexual partners.
Participants, Dan and Poomp blatantly expressed that it is difficult to trust and take people at
their word, as Dan said, “people will lie to your face“, while Poomp responded that, “[you] just
can’t believe them or trust them”. Even Bishop commented that “it's kind of hard to trust
anything with anybody now,” and Dre said, “There are so many people lying about their status
and stuff.” Additionally, participants voiced that lies are told regardless of the relationship type
or affection a partner can honestly have for the other. Beyonce detailed his experience of a
friend contacting HIV after being deceived by a partner
Even if you with a person that says they love you, no matter what, you still can't trust
them, not these days. Because this guy sle[pt] beside you every night, and sa[id] he loves
you, and he cares about you, but when you asked him, what was his status, he sat there
and blatantly lied to you, and said that he was negative, knowing that he was positive.
And now you have to live with this.
That acknowledgement of deception and distrust created a heightened sense of fear and
concern. Jay expressed, “I'm just afraid, right now. There [are] so many people [out] here just
telling you, ‘They ain't got this, and I know my status.’ I don't believe that anymore.”
Additionally, participants did not feel they had a way to confirm a partner’s status, as Dre
responded, “I don't really fuck with positive guys, but you don't really know who's really what
here, because a lot of people aren't telling a lot of things." That inability to truly know or verify
a person’s HIV status was concerning, which was rationalized as a reason to initiate PrEP since
they believed people to be dishonest and deceptive regarding their actual HIV status. PrEP
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provided added protection from contracting HIV, as Bill explained that he tried “to take
somebody at their word, but sometimes that's just not enough.” In a similar way, Alex described,
“Somebody can tell you, ‘Oh yeah, I'm fine.’ They can even show you their paperwork and
everything. You still don't know 100%. People lie, and they can really, really deceive you, so it's
best to keep yourself covered and checked.”
STI or HIV scares and experiences were also commonly recognized as an HIV risk factor
encouraging this sample’s decision to initiate PrEP. Justin and Bishop both expressed an STI
scare convinced them of their HIV risk. In these instances, participants had known about PrEP
before the exposure scare, as Justin admitted that he “thought about the pill [PrEP] months
before,” but did not perceive initiating PrEP to be necessary. The threat of contracting an STI
made the threat of HIV real and apparent. Bishop recalled his exposure scare to influence his
decision to initiate PrEP, “I had been hearing a lot about PrEP anyhow [and] I didn't really think
nothing of it at that time then. Then after I got intimate with this guy and I realized the condom
had popped then, I was like, “Yeah maybe it's a sign you need to go ahead and take PrEP”. Alex
experienced an HIV exposure scare, triggering his decision to initiate PrEP. After having a
protected sexual encounter, Alex became sick, and he immediately thought he had contracted the
virus. Regarding that feeling of thinking he contracted HIV he said, “I'd never been that nervous
or scared. Even though during that encounter, I was safe, but I still was like, 'Okay, this doesn't
feel right.' And I was to the point where like, you know what, I don't want this to happen again.
I don't like this feeling." On the other hand, Dre actually contracted gonorrhea and detailed that
experience to prompt his decision to initiate PrEP, as he thought, “You know what? Let me go
ahead and give it a try. . . If I can easily catch a STD like that [then] I can easily catch something
else."
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When asked to explain the impact their perceived HIV risks including sexual behaviors
and factors had on the decision to initiate PrEP, all participants verbalized that these experiences
or encounters made the threat of contracting HIV real and probable. That particular threat made
them acknowledge their HIV risks, and was a catalyst for making them believe initiating PrEP
was necessary given their risks. Dre stated
I'm at risk, you know? Very much so at risk. And I feel like I'm just always a step away
from being the people that [are HIV positive]. I don't look down on positive people or
anything like that, it's just I could become that. So let me take the steps now to not
become that. Like another statistic.
This data thus showed that in this sample’s PrEP decision-making process, HIV-risk
acknowledgement was a part of the process. For this sample, the acknowledgement came in the
person’s own time, based on their own perception and understanding of HIV. Additionally, the
acknowledgment resulted from a self-assessment of how much the individual believed they were
at risk for contracting HIV. Due to acknowledging his HIV-risks, Dre initiated PrEP as “an extra
precautionary step”. He went on to explain his decision-making:
I was tired of having sex when condoms break or slip off, tired of people lying about their
status, tired of running into people who were positive. That's a lot. And I finally was
like, “You know what I definitely need to go ahead and get on this”. . . I'm sexually
active, I'm grown, so I need to be an adult about [it].
Bill initiated PrEP based on his acknowledged HIV risks by stating, “I know me, and I know
how much I hook up,” and Bruce responded that “I just thought it was just a wonderful thing to
do as a preventative measure, [be]cause I'm gonna have sex.” Without acknowledging their
HIV-risks, the act of considering and initiating PrEP was unnecessary, because the individual
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perceived the threat of HIV to be absent, extremely low, or insignificant. Due to their
recognized risks, PrEP was viewed as a proactive approach to HIV prevention, as Ace stated,
“Just in case I come across someone that is positive, I don't wanna be trying, I wanna prevent
from getting HIV”. Participants were driven to remain negative as Dre reiterated, “I'm not going
to become one of yall [an HIV positive person] . . . I'm not going to let it [HIV] take me. I'm not
going to become another statistic, and PrEP keeps me from becoming another statistic.”
HIV Concern
Participants were asked about their perception regarding HIV. Due to the advances in
HIV care and treatment, this sample recognized the disease is manageable and a chronic disease,
as PLWH on treatment can live a normal life. Ace stated, “I look at it as any other thing, like
diabetes and cancer”. Bill speculated that contracting HIV is “something that you can manage.”
Despite this optimal perspective, participants still viewed HIV negatively, as Dan expressed,
“My first instinct is, 'Ew, gross’, and then my second reaction is sympathy.” This sample
continuously described HIV to be a devastating disease, inflicting mental and physical hardships.
Bill recalled HIV-positive peers to discuss having “episodes [when they] don't feel good because
of [their] status," and Justin thought that HIV “shortens your lifespan.” For this sample, HIV has
not escaped its deadly history. HIV’s morbidity and mortality of the 1980s is unforgettable, as
Jeff recalled an HIV-positive friend dying from Cryptosporidium to be a “pretty gruesome
death,” as he described his friend to have “really suffered.” Logically, participants recognized
HIV to be a chronic disease, but it is challenging to be fearless of HIV. Therefore, there is a
conflict between present day’s HIV and HIV of the 1980s. Additionally, the data indicated that
HIV is placed on a higher pedestal than other STIs due to HIV’s mortality and incurability.
Percy explained that the treatment regimen for other STIs is more favorable or easier to deal
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with, as “you can take a pill, get a shot in your butt, boom, [and it goes] away. HIV, they ain't
got no cure for that yet.” Steve explicitly explained HIV’s distinction and separateness from
other STIs by stating,
In our heads, when it comes to HIV, limiting your exposure to that [is priority, because]
the rest of that stuff seems treatable. HIV is the king of king’s disease when it comes to
STIs. That is the number one [STI], and of course, we are from a generation that we
weren't necessarily around when HIV was definitely a practical genocide of gay men . . .
And now, yes, it is treatable, and people consider it under control, but I was just always
taught [that] it's not a disease to fear, but [to] have a fearful respect of, it's something you
shouldn't fuck around with.
Participants were then asked about their perception regarding the impact HIV has on the
lives of PLWH. Consistent with this sample’s HIV fears, they expressed that HIV significantly
and negatively affects the lives of that population. HIV was viewed as a life altering,
devastating, and changing disease. Percy speculated his reaction if he ever contracted the virus:
“I feel like that would like break my self-esteem. I feel like mentally I would be like everywhere,
emotionally I'd be broke down. I used to tell myself that I would probably have committed
suicide.” Dre expressed similar feelings and reaction about receiving a positive diagnosis as he
stated,
Oh my lord, I've thought about that so many times. Yeah, I'm always just on edge. It
would be a whole 360 for me. So much stuff would change, honestly. I would still have a
life, but I would feel like I fucked myself over . . . I would really feel bad about [it, and],
I would be down on myself if I was to become positive. I would feel like I fucked myself
over.
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The devastation arises from the social implications from contracting HIV, as HIV’s social
consequences were perceived as more feared and damaging than the physical impact of living
with HIV. Repeatedly, participants described PLWH to experience depression, discrimination,
judgment, and abandonment from peers and family; however, participants viewed the most
significant change from contracting HIV to be within the context of romantic and sexual
relationships. Dre commented that PLWH are stigmatized and can be “seen as damaged goods,”
and he actually emulates that perception, as he refuses to date someone positive stating, “I'm not
interested in getting to know you [an HIV positive person]. It's just, no." Bill admitted to
hearing PLWH state: “You know if I wasn't positive, this [dating/romantic] situation might have
been different." The perception from this sample is that PLWH face and experience rejection
routinely due to their status. Jay stated that for those PLWH that have been honest and upfront
with him about their status, have prefaced the disclosure with a statement like “You may not like
me anymore, because I'm HIV positive."
Participants were asked to explain the impact their HIV concern had on their PrEP
initiation decision-making process. The physical and social consequences of living with HIV
was indicated as a driving factor for them to initiate PrEP. PrEP provided added HIV protection
to reduce their chances of contracting the disease. Participants were cognizant that it only takes
one encounter to contract HIV, and they decided to initiate PrEP to reduce the chances of
encountering a lifelong battle with HIV. Alex stated he initiated PrEP, because he did not want
to be in the position to say, “This one mistake has changed my life drastically,” and Dre believed
that “HIV is costly . . . and I'm not even talking about costly as far as money. It's costly for your
life.” Initiating PrEP was viewed to be rather easy and simple than enduring the life changing
alternative, as Dre explained, “I see PrEP like this, I voluntarily take this pill so that I don't have
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to take a regular mandatory pill for the rest of my life." Participants did not want to deal with the
social challenges associated with being HIV positive, especially in romantic and social
situations. Participants sympathized with PLWH having to disclose their positive status to
someone they genuinely liked or loved, as Percy stated, “I know it's hard”. Percy continued by
stating
Right now, I don't have to sit here and give a guy this sob story on how I contracted this
[virus], and how they don't have to worry because I'm undetectable, and how I’m taking
my medicine. [I’m not] worrying about if he's gonna continue talking to me, or if I'm
gonna hear from him after I told him this. You know, like getting involved with
somebody. Then you tell them something like that and you really like them, and you
trust them with that information, and then they go out and bash your name. Then I'm
hearing stuff about me that I told only this person. I don't wanna go through all that.
Although not a part of the decision-making process, the data indicated that the added HIV
protection garnished from initiating PrEP initiation changed some participants’ sexual
encounters. For some participants, the peace of mind from the added protection improved
quality and pleasure during sex. Steve said, “It makes you feel a lot more freer. . . Not having
that fear, knowing you're protected, it truly opens you up”. Three participants’ PrEP initiation
indicated occurrences of risk compensation, as they changed sexual behaviors, increasing HIV
and other sexual risks. The investigator has already reported that Dan initiated PrEP for the
purpose of engaging in risky sex, and he admitted to having, “more sexual partners, [with] full
exchange of fluids." On the other hand, Bill stated, “[I am] a lot more brave than I used to be . . .
I'm more open to meeting up with people and having less conversation and more action with
them if that's what they're into. Also, trips out of town, there's bars you can hook up at, and you
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have yourself a real good time.” Dre admitted that “being on PrEP has made me a lot more open
to raw sex with somebody that I trust.” Only one patient reported that he believed initiating
PrEP decreased his sexual libido, as Justin stated that since initiation of PrEP “the [sexual] desire
is not there.”
PrEP Understanding
In order to make a decision to initiate PrEP, one has to be aware of the regimen. While
not a part of the decision-making process, participants voiced their opinions and concerns about
society’s awareness and knowledge of PrEP, and their insight provides context to PrEP initiation
decision-making. A few participants believed most people know about PrEP, as Ace gave his
perspective saying, “Well it's just that, out of 100 people, I think probably it's a 60% chance that
people know;” however, this is not the popular opinion. For the participants who chose to speak
about society’s PrEP awareness, most expressed concern, as they perceived there to be a lack of
PrEP awareness, especially in MSM and other HIV vulnerable populations. Steve described his
experience from finding out about PrEP, “When I learned about it I was like, ‘Wait a minute, I'm
sorry. This drug exists?’ And not knowing that it was public knowledge for years, I was like,
‘So this drug exists.’ I don't know why everyone doesn't know about this." In a similar way, Bill
detailed that “There's a lot of people [that] just don't know. Even in the gay community, [they]
don't know a whole lot about it [PrEP].” Beyonce said some of his previous sexual partners were
oblivious to PrEP, as he reported, “A lot of them have been like, 'What is that?' And I'm like 'Oh
my goodness.'” Although MSM is an HIV vulnerable population, adolescents and young adults
were also identified as an HIV vulnerable group lacking PrEP awareness and knowledge. Jeff
stated “I think it should really be pushed towards our younger generations,” and his reasoning
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was that “our younger generations are more sexually charged and they are more [likely to]
experiment with sex with different partners, with different men, women, [or] alcohol.”
Specific to the decision-making process, participants were asked their initial impressions
of PrEP. For this sample, participants learned about PrEP from either one of three entities:
health professional (6/14, 43%), peer or partner (3/14, 21%), or social event/advertisement (5/14,
36%). Upon initially learning about PrEP, patients formulated different types of preconceived
notions and misconceptions about PrEP. Dre stated, ”My feelings of it were very iffy back
then,” which “kind of kept me from really getting on it.” Participants experienced moments of
disbelief, as they found it difficult to believe that a medication existed for HIV prevention. Some
participants initially perceived PrEP to be fake or a placebo pill that does not really work to
prevent HIV. Percy said, “I was thinking that it was like a gimmick. I didn't know if it was
proven to prevent HIV. I didn't think it would be effective, honestly.” Others initially thought
PrEP to be a scheme, presenting users with a false sense of protection that causes them to
eventually contract the virus or increases one’s HIV risk. Jeff said, “At first I was like, is it
going to lean me towards saying that I’m going to become that way,” while Beyonce thought, “it
gon' give me HIV”.
Participants were also confused about PrEP’s clinical indications. Jay said, “I thought it
was to cure HIV,” and even Jeff grappled with initiating PrEP, as he stated, “I don't want anyone
thinking that I got HIV”. Bill said, “What is confusing to me about it, or at the time was, the
medication itself. That it didn't really make sense to me that this was something that you take if
you already had it.” Data showed the consequences of these misconceptions to be significant, as
Justin commented that ”a lot of people look at PrEP, and the way that it's put out in the streets is
if you're on PrEP, you have HIV.” Dre reiterated this social perception of PrEP stating there is

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

109

“a lot of suspicion, a lot of stigma. . . Like a lot of people think that I'm positive because I'm' on
PrEP.” The data showed the consequence of this confusion to be continued social
misconceptions and negative stigma surrounding PrEP, as Justin explained, “A lot of people run
from people that say that they're taking PrEP.” Additionally, those with PrEP interest or
indications are deterred from seeking PrEP, as Jeff stated, “People are scared to ask [about
PrEP], because people want to know why [are] you asking.” Dre stated that “people either feel
like either you're promiscuous if you're on PrEP, or you're lying about your status." From this
sample’s perception, these societal stigmas and misconceptions occur because, PrEP information
is not clear in the beginning, as Bill went on to explain that the available PrEP information was
“very vague to start with [and] the basic things of it were not so simple.”
Despite participants’ awareness of the social perceptions and stigma about PrEP, social
motivations were not apparent in this sample’s PrEP initiation decision-making process. As the
data indicated above, participants were cognizant of the stigma surrounding PrEP, but those
perceptions and opinions, were not revealed to be directly involved in the decision-making
process. Participants did not state that their decision to initiate PrEP to be driven or dependent
by the potential reaction of anyone, including peers, partners, or family members. Dre addressed
the lack of social motivation in his decision-making process stating, “I don't give a fuck about
the stigma. I don't give a fuck about what you've got to say. I feel like we should take advantage
of these programs that are here to help us.”
Whether out of confusion or a desire to know more, after learning about PrEP, each
participant gathered more information. Participants primarily performed internet searches on
PrEP to seek clarifying information. Beyonce said, “Uh, google” was his means for conducting
research, as he stated, “I had to go through google.” Similarly, Justin said “I just typed it in [the
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search engine] and then I read a small paragraph about it.” Only one participant reported to
make his decision from accessing empirical evidence about PrEP’s chemical make-up and
efficacy reports, as Dan “did a little bit of research into the biochemistry of it all and made a
decision.”
Some participants gathered more information by consulting with a health professional,
and the data showed these participants expressed feeling more at-ease and comfortable making
their decision. Alex, who worked in a health-care facility discussed it with a pharmacist, as
“That's the main person I talked to, was our pharmacist. And she was like okay, these are the
benefits to it, but these are the risks.” Steve stated that “sitting down with your doctor that you
know and trust, and just breaking it down very simply” was significantly helpful in him making
his decision. He continued by stating
I talked to my doctor, and I made him give me a 30 minute breakdown on literally the
history of the pill for HIV treatment and then evolving into PrEP. It was incredible to
hear, and it was at this time I was like, “I understand.” Somebody sat down and
explained the science of it, and the history, and where it came from . . . When something
[gets] broken down to you in layman terms, but not shortened to a 30 second commercial,
but maybe a four or five minute video, that's what you need.
However, not all available PrEP information from health professionals is accurate. Steve shared
his experience of discussing PrEP with his local pharmacist on the length of time it takes before
PrEP becomes effective in the body. Steve recalled, “Some said ten days. Some said two to three
weeks. Some said 30 days.”
Even though not all PrEP information available is of equal merit and accuracy,
participants did express that they came to understand PrEP to be complementary. This sample
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acknowledged that PrEP does not create HIV invincibility, and therefore is to be used in
conjunction with condoms and other risk-reduction practices, as Jay stated that, “they told me,
you still have to use condoms.” Bill thought PrEP to be a magic pill initially, granting him
permission to engage in any risk behavior, as he said, "Woohoo, I can do whatever I want now;”
however, after gaining more education, Bill realized that PrEP is like any other non-abstinence
prevention method, as “nothing [else] is 100 percent” protective against HIV. Ace reiterated this
also by stating, “I have to make sure that I continue to [have] safe sex, continuing to use
condoms, and taking the PrEP.”
The data indicated that not all misconceptions and ambiguities were resolved prior to
initiating PrEP. Bill stated that he was not informed or understood the full implications or
requirements of adherence. From his perspective, he was told initially, “Well, here's your bottle,
take your medicine.” He did not feel that anyone gave him specific instructions that PrEP “needs
to be [taken] the same time every day; you need to take it regularly; [and] don't miss your doses”
in order to achieve optimal efficacy and protection. Therefore, participants suggested that
having clear and complete instructions and education from health professionals on how PrEP
works to be effective, and explaining the reasons behind the follow-up schedule would make
things less confusing. According to Steve, the availability of in-depth patient education “just
doesn't exist, unless you go out of your way to look for it on YouTube. And You Tube is wrong,
I’m sure.”
Initiating PrEP is not without some requirements, and the data showed participants to
factor their understanding of those aspects into the decision-making process. PrEP’s required
daily intake was primarily viewed as an inconvenience, but that inconvenience was not
significant enough to deter this sample from initiating PrEP. Jeff said, “Yeah, I was concerned,
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but I started thinking, I take high blood pressure medicine every day, and I don't think a second
thought about it. It's just natural.” Although not an aspect of the investigated phenomenon, data
revealed that despite the inconvenience of the daily regimen, that PrEP adherence improved
when it was associated with an activity or entity they performed on a routine basis. Steve stated
that a routine “absolutely helps me. It's habit building.” Ace said, “At first it was, [challenging],
and then eventually it became like natural. Taking it every day, like a vitamin, because I would
put it with my vitamins, so that way I know I would see it every day, so I know to take it.”
Beyonce reported that his job was his daily reminder or trigger to take PrEP, “I just think about it
as, well, every day when I take the medication, it's time for me to clock in for work. So therefore,
I need my job, I need this medicine. I need my job, I need this to stay healthy.”
Initiating PrEP is also associated with side effects, and a few participants had serious
concerns about PrEP’s side effects. Knowledge of the potential side effects (i.e., nausea,
vomiting, kidney issues, and bone density loss) caused a few participants to really question and
the need to initiate PrEP, as the side effects were frightening and delayed initiation for some
participants. After learning about the side effects, Jay stated, “So then I didn’t get on it,” and
Percy was deterred from initiating PrEP thinking, “I'm gonna stick to trying to wear condoms.”
Although some participants were concerned about the side effects, it did not prevent them from
initiating PrEP; however, they identified experiencing side effects would be reason enough to
discontinue PrEP. Jeff initiated PrEP with a disclaimer, “I was thinking that as long as I don’t
have any [side effects] then” he would continue taking PrEP.
Participants were asked to explain the impact their understanding of PrEP had on their
decision to initiate PrEP. Ultimately, despite the participants’ knowledge or perception of PrEP
being accurate or not, participants were satisfied or accepting of their understanding of the
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perceived benefits and risks associated with PrEP initiation, as Dre stated, "I said, 'You know
what, let's give it a try.’" Although uncertainties regarding how PrEP is efficacious remained,
participants admitted to initiating PrEP, because of its indication to reduce HIV risks. That
knowledge alone was worth initiation, as Bishop remembered thinking, “I'll just gamble with it,”
and Poomp also took the trial approach saying, “I just wanted to try it and see if it’d work”.
PrEP Accessibility
Participants were asked to explain the means and manner in which they accessed PrEP.
The data showed that accessibility encompassed two aspects: cost/financial means and provider
availability. In the PrEP initiation decision-making process, participants’ abilities to afford the
monthly cost of PrEP was a factor. Most participants found accessing PrEP challenging, as
participants were aware of PrEP’s exorbitant out-of-pocket/cash price. Table 4 provides a list of
this sample’s reported financial means to accessing PrEP.
Table 4
Participants’ Financial Means to Accessing PrEP
# of Participants Utilizing Financial Accessibility Options
6
Assistance Program*
3
Employer/Private Insurance
2
Employer/Private Insurance & Assistance Program*
1
Clinical Trial/Study
1
State Medicaid
1
Other Personal/family Resource
*Program provided by PrEP clinic and/or Gilead®

As Table 4 indicates, most participants utilized an assistance program sponsored by either
the providing PrEP clinic and/or PrEP’s pharmaceutical company, Gilead®. Only one
participant, Dre, reported accessing PrEP as a clinical trial research subject. Despite participants
having different avenues to covering PrEP’s financial cost, repeatedly participants stated that
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they would not have been able to initiate PrEP without financial assistance from the program or
an insurance company covering most or all of the cost. Since most participants stated that they
accessed PrEP through an assistance program at minimal or no cost, this study could not quantify
PrEP’s monetary value or worth, as this investigation did not inquire about the maximal dollar
amount they would be willing to pay for PrEP.
Even participants with private insurance and more affluent salaries placed a value limit
on accessing PrEP. In this instance, Dan is an outlier again, as he reported having an annual
income greater than $80,000 and private insurance that covered 100% of PrEP’s monthly cost.
Although he had more financial resources than any other participant, he admitted that there was a
limit to paying for PrEP, as Dan stated, “I'm telling you that I wanted to engage in risky sexual
behavior, but I wasn't willing to pay more [than] $100 a month . . . I wouldn't pay a lot of money
to take PrEP, it's not that important to me.” Another example is Alex’s situation, a health
professional with a reported annual income range of $40,001- $60,000, but his private insurance
declined to cover any cost of PrEP, and only covered a smaller portion of the drug after the drug
discount card was applied. He stated, “Initially, my health insurance, [was] like, ‘Oh no, no,
we’re not gonna cover this,’ but then with that discount [card], they were like, ‘Okay’, [be]cause
after the discount, it was like $200 or $300, and they were like, ‘Fine, we'll pay for it.’” Alex
confessed that he could not afford to pay $200 or $300 a month for PrEP, and as Bill stated,
“Even if somebody makes good money, and once your bills are paid, that doesn't leave a whole
lot left over for something like that. It'd be cheaper to get sick. I hate to say that, but it almost
feels that way.” A similar sentiment was echoed by Jeff when he stated, “I feel sorry for the
young kids who need it and can't afford it, because they don't have any insurance. You know it's
almost like giving them a death sentence, for catching HIV.”
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The other aspect of PrEP accessibility pertained to the availability of and ability to access
PrEP services. Without access via telemedicine or in-person, participants could not initiate
PrEP. This sample of MSM PrEP patients mostly lived in urban areas that had available local
PrEP clinics and providers. Only one participant, Bill, lived in a rural area where the nearest
PrEP clinic was over 150 miles away. Despite the distance, he decided initiating PrEP was
worth having to act as his own advocate:
I felt that it was a good option for me, and it was definitely worth kinda the struggle to
get a referral. I've had to do all the extra work. I've had to make the phone calls, I've had
to do the follow-ups, and stuff like that, whereas in big cities, people are like, ‘Oh, I just
told so and so, and just got started on it after doing the testing process.’ Whereas for me
and for other people in these more rural areas it seems like it's a little more of a challenge.
The data did not indicate if all patients would have been willing to go through such challenges
and adversities to access the services required to initiate PrEP.
PrEP Consideration
The data indicated that this sample had a period in which they weighed and considered all
the available information they had regarding their (1) acknowledged HIV-risks; (2) HIV
concerns, (3) PrEP understanding, and (4) PrEP accessibility. Given their self-assessment of
their HIV risks, knowledge and understanding about PrEP’s benefits and risks, participants
explained that initiating PrEP was necessary, as it was thought to offer them peace of mind and
added assurance for HIV protection. Bill stated, “I thought PrEP was a really good choice for
that, it's just kinda that peace of mind,” and Dre said “as long as I'm single . . . and sexually
active, I'm going to be on PrEP . . . just as a safe umbrella.” Dan said that PrEP allowed him to
engage in risky sex “without thinking of the repercussions, without worrying”. Likewise, Steve
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initiated PrEP to take “a heavy weight off my shoulders.” Lastly, Ace stated, “I just wanted to
feel comfortable, just in case I did or I started to get involved with somebody else again, or got to
the point where we were having sex. It was a comfortable feeling, that I don't have to be always
worried. I just wanted to be comfortable, and PrEP’s there to kind of ease up the stress.”
Initiating PrEP was thought to remove guilt and shame from sexual acts, as Bill said, “You don't
feel as, ‘Oh my gosh, what did I just do?’ You don't have that immediate guilt following your
activities, whatever they might be.” Initiating PrEP was also a way to take control of one’s HIV
risks before the HIV threat appeared, as it is a proactive approach to HIV prevention. Steve
stated, “Inviting new sexual partners into our lives, it is the safer decision . . . And it’s like you're
taking that big boy responsibility of taking this drug to protect your life.” These participants
favorably valued PrEP’s benefit from their self-assessment of HIV risks and concerns, PrEP's
benefits to risks ration, and PrEP accessibility.
Even in the midst of challenges or uncertainties, the data showed initiating PrEP was
considered to be worth those adversities. Bill experienced difficulties finding a PrEP clinic, and
the nearest clinic was over 150 miles away from his home. Despite the logistical challenges, Bill
stated, “I'm very glad that I did it, it's just not the easiest thing to do right now at this time.”
Additionally, the inconveniences that come with initiating PrEP was accepted, as Steve
reiterated, “It is worth your time and money and your patience to get on a medicine that protects
you from a life altering disease.” This is especially true considering the occurrences of HIV
exposure scares or deception, as initiating PrEP was worth more than experiencing HIV scares.
Percy stated, “I ain't fit to be going through these scares, and then worrying about if I'm clean or
not.” Initiating PrEP was also perceived as a way to remain HIV-conscious, as Ace described,
“It was something that kept me on my toes for one, because you have to take it every day. And
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every day you take it is a reminder about HIV.” Lastly, some participants thought taking PrEP
was just a logical decision given their susceptibility and perception regarding HIV. Justin said
after evaluating all of the factors that “it was really like a no brainer for me,” and Jeff said, “I
started thinking, you either want to take this [PrEP] or want to end up becoming positive and
taking a lot of medications or being sick.” Additionally, given PrEP’s frequent follow-up and
testing regimen, initiating PrEP was viewed as a form of self-accountability regarding their own
HIV status, as Ace responded, “PrEP was something I could take, and be aware of my status, and
be protected. I could make sure, everything was good. . . I just wanna check myself, before I
check somebody else.” After considering all of these factors, the data showed that participants
decided to initiate PrEP because that action was viewed to be worth more than not initiating
PrEP.
Although not a part of the investigated phenomenon, participants did discuss their PrEP
disclosure habits including who and when they had or will disclose that they initiated PrEP.
Participants stated that they disclosed their PrEP status to family, peers, or sexual partners, and in
most cases, participants reported that the reaction from their disclosure was positive and
supportive. Bishop repeated a friend’s response from his PrEP status, “You know I think that's a
smart move to make, to take PrEP, to keep yourself secure.” Family members expressed a sigh
of relief from their loved-one having additional HIV protection. Beyonce recalled his mom’s
reaction, “Thank the Lord, [be]cause she was like, ‘I don't wanna get that phone call,’” that he
contracted HIV. In a similar way, Steve stated his mother responded, “Oh, that's nice to hear.
You know, there's a lesser chance that my kid will end up saying ‘I'm HIV positive.’” Some
participants did not feel the need to disclose to family and friends, as Dan stated, “There's no
need for anybody [family or friends] to know that information.” Participants reported that they
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most often disclosed their PrEP initiation to sexual partners, and the reaction is one of security,
as it provides partners with a sense of relief, affirming their partner is negative. Dan stated,
“Well, their reaction is that's good, [be]cause they know you have to be negative to get on it. So
that gives them a sense of security,” and Dre believed that potential sex partners think that upon
hearing he is on PrEP, “Ah, he's clean . . . He's good to go.” Although most participants reported
a positive response from their PrEP initiation disclosure, the data showed that this was not
everyone’s experience. The reason for the disapproval was not known or clearly understood by
the participants, but the data leads the investigator to assume it pertains to the negative stigma or
misconceptions surrounding PrEP. Bishop said he did not have many supporters, as most peers’
responded to his disclosure by stating, “You're stupid, I wouldn't take that stuff.” Beyonce
recalled a peer’s reaction from his PrEP status, “I don't know what to say. I just never thought
you, out of all people, would decide to take PrEP.” Percy explained that he was surprised by the
response from a sexual partner,
I don't think he was too happy when I mentioned about being on PrEP. He was not too
happy about that. He said, "Oh, what, you gonna be out having sex with random people
now?” I said, "Is that what you think PrEP is for?" He was like, "Basically. Like PrEP is
for people who just have sex with a lot of people."
PrEP Initiation Decision-making (PID) Model
The data indicated that the decision to initiate PrEP was a process that occurred after
learning or becoming aware of PrEP. Although this study’s findings could not determine an
average or estimated timeframe for this sample to navigate through the process, the data
indicated the decision to initiate PrEP was not immediate or made impulsively or frivolously.
Instead, deciding to initiate PrEP was discovered to be a thoughtful process of weighing and
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considering specific factors regarding HIV and PrEP seriously and meticulously. Percy stated,
“It definitely was a process. Definitely… it's not something like, ‘Oh, this prevents HIV, let me
get on it.’ Like it wasn't that.” After learning about PrEP, Justin thought, “I have to think about
this. This is something that I have to process in my mental," and Dre admitted that "I still had
like my reservations. . . I wanted to see how [other people taking PrEP] was progressing along
before I jumped into it." From the analysis emerged a conceptual model demonstrating the
process determining and influencing this sample’s decision to initiate PrEP encompassing the
data’s five emerging themes: (1) HIV-risk acknowledgment, (2) HIV concern, (3) PrEP
understanding, (4) PrEP accessibility, and (5) PrEP consideration.
From the data, conceptual definitions and relationships emerged and are depicted in
Figure 3. Acknowledged HIV-risks is the acceptance that certain behaviors or factors place a
real and actual threat to the individual for contracting HIV. HIV concern is the negative and
fearful perception that living with HIV will have on one's life and well-being. While these two
individual concepts do not impact or influence the other, they both impact the decision to initiate
PrEP, as a greater belief in one’s acknowledged HIV-risks and more HIV concern was revealed
to directly influence this sample’s decision to initiate PrEP. PrEP understanding is the
information, accurate or not, that the individual has about PrEP or conceives PrEP to be, which
includes but not exclusive to PrEP’s benefits, risks, and indications. PrEP accessibility is the
ability to access PrEP both financially and from a prescribing clinical practice. Both PrEP
understanding and accessibility are separate entities that influenced and determined this sample's
decision to initiate PrEP. Lastly, PrEP consideration is the act of weighing and evaluating the
need to initiate PrEP based on the four model concepts. Like the four concepts, the result of their
PrEP consideration was shown to influence their decision to initiate PrEP.
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Summary
Fourteen MSM residing in the Southern U.S. participated in the study. The mean age for
this predominantly African-American (10/14, 71%) sample was 34 years. Additionally, most
participants (6/14, 43%) identified as having a low socioeconomic status (SES) of an annual
income of less than $20,000. Although this sample was not significantly diverse, the findings
were insightful, providing rich data on PrEP initiation decision-making process in a sub-sample
of MSM.
The data indicated this sample’s decision to initiate PrEP to be a phenomenon of
considering specific aspects surrounding HIV and PrEP. The emerging themes were identified
as HIV-risk behaviors and factors, deception, and HIV/STI scares. The data also revealed this
sample viewed living with HIV to be burdensome and life altering, inflicting both social and
physical hardships. In regards to PrEP, the related themes in the decision-making process
pertained to knowledge and understanding of PrEP’s indications, benefits, risks, costs, as well as
the ability to afford and access PrEP services. The data demonstrated that these themes were
considered individually and collectively, leading to their decision to initiate PrEP. These themes
were organized into five broader categories: HIV-risk acknowledgement, HIV concern, PrEP
understanding, PrEP accessibility, and PrEP consideration.
From the data, the PID model emerged as a conceptualization depicting this sample’s
decision-making process. The PID model explains these participants initiated PrEP after
considering their perceptions, attitudes, and personal characteristics surrounding their (1)
acknowledged HIV-risks, (2) HIV concerns, (3) PrEP understanding, (4) PrEP accessibility, and
(5) PrEP consideration. Additionally, the data showed this sample’s PrEP initiation decision-
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making to be a non-linear process, as there was no specific or patterned sequence in which each
concepts was weighed or considered.
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Chapter 5: Conclusions and Recommendations
HIV pre-exposure prophylaxis (PrEP) is the inaugural pharmacological HIV-preventative
agent approved in the U.S. (CDC, 2014b). PrEP is the fixed daily dose of Truvada, an
antiretroviral (ART) shown to reduce HIV risk by as much as 92%, and is therefore indicated in
HIV-negative persons with reported and documented high HIV-acquisition risk (CDC, 2014b).
Although other at-risk groups exist, men who have sex with men (MSM) experience the most
disparaging HIV rates in the U.S., accounting for 55% of people living with HIV (PLWH) and
majority of new HIV infections nationally and among men each year (CDC, 2016c). MSM’s
engagement in anal intercourse (AI) with other men is the primary catalyst driving their HIV
incidence disparity. AI in MSM is the overall most common mode of HIV transmission (CDC,
2016d), and the riskiest type of sex (CFA, 2014; Pebody, 2010). Most current and former PrEP
patients are MSM (Krakower et al., 2015; Krakower & Mayer, 2015; Tellalian et al., 2013);
however currently there is a paucity of literature on PrEP initiation decision-making in any
population.
Guided by the Information-Motivation-Behavioral (IMB) skills model, the following
research question was proposed: How do HIV-negative MSM engaging in protected or
unprotected AI decide to initiate PrEP? The study objective was to explore how HIV-negative
MSM decide to initiate PrEP based on the evaluation and perceptions pertaining to their: (a)
PrEP knowledge and HIV concern(s)/risk(s); (b) personal and social motivations to initiate PrEP;
and (c) behavioral skills and abilities to adhere to PrEP. A qualitative study was conducted with
a six-item theory derived questionnaire, and analysis of the one-on-one semi-structured
interviews of 14 MSM living in the Southern U.S. revealed several HIV and PrEP themes to be a
part of this investigated phenomenon. To answer the research question, this sample of MSM
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decided to initiate PrEP by considering the perceived benefits and risks of initiating PrEP based
on their (1) acknowledged HIV-risks, (2) HIV concerns, (3) PrEP understanding, (4) and
accessibility to PrEP.
This chapter details the conclusions and recommendations drawn from the study's
findings. The investigator will expound on the answer to the proposed research question. From
the answered research question, the investigator will discuss the implications the findings have
on the reviewed literature, as well as the health-care industry and nursing profession. Based on
the pre-identified study limitations, the investigator will make recommendations for future
research. Lastly, the investigator will make three critical conclusions drawn from these findings.
Discussion
This sample of HIV-negative MSM decided to initiate PrEP after assessing and
evaluating their perceptions regarding their (1) acknowledged HIV-risks, (2) HIV concerns, (3)
PrEP understanding, (4) PrEP accessibility, and (5) PrEP consideration. From the data, the
investigator was able to define and establish relationships between each of these concepts. From
the inductive content analysis process, these five broader categories emerged as constructs in the
PrEP initiation decision-making (PID) model, a conceptualization of this sample’s defined nonlinear and introspective process of deciding to initiate PrEP.
HIV risk and concern were significant factors in the PrEP initiation decision-making
process. HIV-risk acknowledgment was found to be the moment or event that makes the threat
of contracting HIV real and apparent. This acknowledgement comes in the person’s own time
and is based on their own perception and understanding of HIV. Additionally, the
acknowledgment is the result of a self-assessment of how much the individual believes they are
at risk for contracting HIV, and can be triggered by a recent, planned, or a lifetime of

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

125

experiences and events. HIV concern was shown as the negative and fearful perception that
living with HIV will have on one's life and well-being. Like HIV-risks, participants’ HIV
concern was discovered to evolve from their experiences and perceptions on the hardships
encountered by PLWH and their understanding of HIV’s disease progression and manifestation.
While these two individual concepts do not impact or influence the other, they both impact the
decision to initiate PrEP, as a greater belief in one’s acknowledged HIV-risks and more HIV
concern was revealed to directly influence this sample’s decision to initiate PrEP.
Aspects of PrEP were also a part of the process including understanding and accessibility.
PrEP understanding was the information, accurate or not, that the individual has about PrEP or
conceives PrEP to be, which includes but is not exclusive to PrEP’s benefits, risks, requirements,
and indications. Participants sought additional information from various sources, and despite
reported misconceptions or uncertainties, participants decided to initiate PrEP. Participants
believed that their HIV risks and concerns outweighed any lingering or existing concerns or
uncertainties about what they knew or perceived about PrEP. Despite the possibilities of
participants receiving or perceiving erroneous and misconceived PrEP information, participants’
processed and utilized that information the same. As more knowledge was gained, participants
believed they had a better understanding about PrEP’s benefits, risks, and indications. Each
individual felt comfortable with their understanding of the information they obtained, but being
comfortable did not alleviate all lingering thoughts, concerns, uncertainties, or inconveniences.
Instead, they decided to initiate PrEP based on the PrEP knowledge and understanding they had
at the time of initiation, because PrEP’s added HIV protection out-weighed those wavering
thoughts, concerns, uncertainties, or inconveniences. PrEP accessibility was the ability to access
PrEP both financially and from a prescribing clinical practice. PrEP cannot be initiated without
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the services of health professionals, so while the investigator knows access to a provider was key
to the decision-making process, the data could not determine the impact or influence PrEP
services being conveniently or inconveniently located had on the decision-making process.
Lastly, PrEP consideration was shown to be the act of weighing and evaluating the need to
initiate PrEP based on the other four factors. Like the four concepts, the result of their PrEP
consideration was shown to influence their decision to initiate PrEP. The extent and
consideration each aspect was viewed or valued was person specific, as one person’s value
system was demonstrated to be unique and specific to them.
Conceptualization of this sample of MSM’s PrEP initiation decision-making process
makes a significant contribution to the literature. In order to understand this impact, the
investigator will compare this data derived model to another model commonly used in HIV
health behavioral decision-making research. The investigator will identify consistencies and
inconsistencies these findings have to the reviewed literature. Given the initial knowledge gap
and study limitations, the investigator will reveal and discuss the contribution these findings
make to the current knowledge gap on PrEP initiation in the U.S.
Model Comparison
The IMB skills model guided this inquiry and the resulting conceptualization of this
sample’s PrEP initiation decision-making process is reflective of the IMB skills model. The
IMB skills model conceptualizes the decision to initiate HIV risk-reduction behaviors as
involving one’s information, motivation, and skills regarding the HIV preventative behavior
(Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher &
Fisher, 1992; Macapagal et al., 2016; L. Smith et al., 2012). Information is the knowledge,
myths, and understanding the individual has about the preventative measure, while skills are the
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abilities needed to perform that behavior (Aliabadi et al., 2015; Amico et al., 2005; Amico et al.,
2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016). Motivation, however,
encompasses two forms, personal and social. Personal motivations are the attitudes, beliefs, and
perceptions regarding the outcomes from performing or not performing that behavior, and social
motivations are the perceived social support and acceptance from peers or partners from
performing the behavior (Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et
al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016).
When comparing the IMB skills model to the PID model, the PID model demonstrates
that the decision to initiate PrEP is dependent upon an individual’s acknowledgment of their HIV
risks and out of concern from implications of living with HIV, which is congruent with the IMB
skill model’s HIV information concept. Additionally, the PID model shows that their decision to
initiate PrEP was also derived by their PrEP understanding, which is the accepted perception of
PrEP to provide added protection, and the ability to access PrEP financially and logistically,
which mirrors the IBM skill model’s concepts of personal motivation and behavioral skills,
respectively. The distinction between these two models is the inclusion of social motivation and
the absence of PrEP consideration in the IMB skills model. Although apparent in the IMB skills
model, the PID model does not conceptualize the influence and reactions from an individual’s
peer group to be a part of the decision-making process. Likewise, the PID model recognizes
individuals take a moment to evaluate and weigh all the information they have attained (i.e.,
acknowledged HIV risks, HIV concern, PrEP understanding, and PrEP consideration) in order to
derive that the benefit of initiating PrEP was worth given their perception of the model’s four
other and influential entities.
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The PID model emulates the Health Belief Model (HBM), a health behavioral theoretical
framework historically used to investigate HIV risk-reduction decision-making. The HBM was
developed in the 1950s and 1960s by social psychologists Hochbaum, Rosenstock, and Kegels,
as a cognitive representation of one’s likelihood or intention of performing health behaviors
(Jones et al., 2014; Li et al., 2016; Montanaro & Byran, 2014; Schnall et al., 2015). The HBM’s
outcome of intention and not implementation was the rationale this investigator did not apply the
HBM to guide this inquiry, but the HBM has merit in HIV related investigations. Data analysis
from this study revealed the PID model to represent this sample’s decision-making process for
actually implementing the investigated behavior. While the HBM and the PID model differ in
outcomes, they are comparable, encompassing similar concepts and assumptions.
The HBM depicts one’s perceptions, attitudes, and personal characteristics to explain or
influence health behavioral decisions (Schnall et al., 2015), and shares similarities with this
study’s data derived model. The PID model emulates the HBM, as five concepts: (1)
acknowledged HIV-risks, (2) HIV concerns, (3) PrEP understanding, (4) PrEP accessibility, and
(5) PrEP consideration were revealed to influence this sample’s PrEP initiation decision-making
process. Under the HBM one’s perceptions and attitudes towards the disease and behavior,
along with one’s personal characteristics (i.e., personal demographics factors, socioeconomics
and knowledge), are equivalent to the concepts of acknowledged HIV-risks, PrEP understanding,
and PrEP accessibility. One’s perception regarding HIV susceptibility/threat, severity of disease,
and the behavioral changes’ benefits and barriers are apparent in this model as acknowledged
HIV-risks, HIV concerns, and PrEP understanding. Additionally, the HBM’s financial and
personal characteristics to the particular behavior mirrors this study’s accessibility to PrEP
services. Given the HBM’s credibility in the field of health-behavioral and HIV research, the
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fact that the PID model shares some similarities with the HBM, brings credibility to this data
derived conceptualization.
Model Assumptions
Like the HBM, the PID model is privy to assumptions. In order to make a decision about
a choice or decision, one has to be knowledgeable of the choice or option. The HBM also
assumes individuals are rational, as their behaviors reflect their thought processes, and
behavioral change decisions arise from a concern or threat of disease (Champion & Skinner,
2008). Likewise, this study and therefore the results from this study presume that participants
instituted prevention behaviors due to HIV concerns and desire to prevent contracting the
disease. Therefore, both the HBM and PID models assume that the process cannot occur until
the need for behavioral change or awareness occurs. The data demonstrated that the fear or
concern the individual has regarding HIV is not only an assumption, but also a factor and
concept incorporated in the model. Additionally, the PID model assumes that the decisionmaking process occurs regardless of one’s known or assumed HIV status. The reason HIV status
is not a factor in initiating the process is due to the second assumption. While PrEP is indicated
for HIV negative persons, the data showed that PrEP misconceptions existed upon patients
becoming aware of PrEP’s clinical indications. Thirdly, this model also assumes the process
does not have a defined beginning point, as the data did not indicate a sequence in which of the
four primary concepts were considered first. Participants were shown to go through and consider
each of these concepts one at a time and/or simultaneously.
These findings share consistent and inconsistent aspects with the reviewed literature
pertaining to health-behavioral decision-making, MSM HIV prevention, and MSM and PrEP.
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Comparing the reviewed literature to this study’s evidence identifies the contribution the findings
make to the literature and current knowledge gap.
Health Behavioral Decision-making
Consistent with this investigation’s literature review and theoretical framework, this
study found that the sample’s PrEP initiation decision-making process was an individualistic
process of weighing and considering different factors. Systematic and meta-analysis research
repeatedly identified those factors to involve one’s personal and social circumstances (Poortaghi
et al., 2015; Popejoy, 2005). Additionally, knowledge and perspectives about health, the health
behavior, and the disease or condition itself are also weighed in this process (Bui et al., 2014;
Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et
al., 2013; Nichol et al., 2011). In this study, participants readily identified the behaviors placing
them at risk for contracting HIV, and from that acknowledgment, they perceived a genuine and
real HIV threat to exist. This study found participants to have an overwhelming fear of HIV
from a lifetime of interacting with or hearing about social and health hardships associated with
being HIV-positive. Not wanting to endure such hardships motivated participants to initiate
PrEP. Participants made decisions based on their own evaluation of PrEP’s benefits, risks, and
requirements. Lastly, participants’ financial means greatly determined their decision to initiate
PrEP, as all needed some form of assistance to access PrEP. Consistent with the literature, this
process was introspective, determined by the individual and based on their experiences regarding
HIV and PrEP knowledge.
Also consistent with the literature, the findings acknowledged the role of health
professionals in health related decision-making. The literature showed that health professionals
play an important role in patients’ decision-making process (Chong et al., 2013; Coombs et al.,
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2016; Popejoy, 2005; Rose et al., 2017; Siouta et al., 2015; Thom et al., 2016). For example,
health professionals coach and support patients when deciphering between health choices
(Popejoy, 2005; Thom et al., 2016). Health professionals educate and clarify misunderstandings
regarding health-care options, and they assist patients in making an appropriate decision based
on the patient’s self-defined goals (Popejoy, 2005; Thom et al., 2016). Additionally, the CDC’s
compendium synthesis demonstrated that health professionals are integral to increasing MSM’s
use of risk-reduction behaviors, as MSM need support and guidance from a professional, trusted
resource, or program knowledgeable in HIV prevention in order to increase utilization of HIV
risk-reduction behaviors (CDC, 2017a, 2017c). The literature showed that patients are receptive
to information utilizing open communication, transparency, and a non-judgmental exchange of
information (Carvajal et al., 2017; Chong et al., 2013; Siouta et al., 2015; Thom et al., 2016).
Although PrEP is only accessible from a prescribing practice, some participants did not perceive
that they received such in-depth education, as they admitted to initiating PrEP with lingering
doubt, uncertainties, and misconceptions. On the other hand, some participants expressed that
the counseling and education they received from health professionals was integral to them
having a clear understanding, leading to their decision to initiate PrEP. Additionally, participants
who received in-depth patient education from health professionals prior to initiating PrEP
appeared to be more assured and confident in their choice. Therefore, consistent with the
literature, this study’s evidence demonstrated that providing patients with complete and
transparent PrEP education is conducive to their decision-making process.
Inconsistent with the literature was the influence external and other social pressures had
on this sample’s decision-making process. The IMB skills model conceptualizes the decision to
initiate HIV risk-reduction behaviors to include social motivations like perceived support and
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acceptance from peers and significant others (Aliabadi et al., 2015; Amico et al., 2005; Amico et
al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016). This study’s data
did not demonstrate such influence from peers, family members, or partners to be included in the
process, as the data revealed the process to be introspective. However, participants were aware
and reported the negative and social stigmas associated with PrEP. While social motivations
were not seen to be directly a part of this sample’s PrEP initiation decision-making process, the
investigator recognizes that it is possible that social motivations could have had an indirect or
subconscious effect on this sample’s decision-making process. Additionally, the investigator
acknowledges that lack of social motivation in this process may not be true with other patients
who have initiated or are deciding to initiate PrEP.
MSM HIV Prevention
This study’s findings share consistencies with the literature regarding HIV concern from
susceptibility and living with the virus being a factor in MSM’s implementation of HIV
prevention behaviors. Systematic reviews demonstrated that HIV-negative MSM are concerned
about contracting HIV (Balan et al., 2013; Neville & Adams, 2009; Neville et al., 2016).
Likewise, study participants shared and expressed significant concerns and fears regarding HIV,
as HIV was perceived as a life altering and devastating disease. Participants repeatedly cited
stories of PLWH to experience depression, rejection, and other social hardships, and these
hardships were perceived to be attributed from PLWH’s HIV-positive status. In other
publications, MSM were shown to no longer view HIV as a serious problem or public health
issue due to ART transitioning HIV into a chronic disease (Balan et al., 2013; CDC, 2016b;
Neville et al., 2016; Neville & Adams, 2009). The literature demonstrated conflict regarding the
impact HIV concern has on MSM’s HIV prevention decision-making, and it was apparent in this
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study. This sample exhibited conflict, as they acknowledged PLWH can live a normal life if on
effective HIV treatment, but they were extremely fearful of HIV’s social and physical
implications.
Trust was found to be a part of this sample’s decision-making process, but is inconsistent
with the current literature. The reviewed literature showed partner conversations and emotions
to influence MSM’s decision-making to utilize HIV prevention behaviors. Partner conversations
encompass a couple’s discussion of the relationship status and HIV status and risks, and that
information is used to determine their utilization of risk-reduction behaviors (Campbell et al.,
2014). In addition, the literature found MSM to rely on emotions erroneously to derive the need
to use risk-reduction behaviors (Bauermeister et al., 2009; Campbell et al., 2014; Goldenberg et
al., 2015; Green et al., 2014). Both partner conversations and emotions require a level of trust,
as partners do not perceive their counterparts to be deceptive; however, this sample of MSM
perceived there to be a significant amount of deliberate HIV deception and lack of disclosure.
This sample found it difficult to trust people regarding their HIV statuses even within the context
of an established or committed relationship. This perception of deception heightened this
sample’s HIV risks, influencing their decision to initiate PrEP as a way to take control of their
HIV risk.
MSM and PrEP
Although currently PrEP initiation decision-making research is absent from the literature,
this study’s findings are consistent with evidence regarding MSM’s interest and intention to
initiate PrEP. Previous studies found that MSM to be interested in PrEP to promote health and
enhance sexual pleasure (Brooks et al., 2012; Collins et al., 2016; Gamarel & Golub, 2015;
Garcia & Harris, 2017; Golub et al., 2013; Mimiaga et al., 2014; Oldenburg et al., 2016; Taylor
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et al., 2014), as PrEP is perceived as a proactive form of HIV prevention as opposed to reactive
(Oldenburg et al., 2016). During PrEP clinical trials, the literature showed MSM subjects to
initiate PrEP out of motivation to protect themselves from future HIV infections (Taylor et al.,
2014). Previous investigations found patients initiated PrEP for additional HIV protection given
their HIV risks including multiple sex partners, condom failures, and inconsistent or no condom
use (Collins et al., 2016; Garcia & Harris, 2017; Parker et al., 2015). The added protection
reduces anxiety and shame associated with risky sexual behaviors (Brooks et al., 2012; Collins et
al., 2016; Taylor et al., 2014), and fears of contracting the virus when engaging in AI with a
person who has a positive or unknown HIV status (Mimiaga et al., 2014; Oldenburg et al., 2016;
Taylor et al., 2014). This study’s evidence is consistence with the literature, as this sample
initiated PrEP for added HIV protection due to the behaviors placing them at HIV risk (i.e.,
multiple sex partners, inconsistent condom use, condom failures, HIV deception, lack of HIV
disclosure, AI, MSM HIV disparity, STI/HIV scares etc.). PrEP’s added HIV protection,
provided peace of mind, which decreased anxiety and fear during sexual encounters; however,
this added peace of mind has caused have a dreaded consequence for some participants.
This evidence showed that risk compensation was a consequence of PrEP initiation
providing the added peace of mind and HIV-protection, which is consistent with the literature.
Risk compensation is the purposeful increase in HIV risky behaviors (Blackstock et al., 2016;
Calabrese et al., 2014; Calabrese & Underhill, 2015; Karris et al., 2014; Yagoda & Moore,
2016). The literature showed MSM assume their peers would initiate PrEP purposefully to
engage in risky behaviors (Brooks et al., 2012; Collins et al., 2016; Garcia & Harris, 2017;
Golub et al., 2013; Oldenburg et al., 2016; Perez-Figuerora et al., 2015; D. Smith et al., 2012;
Taylor et al., 2014). Three of the fourteen participants reported a form of risk compensation, as
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they reported engaging in riskier sex since their initiating PrEP. Although only one participant
admitted that engaging in risk compensation was the reason he initiated PrEP, the fact that two
other participants reported behaviors indicating risk compensation does give speculations about
risk compensation influencing PrEP initiation to have some validity.
Consistent with the literature, these findings show social barriers to accessing PrEP.
Perceived negative stigma and judgmental reactions from peers and health professionals were
speculated to deter MSM from seeking and initiating PrEP (Auerbach et al., 2015; Collins et al.,
2016; Dolezal et al., 2015; D. Smith, et al., 2012). The data are consistent with the literature, as
participants reported the negative or erroneous social perception about PrEP. Although this
sample did not report the social stigma to influence their decision, the investigator acknowledges
that those social motivations could have subconsciously influenced their decision, and may
possibly influence other at-risk individual’s decision-making process. Cost has also been shown
to be a barrier to initiation, as studies showed patients would be more willing to use PrEP if it
was conveniently available at minimal or no cost (Golub et al., 2013; D. Smith et al., 2012).
This study’s data did find financial means to be a factor in PrEP initiation, as participants openly
voiced that they were unable to access PrEP without assistance, and this perspective was
apparent regardless of SES. Due to most participants accessing PrEP at minimal or no cost, the
investigator cannot determine PrEP’s value limit to this sample. Another aspect of accessing
PrEP is provider and clinical services availability. Approximately 9% to 34% of prescribing
providers have adopted PrEP guidelines into their practices (Blackstock et al., 2016; Hakre et al.,
2016), and 30% of providers who have never prescribed PrEP believe they are unlikely do so
(Krakower et al., 2015). Although most of this sample did not have challenges in locating a
PrEP provider, one participant did experience such challenges. Therefore, this data
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demonstrated that access due to financial or provider means is ongoing, and implicates other atrisk individuals or populations wanting to initiate PrEP, but have accessibility constraints.
Knowledge Gap Contribution
Prior to this investigation, an absence of PrEP initiation decision-making inquiries in any
population existed. Therefore, this evidence is foundational to the current knowledge gap
regarding PrEP decision-making. The proposed investigation contributes to filling this
knowledge gap, as the purpose was to explore MSM’s decision to initiate PrEP, and the findings
revealed the factors and process involved in how this MSM sample derived to their decision.
Additionally, the evidence confirmed that initial misconceptions about PrEP’s indications and
requirements exist. This study demonstrated that patients require support, education, and
counseling when considering PrEP initiation from knowledgeable health professionals.
Although these findings are specific for this sample of MSM, the findings provide insight into
the factors and process of PrEP initiation decision-making, which may occur in other patient
populations.
Despite this contribution, study limitations restrict the magnitude these findings have on
the literature. The investigator utilized a qualitative description approach, as it is synonymous
with naturalistic research, and appropriate for decision-making research. Decision-making is the
process in which individuals consider and evaluate different factors surrounding a choice or
option, making it an individualistic and value dependent phenomenon (Allan & Harden, 2014;
Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al.,
2013; Newson et al., 2013; Nichol et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et
al., 2016). Therefore, this study’s findings are limited by respondent and interviewer bias, as
participant dishonesty or investigator misinterpretation could have distorted the emic view,
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leading to an inaccurate representation of this sample’s PrEP initiation decision-making process.
To the investigator’s knowledge, this was the first investigation into PrEP initiation decisionmaking in any population, therefore, the trustworthiness of these findings are restricted. The
investigator recognizes that other HIV-negative MSM may or may not undergo the same process
when making their decision. Additionally, even if the process is the same, the extent and degree
in which these factors are perceived and evaluated could also vary. Given the personal nature of
decision-making, qualitative methodology, and this study being the first known inquiry into
MSM’s PrEP initiation decision-making process, these findings are limited by transferability,
preventing these findings from being applicable to the larger MSM population. In light of the
identified limitations, the investigator cautions against health professionals generalizing these
findings to all applicable MSM patients, as these findings are transferable to this sample, and
possibly to other MSM sharing similar social demographics, experiences, and PrEP
accessibilities.
Implications
Despite these limitations, the findings provide insight into this phenomenon, and are
significant to the future narrative surrounding PrEP and HIV. Specifically, these findings have
cost saving implications for the health-care system regarding the U.S. HIV epidemic, and the
role nursing practice, education, and research has in providing PrEP care and services.
Health-care Industry
These findings are foundational to gauge if and how PrEP will have an impact on the
current MSM HIV epidemic. HIV care and treatment is extremely expensive on the health-care
system, costing an estimated $12.3 billion annually (CDC, 2015a). PrEP initiation in at-risk
groups is estimated to reduce HIV incidence by 70%, preventing 185,000 U.S. infections by
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2020 (CDC, 2016e), and each prevented HIV infection saves an estimated $355,000 in lifetime
HIV treatment costs (CDC, 2015a). In order for this to be possible, individuals with PrEP
indications have to decide to initiate the complementary regimen.
For this sample, each participant reported having at least one high HIV risk factor,
therefore showing that this sample of MSM were appropriate PrEP candidates. While analysis of
several themes lead to the discovery of five themes to entail their decision-making process, the
data indicated that acknowledged risks and HIV concern to be heavily weighted in the process.
This data demonstrated this predominantly African-American sample to be cognizant of the
epidemic, and were thorough when identifying factors placing them at risk. These findings
implicate other individuals with significant HIV risk factors who are knowledgeable of PrEP, but
have not decided to initiate PrEP. Perhaps this data provides a plausible explanation for PrEP’s
slow initiation in the U.S., as other at-risk individuals have not acknowledged their HIV risks, or
perceived HIV epidemic to be a threat or to even exist. Another possibility is that these other atrisk persons are deterred from initiating PrEP due to the on-going negative and social stigma
associated with PrEP.
One population in particular these findings have implications for is African American
women, as the CDC (2016d) indicates African American women to be the second highest group
infected with HIV after MSM. Additionally, data shows that African-American women are more
than four times less likely to initiate PrEP than Caucasian women, as most PrEP patients are
male (76%) and only 10% of African-Americans have initiated PrEP (NAM, 2018). This study’s
evidence implicates that without other at-risk populations acknowledging the epidemic or their
risks, PrEP initiation may remain slow, and PrEP’s estimated impact will not be realized.
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Given some of the barriers (i.e., stigma, cost, and logistics) identified from and
experienced by this sample, this investigator believes the evidence implicates a need for
discussing the need to devise policies that can address individuals with PrEP indications being
able and willing to access and initiate PrEP. This evidence implicates the need to consider the
development of policies to improve and expand PrEP outreach and access to services to HIVvulnerable groups throughout the U.S. This sample expressed disappointment in their own
experiences and perception of society’s knowledge and awareness of PrEP. While some
participants acknowledged PrEP awareness is low and poor among all patient populations, most
recognized that HIV-vulnerable populations such as MSM, youth, women, and minorities suffer
greatly from the lack of awareness, as the CDC (2016f) identifies these groups as the most
vulnerable to contracting HIV. Increased and widespread PrEP education and outreach from
knowledgeable professionals and advocates can be a mechanism to increase awareness and
decrease PrEP’s negative stigmas and erroneous misconceptions.
This sample also expressed difficulty in accessing PrEP without financial assistance,
implicating the need for federal and state aid to fund PrEP preventative services just as
HIV/AIDS’ treatment efforts are rendered through state level AIDS Drug Assistance Programs
(ADAP), and federal Ryan White services. Although only one participant experienced logistical
issues to accessing a PrEP provider in their local area, this one occurrence does give speculation
that such challenges are apparent for other at-risks persons in areas lacking PrEP services.
Previous evidence demonstrated that the limited number of PrEP providers is not merely an act
of a knowledge deficient. Less than 20% of sampled providers in the U.S. have ever prescribed
PrEP (Krakower et al., 2015; Tellalian et al., 2013), and 30% of providers who have never
prescribed PrEP believe they are unlikely do so in the future (Krakower et al., 2015). These
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limitations give reason for the need for devising strategies to overcome such challenges.
HIV/AIDS’ advocates should consider lobbying for the opportunity to discuss instituting funding
and policies to support providing PrEP-care through telemedicine capabilities, or by requiring
health professionals to inform patients about PrEP and the clinics in their local and neighboring
areas that can provide such services.
Nursing Profession
These findings allow nursing to improve practice and education PrEP standards. Most
participants engaged in risky sexual behaviors prior to PrEP initiation (i.e., multiple sex partners,
using condoms inconsistently or not at all, and engaging in open/casual/impulsive sex), and this
evidence reminds nurses to provide risk reduction counseling regardless of the patient’s decision
to initiate PrEP. The evidence showed the rationale behind this sample’s decision to initiate
PrEP. The identified themes (i.e., HIV risks, fears, concerns; and PrEP risks, benefits, and
requirements) can be used as a guide to provide in-depth PrEP patient education during the
screening and initiation process. The data showed that participants initiated PrEP without having
a complete understanding of or accurate information about PrEP’s requirements and efficacy.
Nursing practice can utilize this evidence to implement in-depth PrEP patient-education,
ensuring that patients are explicitly educated about the correlation between adherence and
efficacy, as well as PrEP’s effectiveness timeframes. Initiating PrEP was revered as a form of
proactive prevention which gave participants more control of their HIV risks and peace of mind;
however, as a result, risk compensation was noted from a few participants, implicating the need
for nursing practice to educate patients that PrEP is complementary, requiring the
implementation of traditional risk-reduction behaviors in combination with PrEP. Another
aspect identified in the decision-making process is the impact affordability had on initiation, as
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all participants admitted to being PrEP’s cash price to be exorbitant. From this evidence, nursing
practice can better advocate for patients, ensuring that all are aware of PrEP access and financial
assistance programs.
This study’s evidence is foundational for nursing research, establishing a new knowledge
base for PrEP initiation inquiries to build upon. Future inquiries can replicate this study design
utilizing a larger sample size, to further evaluate and explore these findings. Replicated studies
can refine the data derived conceptual model, and are necessary before transferring the findings
to the larger population (Houghton et al., 2013). Although this data is specific to MSM in the
Southern U.S., this evidence can be foundational to investigating PrEP initiation decisionmaking in other patient populations and U.S. regions. As more evidence is generated, sequential
findings can lead to the development of evidenced-based PrEP initiation decision-making
practice interventions and tools, which can lead to devising and implementing evidenced based
strategies for achieving PrEP initiation success.
Recommendations for Future Research
This evidence adds to the PrEP initiation literature, but as foundational evidence, there
are opportunities for future research. Given the limitations and implications associated with this
inquiry into a new phenomenon, the investigator recommends replication of this study utilizing
more MSM PrEP patients in the Southern U.S. PrEP initiation decision-making should also be
studied in different patient demographics to determine differences and similarities among the
populations. Although foundational for PrEP initiation, this data does not address other aspects
of post-PrEP initiation, including adherence, risk compensation, decision-making to continue or
discontinue PrEP, and long-term efficacy. Therefore, inquiries into these aspects surrounding
PrEP initiation are recommended in all populations initiating PrEP. Investigation into these
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other PrEP aspects provides a comprehensive account of PrEP implementation in the U.S., and
PrEP’s ability to have the estimated impact on the HIV epidemic in the U.S.
Conclusions
This investigation into MSM’s PrEP initiation decision-making process was shown to be
a personal and introspective phenomenon. This evidence shares consistencies with the reviewed
literature and extends the knowledge base on health-behavioral decision-making, MSM HIV
prevention, and MSM and PrEP. Although these findings are limited and not readily applicable
to all MSM or other patient populations, these findings are significant to PrEP initiation in the
U.S., as three significant conclusions are drawn from this data. The investigator concludes that
the decision to initiate PrEP is a serious endeavor. Secondly, PrEP is still a negatively
stigmatized regimen, which has implications for PrEP initiation in the future. Therefore, health
professionals involved in any aspect of rendering PrEP services should be adequately educated to
combat misconceptions and misunderstandings.
The data showed that in spite of PrEP’s benefits to provide added HIV protection,
participants engaged in serious thought process prior to initiating PrEP. Participants did not take
this decision lightly, as analysis of the data emerged a comprehensive process in arriving at the
decision. Each participant did not report being overzealous or eager to initiate PrEP just to reap
the benefits of having added HIV protection, instead the process was comprehensive and an
evaluation encompassing these five concepts (1) HIV-risk acknowledgment, (2) HIV concern,
(3) PrEP understanding, (4) PrEP accessibility, and (5) PrEP consideration. Although more
evidence is needed on risk compensation in the context of PrEP initiation, this evidence showed
that participants are not initiating PrEP with the intent to engage in riskier HIV and sexual
behaviors.
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Although this sample did not show social motivations and social stigmas to influence
their decision-making process, the data indicated that a significant amount of erroneous and
negative information exist about PrEP. As the literature suggested, these social motivations can
influence decision-making process whereby deterring other at-risk populations from initiation
(Auerbach et al., 2015; Collins et al., 2016; Dolezal et al., 2015; D. Smith, et al., 2012).
Therefore, health professionals have to be knowledgeable of these social perceptions and
opinions, so that they can be prepared to address these misconceptions with the patients and
communities being served, especially those experiencing the highest HIV incidence and
prevalence.
Lastly, this evidence leads to the conclusion that all health professionals providing any
aspect of PrEP services should be knowledgeable to provide accurate PrEP patient-education.
Health professionals play a significant role in patients’ decision-making processes (Chong et al.,
2013; Coombs et al., 2016; Popejoy, 2005; Rose et al., 2017; Siouta et al., 2015; Thom et al.,
2016). Since PrEP is only accessible from the services of health professionals, ideally, there
should not be a reason a patient whom has initiated PrEP should have lingering uncertainties or
misunderstandings about PrEP. Health professionals that are involved in any aspect of PrEP
care, beginning with screening, to initiation, to dispensing, to follow-up care, and discontinuation
are charged to provide education at any interim during this care continuum. Given PrEP’s
uniqueness to traditional risk-reduction behaviors, this study’s evidence requires health
professionals to be vigilant and proactive in the PrEP care and patient education provided.
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Appendix A: CDC’s MSM HIV Prevention Evidenced-based Behavioral Interventions (EBIs)
Name
Males of African
American Legacy
Empowering Self
(MAALES)

Level
Group

Facilitator & Description
Facilitator: African-American males

Effectiveness
Good

Many Men, Many
Voices (3MV)

Group

Description: Delivery of six-2 hour sessions over a 3 weeks
and two-2-hour booster sessions at 16 & 18 weeks postintervention.
Facilitator: Peer-to-Peer

Best

Community

Description: Six consecutive 2 to 3-hour sessions during a
weekend
Facilitator: Outreach Team of MSM peers

Good

Group

Description: A team of 10-15 young gay men design and
carry out our integrated activities: (1) formal outreach, (2)
informal outreach; (3) “M-group”; & (4) ongoing publicity
campaigns that provide skill building, practice correct
condom-use, & safer-sex negations
Facilitator: Technology (video) & Peer counselor

Best

Individual

Description: One 45-minute soap-opera style video in English
& Spanish followed by discussions
Facilitator: Licensed mental health professional

Best

Community

Description: One 1-hour counseling session
Facilitator: Trusted & respected community leaders

Good

Individual

Description: MSM community leaders are trained to engage
in risk-reduction conversations with peers.
Facilitator: Virtual facilitator

Best

Individual

Description: Three 60-90 minute counseling sessions
delivered over 3 weeks followed by discussions
Facilitator: Professional Counselor

Best

Think Twice

Individual

Description: One 30-50 minute Personalized Cognitive
Counseling (PCC); One booster counseling session three
months later
Facilitator: Peer-to-Peer

Best

VOICES/VOCES

Individual

Description: One 40-minute session
Facilitator: Technology (video) & male facilitator

Best

Individual

Description: One 20-minute video (culturally adapted for
African Americans & Hispanics) followed by one 25-minute
group discussion
Facilitator: Professional Therapist

Best

Mpowerment

No Excuses/ Sin
buscarexcusas

Personalized
Cognitive
Counseling (PCC)
Popular Opinion
Leader (POL)

POWER

Project ECHO

Young Men’s
Health Project

Description: Four 1-hour sessions delivered over 12 weeks
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Appendix B: Applied Theoretical Frameworks in CDC’s Compendium Interventional Studies
Intervention Name
Males of AfricanAmerican Legacy
Empowering Self
(MAALES)

Theoretical Framework(s)
• Theory of Reasoned Action/Theory of Planned Behavior
• Empowerment Theory
• Critical Thinking and Cultural Affirmation Model

Many Men, Many
Voices (3MV)

•
•
•
•

Social Cognitive Theory
Behavioral Skills Acquisition Model
Transtheoretical Model of Behavior Change
Decisional Balance Model

Mpowerment

•

Diffusion of Innovations Theory

No Excuses/ Sin
buscarexcusas

•

Social Cognitive Theory

Personalized
Cognitive
Counseling (PCC)

•
•

Gold’s Model of “on-line” versus “off-line” self-appraisal of risk
behavior
Model of Relapse Prevention

Popular Opinion
Leader (POL)
POWER

•

Diffusion of Innovations

•

Information, Motivational, and Behavioral Skills Model

Project ECHO

•
•
•

Bandura’s Theory of self-regulation
Transtheoretical Model
Gold and colleagues concept of self-justification for high risk sexual
behaviors among MSM

Think Twice

•

Conflict Theory of Decision-Making

VOICES/VOCES

•
•

Health Belief Model
Theory of Reasoned Action

Young Men’s Health
Project

•

Motivational Interviewing
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Appendix C: Tentative Research Study Timeline
Research Tasks
Institutional Review Board (IRB)

Month: 1

2

3

4

5

6

7

8

9

10 11 12

X X

Submission for Approval
Study Open to Enrollment

X

X X

X X

Recruitment

X

X X

X X

Data Collection

X X

X X

X X X X

Data Analysis

X X

X X

X X X X

X X

X X

X X X X

Results & Implications

X

X X X X

X

X

Dissemination
IRB Submission for Closure

X

X
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Appendix D: List of PrEP Clinics in Alabama*
City
Alexander City

Clinic Name, Address, & Phone Number
Health Services Center - Alex City
218 South Central Ave
Alexander City, AL 35010
256-832-0100
Anniston
Health Services Center - Hobson City
608 Martin Luther King Dr
Anniston, AL 36201
256-832-0100
Birmingham
Birmingham AIDS Outreach
205 32nd Street S
Birmingham, AL 35233
Phone: (205) 322-4197
Birmingham
The 1917 Clinic at UAB
Community Care Building
908 South 20th Street
Birmingham, AL 35294-2050
Phone: (205) 934-1917
Huntsville
Thrive Alabama
600 St. Clair Ave., Building 3
Huntsville, AL 35801
Phone: (256) 536-4700
Fax: (256) 536-4117
Montgomery
Medical AIDS Outreach
2900 McGehee Road
Montgomery, AL 36111
Phone: (334) 280-3349
Toll Free: (800) 510-4704
Tuscaloosa
Five Horizons Health Services
2720 6th St.
Tuscaloosa, AL 35401
Phone: (205) 759-8470
*List of practices/clinics providing PrEP as of 02122018 in Alabama from Greater Than AIDS
website: https://greaterthan.org/get-prep/&Alabama Dept of Public Health HIV/AIDS website
http://alabamapublichealth.gov/hiv/prep.html
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Appendix E: List of PrEP Clinics and Providers in Georgia*
City
Atlanta

Atlanta

Atlanta

Atlanta

Atlanta

Atlanta

Decatur

Clinic Name, Address,
& Phone Number
Absolute CARE
2140 Peachtree Rd. NW
Suite 232
Atlanta, GA 30309
404-231-4431
Druid Hills Primary
Care
1700 Briarcliff Road NE
Atlanta, GA 30306
404-228-2648
Frieda Millhouse-Jones
MD - Laureate Medical
Group Midtown
550 Peachtree Street NE
550 Peachtree Street NE
Suite 1550
Atlanta, GA 30308
404-892-2131
Infectious Disease of
Atlanta, LLC
735 Piedmont Ave. NE
Atlanta, GA 30309
404-588-4680
Intown Primary Care
2215 Cheshire Bridge
Rd
Atlanta, GA 30324
404-541-0944

Southside Medical
Center
1046 Ridge Avenue SW
Atlanta, GA 30315
404-688-1350
Oak Grove Family
Medicine
2840A Lavista Road
Decatur, GA 30033
404-639-9180

Clinic Name, Address,
& Phone Number
AID Atlanta
1605 Peachtree Rd. NE
Atlanta, GA 30309
404-870-7762
Empowerment Resource
Center
230 Peachtree Road NW
Suite 1800
Atlanta, GA 30303
404-526-1145
Fulton County Board of
Health
10 Park Place South, SE
Atlanta, GA 30303
404-613-4708

Internal Medicine
Specialists
1800 Howell Mill Rd.
Atlanta, GA 30318
404-607-1777
Intown Primary Care
730 Ponce De Leon Pl.
Unit B
Atlanta, GA 30306
404-541-0944

Dr. T. Douglas Gurley
659 Auburn Ave NE
#156
Atlanta, GA 30312
404-888-0228
Ponce Primary Care
402 Ponce de Leon
Avenue
Decatur, GA 30300
404-537-2521

Clinic Name, Address,
& Phone Number
Atlanta ID Group
275 Collier Road
Suite 450
Atlanta, GA 30309
404-355-3161
Family Healthcare of
Atlanta PC
1935 Howell Mill Rd
NW
Atlanta, GA 30318
404-355-2000
Georgia Infectious
Diseases
5673 Peachtree
Dunwoody Road
Suite 600
Atlanta, GA 30342
404-256-4111
Intown Infectious
Disease
619 Rankin Street NE
Atlanta, GA 30308
404-874-3102
Someone Cares LGBT
& Ally Resources
Center
236 Forsyth Street
Suite 204
Atlanta, GA 30303
678-921-2706

Positive Impact Health
Centers
523 Church St
Decatur, GA 30030
404-589-9040
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Peach County Health
Department
406 East Church Street
Fort Valley, GA 31030
478-825-6939
Lawrenceville Gwinnett Clinic - Webb
Gin
1289 Scenic Highway
Lawrenceville, GA
30045
770-972-9000
Macon
Macon Bibb County
Health Department
171 Emery Highway
Macon, GA 31217
478-745-0411
Marietta
Someone Cares Inc. of
Atlanta EDIC
1950 Spectrum Circle
SE
Suite 145
Marietta, GA 30067
678-921-2706
Snellville
Gwinnett Clinic
Snellville
2764 West Main Street
Snellville, GA 30078
770-978-3388
Tucker
ID Consultants, PC
1370 Montreal Road
Suite 130
Tucker, GA 30084
770-939-1601
Warner
North Central District
Robins
Houston County Health
Department
98 Cohen Walker Drive
Warner Robins, GA
31088
478-218-2000
*List of practices/clinics providing PrEP as of 02122018 in Georgia from Greater Than AIDS
website: https://greaterthan.org/get-prep/
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Appendix F: Invitation Letter

PORTIA Thomas, (DNSc), MSN-CNE, MPH
Nursing Doctoral Candidate
Kennesaw State University
Dissertation Research Proposal
Date
Recipient Name
Recipient Company Name
Recipient Address
Dear Recipient Name,
I am writing to let you know about an opportunity to participate in a research study about HIV Preexposure prophylaxis (PrEP) decision-making. Portia Thomas, a nursing doctoral candidate at Kennesaw
State University, is conducting the study to explore men who have sex men’s (MSM’s) decision-making
process to initiate PrEP.
I am seeking your assistance and support with recruiting participants. I understand that your first priority
is patient safety and confidentiality, and I certainly agree with and respect this responsibility. Therefore, I
request permission to recruit your patients by posting and providing study advertising posters and
handouts in your clinic patient areas (i.e., exam rooms and waiting areas). The advertisements will have
all of my contact information so interested patients can follow-up with me at their choosing.
Please review the attached study synopsis for further details. I will be following up with you in the 5-7
business days to determine your interest in assisting me with my research. If you have any questions or
concerns before then, please feel free to contact me at your convenience by phone: 334-425-8516 and/or
email: pthoma48@students.kennesaw.edu.
Thank you for considering this research opportunity.
Sincerely,

Portia Thomas
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Appendix G: Study Synopsis
Dissertation Study Synopsis
TITLE: Exploring Men who have sex with men’s (MSM’s) Pre-exposure Prophylaxis (PrEP) Initiation
Decision-making Process
TITLE ACRONYM: His PrEP Decision
Investigator’s Information:

Portia Thomas, (DNSc), MSN-CNE, MPH
Mobile: 334-425-8516
Email: Pthoma48@students.kennesaw.edu

Investigator’s University:

Kennesaw State University in Kennesaw, GA
URL: http://www.kennesaw.edu/

Program/Department:

WellStar School of Nursing
Doctorate of Nursing Science (DNS)

Dissertation Committee Chairperson:

Richard Sowell, PhD, Professor
470-578-6062
rsowell@kennesaw.edu

INTRODUCTION: The MSM HIV epidemic continues to thrive in the U.S., as MSM account for
majority of current and past HIV/AIDS diagnoses. MSM’s HIV incidence rate is 44 times higher than in
other men and 40 times higher than in women (Centers for Disease Control & Prevention [CDC], 2016b),
and at this rate the CDC (2016a) estimates that 1 in 6 MSM will contract the virus in their lifetime. HIV
prevention is the key to stopping MSM’s current and predicted HIV incidence in the U.S. (CDC, 2016a;
Fan, Conner, & Villarreal, 2014).
HIV pre-exposure prophylaxis (PrEP)is the newest HIV prevention modality, as HIV’s first
pharmacological prevention agent. PrEP is the fixed daily dose of Truvada in HIV-negative persons with
reported and documented high HIV-acquisition risk (CDC, 2014). Clinical trial data show that in the
event of an exposure, PrEP is efficacious, reducing HIV seroconversion by as much as 92% (CDC, 2014;
Koenig, Lyles,& Smith, 2013). Experts estimate that PrEP initiation in at-risk groups can reduce HIV
incidence by 70%, and prevent 185,000 U.S. infections by 2020 (CDC, 2016c). Each prevented HIV
infection saves an estimated $355,000 in lifetime HIV treatment (CDC, 2015). Therefore, PrEP initiation
in at-risk groups can significantly change the current HIV epidemic in the U.S. and MSM population.
Most current and former PrEP patients are MSM (Krakower et al., 2015; Krakower & Mayer, 2015;
Tellalian, Maznavi, Bredeek, & Hardy, 2013), but currently there is no research exploring their decisionmaking process to initiate PrEP. The purpose of this study is to explore PrEP initiation decision-making
process of HIV-negative MSM engaging in protected and unprotected anal sex. Decision-making details
what and how individuals consider and evaluate the different factors surrounding a choice or option
(Poortaghi et al., 2015; Popejoy, 2005). Knowledge from this study may be a step to gauge if PrEP can
have the estimated impact on the HIV epidemic and change the current MSM HIV disparity. MSM's
PrEP initiation decision-making process can inform nursing practice on factors that influence PrEP
decision-making and how MSM rationalize initiating PrEP based on their HIV and PrEP perceptions and
understanding. With this knowledge, nurses can be able to identify opportunities to assist patients during

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

184

the decision-making process, and clarify HIV and PrEP misunderstandings and misconceptions. This
study’s findings can be used to educate nurses on ways to counsel and support MSM considering PrEP.
This study can contribute to future development and testing of MSM PrEP initiation decision tools and
interventions, which can lead to devising and implementing evidenced based strategies for achieving
PrEP initiation success.
OBJECTIVES: The study objectives are to explore how HIV-negative MSM decide to initiate PrEP
based on the evaluation and perceptions pertaining to their: (a) PrEP knowledge and HIV
concern(s)/risk(s); (b) personal and social motivations to initiate PrEP; and (c) behavioral skills and
abilities to adhere to PrEP.
STUDY DESIGN: This study will be conducted following Sandelowski’s (2000, 2010) approach to
qualitative description, which is rooted in naturalistic and constructivism research, used to gather,
understand, and describe individuals’ authentic experiences.
SETTING: Clinics with providers offering PrEP and PrEP services.
DURATION OF STUDY: Approximately 4-6 months.
SAMPLE SIZE: 10-30 participants
PARTICIPANT COMPENSATION: Participants will be compensated once with a $30 Visa® credit
gift card.
SAMPLE SELECTION: Participants must meet the following inclusion criteria: (a) assigned a sex of
male at birth; (b) 18 years of age or older; (c) verbally confirm engagement in sex with men; (d) currently
taking PrEP; (e) began taking PrEP in the past six months; (f) verbally confirm being HIV-negative; (g)
read, speak, understand, and write English; and (h) provide written informed consent.
DATA COLLECTION PROCEDURE: Each participant will undergo one 60-minute one-on-one semistructured interview with questions to elicit information regarding their PrEP initiation decision-making
process. At the completion of the interviews, participants will complete a demographic form.
DATA ANALYSIS PROCEDURE: Descriptive statistics will describe the sample’s demographics.
Interviews will be transcribed verbatim, and will follow Elo and Kyngas’ (2008) three-phase inductive
content analysis process.
REFERENCES:
Center for Disease Control & Prevention (CDC). (2014). Preexposure prophylaxis for the
prevention of HIV infection in the United States- 2014 clinical practice guidelines. Retrieved
from http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf
Centers for Disease Control and Prevention (CDC). (2015). CDC’s HIV prevention progress in
the United States. Retrieved from https://www.cdc.gov/hiv/dhap/progress/index.html
Centers for Disease Control and Prevention (CDC). (2016a). HIV among gay and bisexual men.
Retrieved from: https://www.cdc.gov/hiv/pdf/group/msm/cdc-hiv-msm.pdf
Centers for Disease Control and Prevention (CDC). (2016b). HIV and AIDS in America: A
snapshot. Retrieved from: https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/hiv-and-aidsin-america-a-snapshot-508.pdf
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Centers for Disease Control and Prevention (CDC). (2016c). HIV prevention modeling study.
Retrieved from:
http://www.cdc.gov/nchhstp/newsroom/2016/croi-press-release-prevention.html
Elo, S. & Kyngas, H. (2008). The qualitative content analysis process. Journal of Advanced
Nursing, 62, 107-115. doi: 10.1111/j.1365-2648.2007.04569.x

Fan, H. Y., Conner, R. F., & Villarreal, L. P. (2014). AIDS: Science and Society, 7thed.
Burlington, MA: Jones & Bartlett Learning.
Koenig, L. J., Lyles, C., & Smith, D. K. (2013). Adherence to antiretroviral medications for HIV
pre-exposure prophylaxis. American Journal of Preventative Medicine, 44, S91-S98.
doi: 10.1016/j.amepre.2012.09.047
Krakower D. S., & Mayer, K. H. (2015). Pre-exposure prophylaxis to prevent HIV infection:
Current status, future opportunities and challenges. Drugs, 75, 243-251.
doi: 10.1007/s4026-015-0355-4

Krakower, D. S., Oldenburg, C. E., Mitty, J. A., Wilson, I. B., Kurth, A. E., Maloney, K. M., . . .
Mayer, K. H. (2015). Knowledge, beliefs, and practices regarding antiretroviral
medications for HIV prevention: Results from a survey of health-care providers in New
England. PLoS ONE, 10, e0132398. doi: 10.1371/journal.pone.0132398
Pebody, R. (2010). HIV transmission risk during anal sex 18 times higher than during vaginal
sex. Retrieved from http://www.aidsmap.com/HIV-transmission-risk-during-anal-sex-18-timeshigher-than-during-vaginal-sex/page/1446187/
Poortaghi, S., Raiesifar, A., Bozorgzad, P., Golzan, S. E.J., Parvizy, S., &Rafii, F. (2015).
Evolutionary concept analysis of health seeking behavior in nursing: a systematic review. BioMed
Central Health Services Research, 15, 523. doi: 10.186/s12913-015-1181-9
Popejoy, L. (2005). Health-related decision-making by older adults and their families. How
clinicians can help. Journal of Gerontological Nursing, 31(9): 12-18.
Sandelowski, M. (2000). Focus on research methods: Whatever happened to qualitative
description? Research in Nursing & Health, 23, 334-340.
Sandelowski, M. (2010). What’s in a name? Qualitative description revisited. Research in
Nursing & Health, 33, 77-84.
Tellalian, D., Maznavi, K., Bredeek, U. F., & Hardy, W. D. (2013). Pre-exposure prophylaxis
(PrEP) for HIV infection: results of a survey of HIV health care providers evaluating their
knowledge, attitudes, and prescribing practices. AIDS Patient Care and STDs, 27, 553-559. doi:
10.1089/apc.2013.0173

At least 18 years of age
Read & speak English

At least 18 years of age

Read & speak English

If interested or for more information, please call

If interested or for more information, please call

(334) 425-8516.

You WILL recieve $30.00 compensatation for your time

You WILL recieve $30.00 compensatation for your time

(334) 425-8516.

You WILL need to be able to give one 60-minute interview

You WILL need to be able to give one 60-minute interview

EXTRA STUDY DETAILS INCLUDE . . .

Currently taking PrEP & began taking PrEP in the past 6 months

Currently taking PrEP & began taking PrEP in the past 6 months

EXTRA STUDY DETAILS INCLUDE . . .

A man who has sex with men

YOU CAN BE A PART OF THE STUDY IF YOU ARE. . .

HIS PREP DECISION RESEARCH STUDY
His PrEP Decision study is recruiting research participants. The
purpose of this study is to gather information on your decision to
initiate PrEP. Your perspective on this will help nurses better
understand this process, so we can improve how we support you
& future patients during this process. Read further for more
information.

A man who has sex with men

YOU CAN BE A PART OF THE STUDY IF YOU ARE. . .

HIS PREP DECISION RESEARCH STUDY
His PrEP Decision study is recruiting research participants. The
purpose of this study is to gather information on your decision
to initiate PrEP. Your perspective on this will help nurses
better understand this process, so we can improve how we
support you & future patients during this process. Read further
for more information.
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Appendix H: “His PrEP Decision” Recruitment Handout
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Appendix I: “His PrEP Decision" Recruitment Poster

HIS PREP DECISION STUDY
His PrEP Decision study is recruiting research participants. The
purpose of this study is to gather information on your decision to
initiate PrEP. Your perspective on this will help nurses better
understand this process, so we can improve how we support you
& future patients during this process.
YOU CAN BE A PART OF THE
STUDY IF YOU ARE. . .
A man who has sex with men
Currently taking PrEP & began
taking PrEP in the past 6 months
At least 18 years of age
Read & speak English
EXTRA STUDY DETAILS
INCLUDE . . .
You WILL need to be able to give
one 60-minute interview
You WILL recieve $30.00
compensatation for your time
If interested or for more
information, please call (334) 4258516.
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Appendix J: “His PrEP Decision" Informed Constent Form
SIGNED CONSENT FORM
Title of Research Study: Exploring Men who have sex with
men’s (MSM’s) Pre-exposure Prophylaxis (PrEP) Initiation
Decision-making Process
Research Study Acronym: His PrEP Decision
Researcher's Contact Information:

Portia Thomas, DNSc, MSN-CNE, MPH
Mobile: 334-425-8516
Email: Pthoma48@students.kennesaw.edu

Introduction
The nurse-researcher, Portia Thomas, of Kennesaw State Universityis conducting a study. You
are being invited to participate because you started taking PrEP and have identified as being a
man who has sex with men (MSM). Before you decide to participate, you should read this form
carefully. If you have questions regarding this consent or study, please ask at any time.
Description of Project
The purpose of the study is to understand how you came to thedecision to start taking PrEP.The
nurse-researcher wants to know the factors and process you considered that led to your decision.
As a participant,you will be asked to share your story as an MSM, thoughts and concerns about
HIV, and your journey to starting PrEP.
Explanation of Procedures
Participation in this study requires you to undergo a one-on-one60-minute interview with the
researcher. The researcher will discuss with you dates, times, and a location that makes you
comfortable, and will not interfere with the nurse-researcher’s ability to listen to your responses
or audio-record the interview. You are the expert in PrEP initiation decision-making, so you will
beasked and are encouraged to answer the questions openly and honestly.You will also be
required to complete aone-page demographic form.
Time Required
To participate in this study, you will need to complete a one 60-minute interview with the nurseresearcher and fill out a demographic form. Therefore, the total required time for this study is
approximately 65 minutes.
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Risks or Discomforts
There are no physical or bodily risks from participating in this study. However, talking about
your decision to startPrEPon a recording device may make you uncomfortable. Additionally, the
interviewerwill ask questions about your sexual history and behaviors and beliefs about HIV and
PrEP.Discussing these topics with a female may cause you to feel uneasy or embarrassed.
Benefits
There are no guaranteed benefits from you participating in this study. By taking part in this
study, the nurse-researcher hopes to give you a voice and opportunity to tell your story about a
decision you made. Your words and responses can inform doctors and nurses about ways to
improve care provided to you and other MSM PrEP patients.
Compensation
After you complete the interview and demographic form, you will be compensated for your time
with a $30 Visa® credit gift card.
Confidentiality
Protecting the confidentiality of your information is thefirst priority. Aftersigning this form, you
will be assigned an identification number and be asked to provide a fictional name. The fictional
name is to be used during the interviews instead of your legal name. If you cannot think of a
fictional name, one will be provided for you.
Inclusion Criteria for Participation
You must meet all of the following criteria in order to participate in this study: (a) assigned a
sex of male at birth; (b) 18 years of age or older; (c) verbally confirm engaging in anal sex with
men; (d) currently taking PrEP; (e) began taking PrEP in the past six months; (f) verbally
confirm being HIV negative; (g) read, speak, understand, and write English, and (h) provide
written informed consent.
Signed Consent
I agree and give my consent to participate in this research project. I understand that participation
is voluntary and that I may withdraw my consent at any time without penalty.

__________________________________________________
Signature of Participant or Authorized Representative, Date
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___________________________________________________
Signature of Investigator, Date
______________________________________________________________________________
PLEASE SIGN BOTH COPIES OF THIS FORM, KEEP ONE AND RETURN THE OTHER
TO THE INVESTIGATOR
Research at Kennesaw State University that involves human participants is carried out under the
oversight of an Institutional Review Board. Questions or problems regarding these activities
should be addressed to the Institutional Review Board, Kennesaw State University, 585 Cobb
Avenue, KH3403, Kennesaw, GA 30144-5591, (470) 578-2268.
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Appendix K “His PrEP Decision" Study Enrollment Form
Consent & Enrollment Date: ________________
Participant ID: PID- _________

Pseudonym: _____________________________

Interview Details:
Scheduled Interview Date & Time _________________________________________________
Scheduled Location ____________________________________________________________
____________________________________________________________________________

Interview Details Confirmation Notes:

END OF PAGE 1 OF 2 STUDY ENROLLMENT FORM

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

192

INCLUSION CRITERIA
Circle “Yes” to confirm the patient meets the following criteria, if not circle “No"
1. Assigned a male sex at birth

Yes/ No

2. 18 years of age or older

Yes/ No

3. Verbally confirm to engage in anal intercourse (AI) with men

Yes/ No

4. Currently taking PrEP

Yes/ No

5. Began taking PrEP in the past six months

Yes/ No

6. Verbally confirm a HIV-negative status

Yes/ No

7. Read, speak, understand, and write English

Yes/ No

8. Provide written informed consent

Yes/ No

1. Does the patient meet ALL of the INCLUSION criteria? YES, or NO
If “YES” the participant is ELIGIBLE, if “NO” the participant is INELIGIBLE.
2. This participant is (circle one) INELGIBLE/ ELIGIBLE.
Research Personnel Completing Enrollment form & process please complete the area below.
________________________________________________
________________
Print Name
Signature
Date (mm/dd/yyyy)

This portion of the paper was
purposefully left blank

END OF PAGE 2 OF 2 STUDY ENROLLMENT FORM
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Appendix L: “His PrEP Decision "Script& Interview Guide
PID-______________

Interview Date: _________________

Thank you for taking the time to speak with me today. You are the expert in taking PrEP, and I need to
learn from you how you came to that decision. I am interested in your story, so there is no right or wrong
answer. Please share as much as you feel comfortable.
1. How do you identify your sexuality (gay, bisexual, or MSM)? Tell me about you and your
story of being and becoming aware and accepting of your identity in the South. (target 10
minutes)
Are you open about your sexuality with family and friends? How did you decide to whom you
would disclosure your sexual orientation?
Tell me about your family, friends, and partners and how they affect your life.
2. Are you sexually or romantically involved with anyone? If no, in the past 1-2 years? (target
10 minutes)
Do you have a partner or are you married? Is this a long term or casual relationship?
Are you sexually monogamous? Did you have a discussion about being monogamous or not? Tell
me about the discussion.
Do you know if your partner is HIV positive or negative? If negative, are they on PrEP?
Besides PrEP, what other protections do you take to prevent getting HIV?
Do you implement these behaviors consistently or how to you decide when or with who to take
prevention precautions?
3. Tell me about your thoughts and concerns about your HIV risks. (target 10 minutes)
What behaviors place you at risk for getting HIV?
What are your thoughts and concerns about becoming HIV infected?
Do you know or have you met anyone with HIV?
What has been your experience with people living with HIV?
What have you heard others say about people living with HIV?
4. Tell me how you came to know about PrEP. (target 10 minutes)
How did you learn about PrEP? What did you think about it?
What led you to wanting to know more about PrEP?
Do you know other men who are on PrEP and what has been their experience (what have they
told you about PrEP)?
How did you find your PrEP provider?
What concerns do you have about being on PrEP? (taking it every day, cost, going to the doctor
every 3 months for monitoring or what other concerns you might have).
How has being on PrEP changed your sexual behaviors? Explain.
Do you feel being on PrEP has changed your risk of getting HIV? Explain how.
Do your friends, family and/or partner(s) know you are on PrEP? How do they feel about it?
5. Tell me how you decided to start PrEP. (target 15 minutes)
Tell me about factors or any events that made you feel PrEP would be right for you (i.e., life
experiences, specific event or occurrence, your HIV risk/concerns, your understanding of PrEP).
Tell me more about the process you went through in deciding to start PrEP.
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Was it an immediate decision once you learned about it or did you take a period of time to
consider it?
6. You have given me a lot of insight into your decision-making in starting PrEP. I appreciate
your willingness to share your story with me. Is there anything else you want to tell me
about you or your journey to beginning PrEP? (target 5 minutes)
END OF INTERVIEW GUIDE
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Appendix M: “His PrEP Decision” Demographic Form
PID- _____________
Patient Information

Interview Date: ________________

1) Pseudonym: __________________

2) Ethnicity (select one): ☐ Hispanic ☐ Non-Hispanic

3) Age: _______________
4) Race (select one):

☐American Indian
☐Asian
☐Native Hawaiian
☐Pacific Islander

5) Highest education level completed
(select one):

☐Alaska Native
☐Black or African American
☐Other ________________
☐White

☐ Less then high school
☐ High school
☐ College (associate, bachelor, or technical school)
☐ Graduate school

6) Annual Income (select one): ☐ less than $20,000
☐ $40,001- $60,000
☐more than $80,000

☐ $20,001- $40,000
☐$60,001- $80,000

7) When did you start taking PrEP? Date ________________
8) Including all sexual encounters, how many sex partners have you had in the last 3 months?
_________________
Regarding the sexual encounters asked about in question 8, answer questions 9 and 10.
9) What percentage (0%-100%) of the time did you use condoms? _______________
10) Which behaviors did you practice?(Check all that apply)
☐Anal sex (bottom)
☐Anal sex (top) ☐Oral sex (give)

☐Oral sex (receive)

Please sign acknowledging that you received your $30 Visa® credit gift card.
_________________________________________
Participant'sPseudonym Signature
_________________________________________
Interviewer's Signature

____________________
Date
____________________
Date
END OF DEMOGRAPHIC FORM
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Appendix N: Inductive Content Analysis Process
The following details the three-phase process of inductive content analysis according to Elo and
Kygnas (2008).
I.

Preparation
1. Read through the transcribed narratives several times to acquire a feeling and
understanding of the main ideas
2. Select the unit of analysis, either a word or theme, that emerges from the narrative
3. Make sense of the data by asking: Who, what, where, when, and why regarding
the content

II.

Organizing
1. Begin open coding by writing notes and headings (that describe all aspects of the
content) while reading through the narratives
2. The open coding process is repeated until as many as necessary headings are
written down
3. The headings are transferred to coding sheets, and the headings are grouped into
broader and more abstract categories
4. Abstraction follows which is naming each category using content related words
5. Perform peer checking with oversight research committee throughout this process

III.

Reporting
1. To enhance trustworthiness, detail the content analysis process clearly and
sufficiently
2. To improve reliability, explain the link between the data and results
3. Use actual participants’ phrases and statements to show authenticity

MSM'S PREP INITIATION DECISION-MAKING PROCESSES

197

Appendix O: Study Recruitment Sites
Clinic Name
Birmingham AIDS Outreach
The 1917 Clinic at UAB
Medical Advocacy & Outreach
Five Horizons Health Services
AID Atlanta
Empowerment Resource Center
CrescentCare Health & Wellness Center
Someone Cares Atlanta

City, State
Birmingham, AL
Birmingham, AL
Montgomery, AL
Tuscaloosa, AL
Atlanta, GA
Atlanta, GA
New Orleans, LA
Marietta, GA

Date Flyers Received
6/4/2018
3/20/2018
3/19/2018
3/15/2018
4/27/2018
5/24/2018
5/11/2018
6/5/2018

